CANCEROPTION COM INC
10SB12G, 2000-01-05
BUSINESS SERVICES, NEC
Previous: ON LINE PRODUCTION SERVICES INC, 10SB12G/A, 2000-01-05
Next: SATYAM INFOWAY LTD, 6-K, 2000-01-05




                                   FORM 10-SB
          GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL BUSINESS
           ISSUERS PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             CancerOption.com, Inc.
             (Exact name of registrant as specified in its charter)


FLORIDA                                                    65-0744370
- -------                                                    ----------
(State or other jurisdiction of                            (I.R.S. Employer
incorporation or organization)                             Identification No.)



          7332 E. Butherus Drive, Suite 101, Scottsdale, Arizona 85260
          ------------------------------------------------------------
          (Address of principal executive offices)          (Zip Code)


       Registrant's telephone number, including area code: (480) 991-8080

     Securities to be registered pursuant to Section 12(b) of the Act: None

        Securities to be registered pursuant to Section 12(g) of the Act:

                       100,000,000 Shares of Common Stock



<PAGE>

<TABLE>
<CAPTION>
<S>                                                                       <C>


                                TABLE OF CONTENTS



                                                                          Page
COVER  PAGE                                                                    1

TABLE OF CONTENTS                                                              2

PART  I                                                                        3

DESCRIPTION OF  BUSINESS                                                       3

DESCRIPTION OF PROPERTY                                                        5

DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES                        5

REMUNERATION OF DIRECTORS AND OFFICERS                                         6

SECURITY OWNERSHIP OF MANAGEMENT AND
CERTAIN SECURITY HOLDERS                                                       6

INTEREST OF MANAGEMENT AND OTHERS IN
CERTAIN TRANSACTIONS                                                           7

SECURITIES BEING OFFERED                                                       7

PART II                                                                        8

MARKET PRICE OF AND DIVIDENDS ON THE REGISTRANT'S
COMMON EQUITY AND OTHER STOCKHOLDER  MATTERS                                   8

LEGAL  PROCEEDINGS                                                             8

CHANGES IN AND DISAGREEMENTS WITH  ACCOUNTANTS                                 9

RECENT SALES OF UNREGISTERED SECURITIES                                        9

INDEMNIFICATION OF DIRECTORS AND  OFFICERS                                     9

PART   F/S                                                                     9

FINANCIAL STATEMENTS                                                           9

PART III                                                                      10

INDEX TO EXHIBITS                                                             10

SIGNATURES                                                                    10
</TABLE>




                                       2
<PAGE>

                                     PART I

The issuer has elected to follow Form 10-SB, Disclosure Alternative 2.

ITEM 6.  DESCRIPTION OF BUSINESS

     CancerOption.com, Inc., (The Company) is a developmental stage company. The
Company  was  incorporated  in  Florida,  on April  17,  1997  under the name of
Pantheon Technologies,  Inc. with an authorized capital of 100,000,000 shares of
common  stock  with a par  value of $.001  per  share  and  1,000,000  shares of
preferred  stock with a par value of $0.0001 per share.  The Company's  name was
changed to  CancerOption.com,  Inc., at a Special  Shareholders meeting on April
23, 1999.

     CancerOption.com, Inc., has an online web site (www.CancerOption.com), that
provides educational  information on different forms of cancer being researched,
targeting  specific  cancers with  guidelines and products for  alternative  and
adjunctive  therapies.  These therapies include a recommended diet,  nutritional
supplements, lifestyle maintenance and post remission regimens.

     CancerOption.com, Inc., also features the latest research and statistics on
cancer  treatments  and  immunological   disorders  including   traditional  and
alternative  therapies.  The  Company  provides  links with  cancer  clinics and
physicians. The Company provides links to web sites and medical universities for
educational  purposes.  The  Company  also  provides  books on  cancer,  health,
immunological  disorders and general  health,  an online  newsletter and various
products related to cancer treatments.

     The Company has  developed a plan to provide its  information,  nutritional
supplements and other products for sale through the Internet.  The products will
be  distributed  from the Company's  principal  place of business in Scottsdale,
Arizona  to  the  customer.  The  Company  expects  to be  selling  to  doctors,
hospitals, special clinics and health care facilities.

         A partial list of the Company's products follows:
<TABLE>
<CAPTION>


Product                                        Description
- -------                                        -----------
<S>                                            <C>

1.   AngioSharkOption                          a pure liquid  shark  cartilage  extract that retards the body producing vascular and
                                               capillary  network,  by reducing the blood flow it reduces cancer growth;

2. Beta Glucan CAOP                            a macrophage phagocyte, which activates the white blood cells to fight foreign
                                               viral, bacterial, fungal and parasitic invaders;

3. FlorPlusOption                              restores nine natural bacteria in the intestine and colon, which fight parasitic
                                               fungus;

4. ImmuneEssential CAOP                        an ozonated geranium flower oil, which enhances the production of white blood
                                               cells;

5. ImmuneOption                                fifty (50) herbs that decrease oxidative damage, promote liver detoxification, the
                                               supplement contains antioxidants that retard oxidation and support the digestive
                                               system;

6. ImuPlus                                     a pre-digested protein that decreases enzymes;

7. ModifiedCitrusOption                        pectin from apples and other fruits making it rich with carbohydrates;

8. OliveLeafOption                             a concentrated extract from the olive plant, which inhibits viral replication;

</TABLE>


                                       3
<PAGE>
<TABLE>
<CAPTION>
<S>                                            <C>

9. ProsCareOption                              mixture of natural substances, including saw palmetto, which suppress the
                                               conversion of testosterone to dihydrotestosterone, which can cause the enlargement
                                               of the prostate glands;

10. SoyOption                                  genistein and isoflavones derived from soybeans, which reduce menopause and
                                               PMS symptoms;

11. ThymusOption                               derived from lamb, it increases the production of thymus cells (T-cells);

12. Vita-C Option                              corn-free, buffered vitamin C, calcium, magnesium and potassium, enhancing the
                                               functioning of white blood cells and natural killer of cell activity, it also aids in
                                               detoxification of the body and liver;

13. EnzymeOption                               porcine pancreatic concentrate that increases enzymes in the system to support
                                               digestive function.
</TABLE>


     The products are available for sale currently but will begin being marketed
in the late fourth quarter of 1999, through the Internet. The Company applied in
July,  1999, with the patent and trademark  office to register and trademark its
name and logo as well as the  names of the  nutritional  supplements  as  listed
above.

     The supplements are manufactured  and formulated by Immune  Nutraceuticals,
Inc. in Reno, Nevada. There is no contract between Immune Neutraceuticals,  Inc.
and the Company.

     The Company does not require any governmental  approval for the educational
and research  information  to be carried on the Company web site. The Company is
not  subject to any type of  compliance  as set out by the FDA under the Dietary
Supplement Health and Education Act (DSHEA) to sell its nutritional  supplement.
The Company is required  to show the  content  and dosage  required  for a daily
serving on each supplement sold, which it does.

     The Company's business model does not face any type of environmental  issue
federal, state or local.

     The Company will be competing  with other consumer  health related  portals
that offer both general and specialized health information.  The competition for
traffic on web sites is highly  competitive  and the Company  will be  competing
with  highly  visible  and  recognized  web sites that  contain  general  health
information. A partial list follows of general health sites:

1. www.WebMd.com;
2. www.Healtheon.com;
3. www.Adam.com;
4. www.Onhealth.com; and
5. www.Drkoop.com.

     The following sites have cancer specific information:

1. www.Cancerfacts.com;
2. www.Oncolink.com;
3. www.Cancer.org;
4. www.asco.org;
5. www.Nih.gov;
6. www.Cancerguide.org;
7. www.cancereducation.com; and
8. www.911Cancer.com.

     These  sites have been in  existence  for some time and have been  branding
their names on the World Wide Web.




                                       4
<PAGE>

    CancerOption.com,  Inc., has generated  minimal revenues from operations to
date. The Company does anticipate  additional revenues during the fourth quarter
of 1999.  The  Company's  present  efforts are to: (1)  develop the  educational
research and  nutritional  supplements,  (2) develop its market,  and (3) obtain
sufficient capital to commence full operations.

     In  the  last  two  fiscal  years,  the  Company's  cost  of  research  and
development of an Internet related business has been approximately  $400,000.00.
All of these expenses have been borne by the Company  through its  shareholders,
who  provided  the  funding for equity.  The Company has  sufficient  capital to
enable it to operate at its normal  capacity for the next  eighteen (18) months.


     The Company  currently has two full time employees for web page development
and technical support. The Company also has three officers. The Company plans to
subcontract  to outside  sources for marketing  and investor  relations and will
hire staff for technical  support,  sales,  warehousing,  accounting and related
functions as funding  permits.  The Company will continue to provide research on
cancer,  additional proprietary protocols for various other forms of cancers and
create new  formulations  of nutritional  supplements.  The Company will require
additional space for warehousing and offices as the sale of products increase.

     The Company's  portal computer  servers,  including  hardware and software,
utilize the date format specified in the underlying  operating system of Windows
NT and,  as a  result,  are fully  Year 2000  compliant.  The  Company  does not
anticipate  any Year  2000  issues  to  arise,  nor will  there be any  expenses
required in order to resolve Year 2000 issues. The Company has not contacted any
vendors or third parties to determine year 2000 compliance.

ITEM 7. DESCRIPTION OF PROPERTY:

     The  Company's  principal  place of business is located at 7332 E. Butherus
Drive,  Suite 101,  Scottsdale,  Arizona  85260.  The  Company has no other real
property interests.

     The Company's  principal office is approximately 1500 sq. ft. and the lease
rate is $2,690 per month,  with an escalation  clause each year.  The Company is
subleasing  it's office from Thor Equity Group for three years and which expires
on April 1, 2001.  The  Company  has an option to renew this lease for a term of
three  additional  years.  The  office  is  eight  years  old  and in  excellent
condition.  The contemplated  additional office space is approximately 1,000 sq.
ft., and the monthly  rent has not been  determined  at this time.  There are no
plans in place for renovation or improvement of the offices. The Company carries
adequate insurance coverage for the office's contents and equipment.

     The Company's principal office is used for corporate  development and other
matters  relating to the  development of the Company web site and services.  The
contemplated  additional  office space would be  primarily  used for storage and
shipping it's nutritional  supplements.  The Company does not own any properties
currently and there are no mortgages or loans outstanding.

     The Company does not have any policies in place regarding  investments made
by the Company but may elect to adopt such policies in the future.

ITEM 8. DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES:

     The  following  information  sets  forth  the  names  of the  officers  and
directors  of  the  Company,  their  present  positions  with  the  Company  and
biographical information.

ARNOLD TAKEMOTO (Age 55) President,  Chief Executive  Officer and Director.  Mr.
Takemoto has been President, Chief Executive Officer and Director from March 22,
1999 to the present and his term as director  will expire June 3, 2000.  He will
remain as Chief  Executive  Officer at the discretion of the Board of Directors.
Mr.  Takemoto  has  been  involved  in  his  own  private  consulting   business
specializing in immunological  disorders from 1992 to the present.  He developed
the detailed protocols that are within the CancerOption.com's portal.

MICHAEL QUEL, CPA. (Age 42). Chief Financial Officer and Director.  Mr. Quel has
been a director and officer



                                       5
<PAGE>

since April 27, 1999 and his term as director will expire June 3, 2000. Mr. Quel
has been a certified Public  Accountant since 1983 working for Go Daddy Software
from  2/99  to the  present;  he  also  acted  as an  accountant  for  Community
Association  Management from 4/96 to 2/99 and his own private business from 9/91
to 5/96.

DOUGLAS  BRODIE,  MD. (Age 74).  Director.  Dr. Brodie has been a Director since
April 6, 1999.  Dr. Brodie has had his own practice in Reno,  Nevada since 1982,
providing  cancer  patients with  alternative  methods of supporting  the immune
system along with traditional  protocols.  Dr. Brodie authored the book, "Cancer
and Common Sense - Combining  Science and Nature to Control  Cancer," which is a
guide to alternative treatment of cancer and degenerative  diseases.  Dr. Brodie
also co-authored a portion of the book "An Alternative Medicine Definitive Guide
to Cancer" by Burton Goldberg.

     There are no relations between the Directors and Officers of the Company.

ITEM 9.  REMUNERATION  OF DIRECTORS  AND OFFICERS:

     The  following  table sets forth  certain  information  as to the Company's
officers and directors for the fiscal year ending  December 31, 1998 and for the
fiscal year which will end on December 31, 1999. No other  compensation was paid
or will be paid to any such officers other than the cash  compensation set forth
below.


SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
<S>               <C>      <C>      <C>    <C>                <C>            <C>            <C>      <C>       <C>
                                                                              Long Term
Annual Compensation                                                          Compensation
                                            Other             Restricted        Options/             LTIP      Other

Name & Title      Year     Salary   Bonus   Annual Comp       Stock Award(s)    SARs (#)    Pay-Outs   Comp
- ------------      ----     ------   -----   -----------       --------------    --------    --------   ----

Arnold Takemoto   1998       0        0      0                    0              0              0         0
President, CEO,   1999       0        0    $ 25,769.10*           5,000,000      350,000        0         0
& Director
*Lease payments for vehicle paid in full from April, 1999 to April, 2001.

Michael Quel,     1998       0        0      0                    0              0              0         0
CFO & Director    1999       0        0      0                    0              100,000

Dr. Douglas       1998       0        0      0                    0              0              0         0
Brodie, Director  1999       0        0      0                    0              100,000        0         0

</TABLE>


     In fiscal 1998, the aggregate amount of compensation  paid to all executive
officers and  directors as a group for  services in all  capacities  was nil. In
fiscal 1999, the aggregate amount of compensation paid to all executive officers
and directors as a group for services in all  capacities  will be  approximately
$25,769.10.  No  additional  monies are  expected  to be paid to  Directors  and
Officers in 1999.

ITEM 10.  SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITY HOLDERS

     The  following  table sets forth,  as of August 23,  1999,  the  beneficial
ownership of the  Company's  Common Stock by each person known by the Company to
beneficially  own more than 5% of the Company's  Common Stock  outstanding as of
such date and by the officers and directors of the Company as a group. Except as
otherwise indicated, all shares are owned directly.


- --------------------------------------------------------------------------------
(1)                               (2)              (3)                       (4)



                                       6
<PAGE>

<TABLE>
<CAPTION>
<S>                                 <C>                                <C>                       <C>

Title of Class                      Name and Address of                Amount and Nature         Percent
                                    Of Beneficial Owner                of Ownership              of Class
- ------------------------------------------------------------------------------------------------------------------------------------
Common                              Arnold Takemoto                    5,000,000                   51.1%
                                    8300 N. Hayden Rd, Suite A203        350,000  Options
                                    Scottsdale, Arizona 85260

Common                              Michael Quel                               0                    0%
                                    7332 E. Butherus Dr., Suite 101      100,000  Options
                                    Scottsdale, Arizona 85260

Common                              Dr. Douglas Brodie                         0                    0%
                                    7332 E. Butherus Dr., Suite 101      100,000  Options
                                    Scottsdale, Arizona 85260
___________________________________________________________________________________________
TOTAL                               Directors and Officers as a        5,000,000  Shares
                                    Group (3 persons)                    550,000  Options
___________________________________________________________________________________________
</TABLE>
<TABLE>
<CAPTION>
<S>                        <C>              <C>               <C>                       <C>


         The following table sets forth details of the stock options listed above:

- ------------------------------------------------------------------------------------------------------------------------------------
(1)                        (2)              (3)               (4)                       (5)
Name                       Options          Strike Price      Vesting Period            % of Shares Vesting
                                                              As of June 4, 1999
- ------------------------------------------------------------------------------------------------------------------------------------
Arnold Takemoto            350,000          $5.00             10 years                  20% per year

Michael Quel               100,000          $5.00             10 years                  20% per year

Dr. Douglas Brodie         100,000          $5.00             10 years                  20% per year
</TABLE>


ITEM 11.  INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS

     No officer or director of the Company has had an interest in any  corporate
transaction.


ITEM 12.  SECURITIES BEING OFFERED

Common Stock

     The Company has 100,000,000 common shares authorized with $0.001 par value.
Holders of the Common Stock are entitled to one vote for each share held by them
of record  on the  books of the  Company  in all  matters  to be voted on by the
stockholders.  Holders of Common Stock are entitled to receive such dividends as
may be declared from time to time by the Board of Directors out of funds legally
available,  and in the event of  liquidation,  dissolution  or winding up of the
Company,  to share ratably in all assets remaining after payment of liabilities.
Declaration  of dividends on Common  Stock is subject to the  discretion  of the
Board of  Directors  and will  depend upon a number of  factors,  including  the
future earnings, capital requirements and financial condition of the Company.

     The Company has not declared  dividends on its Common Stock in the past and
the management  currently  anticipates  that retained  earnings,  if any, in the
future will be applied to the expansion and  development  of the Company  rather
than the payment of dividends.

                                       7




<PAGE>
    The holders of Common Stock have no preemptive or conversion rights and are
not  subject  to  further  calls or  assessments  by the  Company.  There are no
redemption or sinking fund provisions applicable to the Common Stock. The Common
Stock  currently  outstanding  is, and the Common  Stock  offered by the Company
hereby will, when issued, be validly issued, fully paid and non-assessable.

Stock Options

     The Company has 1,000,000  shares reserved under its 1999 Stock Option Plan
for  issuance at $5.00 per share until  December  31, 2003.  The  optionees  and
number of options issued thus far are as follows:
<TABLE>
<CAPTION>
<S>                                 <C>

Arnold Takemoto                     350,000
Michael Quel                        100,000
Dr. Douglas Brodie                  100,000
Wendy Appleyard                      50,000
Corrine Wade                         50,000
Kris Strachan                        10,000
</TABLE>



                                     PART II

ITEM 1. MARKET PRICE OF AND  DIVIDENDS  ON THE  REGISTRANT'S  COMMON  EQUITY AND
OTHER STOCKHOLDER MATTERS

     The  shares of the  Company's  stock are traded on the OTC  Bulletin  Board
under the symbol  CAOP and the  following  have been the High and Low prices for
the times indicated:

<TABLE>
<CAPTION>
<S>                                                  <C>                   <C>
                                                     High                   Low
August - September 30, 1999                          $4.24                 $3.24
April - June 28, 1999                                $3.75                 $1.75
January - March 1999                                 $2.37                 $0.37
October - December 1998                              $0.50                 $0.28
</TABLE>

     There are 2,000,000 share purchase warrants  exercisable at $0.05 per share
until September 18th, 2001, and 166,600 share purchase  warrants  exercisable at
$0.65  per share  until  March 1,  2003.  Other  than  stock  options  currently
outstanding, there are no other convertible securities.

     As of April 27, 1999, there were twenty-three (23) registered  shareholders
of the Company.  Cede and Company is one of the registered shareholders and  are
holding shares on behalf of other shareholders in nominee form.

     There are no dividend  restrictions on the Company.  Market makers who have
posted bids or offers during the period April 1996 to April 1999 are as follows:
William V. Frankel & Co.  Incorporated,  Hill Thompson Magid & Co. Inc., Paragon
Capital Corporation and Sharpe Capital, Inc.

     As of July 31,  1999,  the Company  had  9,789,200  shares of common  stock
issued  and  outstanding,  of which  there  are  5,000,000  shares  owned by the
Directors and Officers of the Company.  The Company also has  1,000,000  Options
granted under its 1999 Stock Option Plan, no options have been exercised.

     There have been no cash dividends declared in the past two fiscal years.

ITEM 2. LEGAL PROCEEDINGS

     There  are  no  legal  proceedings   pending  or  threatened   against  the
Corporation.


                                       8
<PAGE>





ITEM 3. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS

     At the Company's 1999 Annual General Meeting,  held June 4, 1999, the Board
of Directors  approved and the  Shareholders  voted to change the auditors  from
Clancy & Co.,  to  Berenfeld,  Spritzer,  Shechter & Sheer,  an  auditor  who is
familiar  with  Internet  related  startup  businesses.  The new  auditors  were
appointed  on July 13, 1999 for the 1999 fiscal year ending  December  31, 1999.
There have been no  disagreements  with accountants and the change was only made
for convenience sake.

ITEM 4. RECENT SALES OF UNREGISTERED SECURITIES

     On June 1, 1997,  the Company in  connection  with a Rule 504  Regulation D
Offering  issued  200,000  shares of common stock for cash at $0.25 per share or
$50,000 less  expenses of the  offering of $5,500,  for net proceeds of $44,500.
These shares were issued to one hundred and four (104) non-accredited investors.
The  proceeds of this  offering  were used for initial  development  of Internet
related products and services.

     During September 1998, the Company in connection with a Rule 504 Regulation
D Offering issued  2,000,000 shares at $0.05 per share or $100,000 less expenses
of the offering of $3,500, for net proceeds of $96,500, this offering included a
warrant  exercisable into common stock at $0.05 per share expiring September 18,
2001.  These  shares were sold to sixteen  (16)  non-accredited  investors.  The
proceeds  from  this  offering  were used for  exploration  and  development  of
Internet products and services.  As of this date no warrants have been exercised
and 2,000,000 warrants are outstanding from this offering.

     On October 13, 1998, the Company in connection  with an Investor  Relations
Agreement with Thor Equity for the issuance of 100,000 restricted shares.  These
shares are scheduled to be issued on October 13, 1999.

     On March 1, 1999,  the Company in connection  with a Rule 504  Regulation D
offering,  issued  166,600 shares of common stock at $0.60 per share for cash of
$100,000 less  expenses of the offering of $3,500,  for net proceeds of $96,500.
This  offering  included a warrant  exercisable  into common  stock at $0.65 per
share up to March 1,  2003.  These  shares  were sold to one (1)  non-accredited
investor.  The proceeds from this offering were used for the  development of the
Company's  Internet site and working  capital.  As of this date no warrants have
been exercised and 166,600 warrants are outstanding from this offering.

     In March 1999, the Company  issued  3,000,000  shares of restricted  common
stock at $0.001 per share for services to Mr. Arnold  Takemoto,  President,  CEO
and Director of the Company.

     Also in March  1999,  the Company  issued  2,000,000  shares of  restricted
common  stock at $0.001  per share for  services  to Mr.  Roger  Wist,  a former
Director of the Company.

     On August 2, 1999, Mr. Roger Wist resigned as Director and Officer from the
Company Board for personal reasons.  The 2,000,000 restricted shares held by Mr.
Wist were transferred to Mr. Arnold Takemoto, the President, CEO and Director of
the Company.

     On August 18, 1999, the Company in connection  with a Rule 504 Regulation D
Offering,  authorized the sale of 128,000  restricted  shares at $2.50 per share
for a total of $320,000.00 Each share carried a Warrant at a conversion price of
$2.35 per share  expiring  August  18,  2002.  All the  shares  were sold to two
accredited investors.

ITEM 5. INDEMNIFICATION OF DIRECTORS AND OFFICERS

     The Directors and Officers, their heirs, executors, and administrators,  of
the Company are indemnified as provided under the Florida  Statutes and pursuant
to the Bylaws of the Company. This indemnification, as described in Article VII,
Section  1 of  the  Bylaws,  includes  "as  authorized  by  current  and  future
legislation  or  judicial  or   administrative   decision   against  all  fines,
liabilities, costs and expenses, including attorneys' fees."






                                       9
<PAGE>

                              FINANCIAL STATEMENTS

     The Company's audited Financial Statements are attached hereto.

                          PANTHEON TECHNOLOGIES, INC.
                              Scottsdale, Arizona

                                  AUDIT REPORT

                           DECEMBER 31,1998 AND 1997

                                    CONTENTS

Independent Auditors' Report                                                 F-3

Balance Sheet at December 31, 1998 and 1997                                  F-4

Statement of Operations For The Year Ended December 31, 1998, For The
   Period From Inception (April 17, 1997) To December 31, 1997, and For
   The Period From Inception (April 17, 1997) To December 31, 1998           F-5

Statement of Stockholders' Equity From Inception (April 17, 1997) To
   December 31, 1998                                                         F-6

Statement of Cash Flows For The Year Ended December 31, 1998, For The
   Period From Inception (April 17, 1997) To December 31, 1997, and For
   The Period From Inception (April 17, 1997) To December 31, 1998         F-7,8

Notes to the Financial Statements                                   F-9,10,11,12

All  schedules  are omitted  because  they are not  applicable  or the  required
information is shown in the financial statements or notes thereto.

                                      F-1
<PAGE>

                              FINANCIAL STATEMENTS

         The Company's audited Financial Statements are attached hereto.

                             CANCEROPTION.COM, INC.
                               Scottsdale, Arizona

                                  AUDIT REPORT

                           SEPTEMBER 30,1999 AND 1998

                                    CONTENTS


Balance Sheet at September 30, 1999 and December 31, 1998                   F-13

Statement of Operations For The Nine Month Period Ended September 30, 1999,
   and 1998                                                                 F-14

Statement of Stockholders' Equity From Inception (April 17, 1997) To
   September 30, 1999                                                       F-15

Statement of Cash Flows For The Nine Month Period Ended September 30, 1999 and
   1998, and From Inception (April 17, 1997) To September 30, 1999       F-16,17

Notes to the Financial Statements
   September 30, 1999 and 1998                                              F-18

All  schedules  are omitted  because  they are not  applicable  or the  required
information is shown in the financial statements or notes thereto.


                                      F-2

<PAGE>

CLANCY AND CO., P.L.L.C.
CERTIFIED PUBLIC ACCOUNTANTS

26TH PLACE                                             PHONE: (602) 266-2646
2601 E. THOMAS RD.                                     FAX:   (602) 224-9496
SUITE 110                                              EMAIL: [email protected]
PHOENIX, AZ 85016


                          INDEPENDENT AUDITORS'REPORT

Board of Directors
Pantheon Technologies, Inc.
Scottsdale, Arizona 85260

We have audited the accompanying balance sheet of Pantheon Technologies, Inc. (A
Development Stage Company),  (the Company), as of December 31, 1998 and 1997 and
the related  statements of operations,  stockholders'  equity and cash flows for
the year ended December 31, 1998, for the period from Inception (April 17, 1997)
to December  31, 1997,  and for the period from  Inception  (April  17,.1997) to
December 31, 1998.  These  financial  statements are the  responsibility  of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards  require that we plan and perform the audit to obtain reasonable
assurance   about  whether  the  financial   statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe  that our audit of the  financial  statements  provides a  reasonable
basis for our opinion.

In our  opinion,  the  financial  statements  present  fairly,  in all  material
respects,  the  financial  position of the Company at December 31, 1998 and 1997
and the results of its operations and its cash flows for the years then ended in
conformity with generally accepted accounting principles.

The accompanying  financial  statements have been prepared  assuming the Company
will  continue  as a going  concern.  As  discussed  in Note I to the  financial
statements, the Company is a development stage Company since its inception April
17, 1997.  Realization  of a major  portion of the assets is dependent  upon the
Company's ability to meet its future financing requirements,  and the success of
future  operations.  These factors raise  substantial doubt about its ability to
continue  as a going  concern.  The  financial  statements  do not  include  any
adjustments that might result from the outcome of this uncertainty.

Clancy and Co., P.L.L.C.
Phoenix, Arizona
April 30, 1999

                                      F-3
<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                                  BALANCE SHEET
                           DECEMBER 31, 1998 AND 1997

<TABLE>
<CAPTION>
                                                            1998         1997
<S>                                                         <C>          <C>
ASSETS

Current Assets
        Cash                                                $    244     $   2,732

        Accounts Receivable                                        0        12,000
        Stock Subscription Receivable (Note 3)                50,500             0
Total Current Assets                                          50,744        14,732
Total Assets                                                $ 50,744     $  14,732

LIABILITIES AND STOCKHOLDERS'EQUITY

Current Liabilities Accrued Expenses                        $    75O     $    None

Stockholders' Equity
  Common Stock: $0.001 Par Value, 100,000,000 Shares
  Authorized; Issued and Outstanding, 5,200,000 and
  3,200,000 Shares at December 31, 1998 and 1997               5,200         3,200

Additional Paid In Capital                                   147,800        49,800
Loss Accumulated During The Development Stage               (103,006)      (38,268)
Total Stockholders' Equity                                    49,994        14,732
Total Liabilities and Stockholders' Equity                  $ 50,744     $  14,732

</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-4

<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                            STATEMENT OF OPERATIONS
              FOR THE YEAR ENDED DECEMBER 31,1998, FOR THE PERIOD
        FROM INCEPTION (APRIL 17,1997) TO DECEMBER 31,1997, AND FOR THE
           PERIOD FROM INCEPTION (APRIL 17,1997) TO DECEMBER 31,1998

<TABLE>
<CAPTION>

                                                                        For The Period   For The Period
                                                                        From Inception   From Inception
                                                  For The Year            (April 17,       (April 17,
                                                  Ended                   1997) To         1997) To
                                                  December 31,            December 31,     December 31,
                                                  1998                    1997             1998
<S>                                               <C>                     <C>              <C>
Revenues                                          $    3,500              $   12,000       $   15,500

Expenses
  General and Administrative                          68,273                  51,081          119,354
Operating Loss                                       (64,773)                (39,081)        (103,854)

Other Income
  Interest Income                                         35                     813              848
                                                          --                     ---              ---
Net Loss                                          $  (64,738)                (38,268)        (103,006)

Net Loss Per Weighted Share of
  Common Stock                                    $    (0.02)             $    (0.02)      $    (0.03)

Weighted Shares of Common Stock and
Common Stock Equivalents Outstanding               3,866,666               2,350,000        3,866,666
                                                   ---------               ---------        ---------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-5

<PAGE>

                           PANTHEON TECHNOLOGIES, INC.
                          (A Development Stage Company)
                        STATEMENT OF STOCKHOLDERS'EQUITY
                 FOR THE PERIOD FROM INCEPTION (APRIL 17,1997)
                              TO DECEMBER 31, 1998

<TABLE>
<CAPTION>

                                                                                               Loss
                                                                                               Accumulated
                                                                              Additional       During the
                                                       Common     Stock       Paid In          Development
                                                       Shares     Amount      Capital          Stage               Total
<S>                                                    <C>        <C>         <C>              <C>                 <C>
Issuance of Common Stock For Services
   Rendered at $.001 per Share as of
   April 17, 1997                                      3,000,000  $ 3,000     $                $                   $  3,000
Issuance of Common Stock For Cash at
   $.25 Per Share                                        200,000      200       49,800                               50,000

Loss From Inception (April 17, 1997)
   To December 31, 1997                                                                          (38,268)           (38,268)

Balance, December 31, 1997                             3,200,000    3,200       49,800           (38,268)            14,732

Issuance of Common Stock For Cash at
   $.05 Per Share                                      2,000,000    2,000       98,000                              100,000

Loss, Year Ended December 31, 1998                                                               (64,738)           (64,738)

Balance, December 31, 1998                             5,200,000    5,200      147,800          (103,006)            49,994
                                                       ---------    -----      -------          ---------            ------
</TABLE>

The accompanying notes are an integral part of these financial statements.

                                      F-6

<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                            STATEMENT OF CASH FLOWS
              FOR THE YEAR ENDED DECEMBER 31,1998, FOR THE PERIOD
        FROM INCEPTION (APRIL 17,1997) TO DECEMBER 31,1997, AND FOR THE
           PERIOD FROM INCEPTION (APRIL 17,1997) TO DECEMBER 31,1998

<TABLE>
<CAPTION>

                                                                         For The Period     For The Period
                                                                         From Inception     From Inception
                                                                         --------------     --------------
                                                       For The Year        (April 17,          (April 17,
                                                       Ended                1997) To            1997) To
                                                       December 31,         December 31,        December 31,
                                                       1998                 1997                1998
                                                       ----                 ----                ----
<S>                                                    <C>                  <C>                 <C>
Cash Flows From Operating Activities
   Net Loss                                            $   (64,738)         $    (38,268)       $  (103,006)
   Adjustments to Reconcile Net Loss to Net
      Cash Used In Operating Activities

   Common Stock Issued for Services                              0                 3,000              3,000
   Write-off of Bad Debt Expense                            12,000                     0             12,000
   Changes in Assets and Liabilities
   (Increase) Decrease in Accounts Receivable                    0               (12,000)           (12,000)
   (Increase) Decrease in Stock Subscription
      Receivable                                           (50,500)                    0            (50,500)
    Increase (Decrease) in Accrued Expenses                    750                     0                750
                                                               ---                     -                ---
Total Adjustments                                          (37,750)               (9,000)           (46,750)
Net Cash Used In Operating Activities                     (102,488)              (47,268)          (149,756)

Cash Flows From Investing Activities                             0                     0                  0
Net Cash Flows From Investing Activities                         0                     0                  0

Cash Flows From Financing Activities
  Proceeds From Sale of Common Stock                       100,000                50,000            150,000
Net Cash Provided By Financing Activities                  100,000                50,000            150,000

Increase (Decrease) In Cash and Cash Equivalents            (2,488)                2,732                244

Cash and Cash Equivalents, Beginning of Year                 2,732                     0                  0

Cash and Cash Equivalents, End of Year                 $       244          $      2,732         $      244

</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-7


<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                            STATEMENT OF CASH FLOWS
              FOR THE YEAR ENDED DECEMBER 31,1998, FOR THE PERIOD
        FROM INCEPTION (APRIL 17,1997) TO DECEMBER 31,1997, AND FOR THE
           PERIOD FROM INCEPTION (APRIL 17,1997) TO DECEMBER 31,1998

<TABLE>
<CAPTION>

                                                                       For The Period    For The Period
                                                                       From Inception    From Inception
                                                                       --------------    --------------
                                                  For The Year             (April 17,      (April 17,
                                                  Ended                     1997) To        1997) To
                                                  December 31,              December 31,    December 31,
                                                  1998                      1997            1998
                                                  ----                      ----            ----
<S>                                               <C>                       <C>             <C>
Supplemental Information:
Cash Paid For:
     Interest                                     $     0                   $     0         $     0

     Income taxes                                 $     0                   $     0         $     0

Noncash Financing Activities:
  Common Stock Issued For Services                $     0                   $ 3,000         $ 3,000

</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-8


<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                       NOTES TO THE FINANCIAL STATEMENTS
                           DECEMBER 31,1998 AND 1997

NOTE 1 - ORGANIZATION
- ---------------------

Pantheon Technologies, Inc. (the Company) was incorporated under the laws of the
State of Florida on April 17, 1997,  with an authorized  capital of  100,000,000
shares of common  stock  with a par value of one mil  ($0.001)  per  share.  The
Company is engaged in the development of Internet related products and services.

On April 17,  1997,  the Company  issued  3,000,000  shares of common  stock for
services rendered at $0.001, or $3,000.

On July 31,  1997,  the Company  completed  an Offering  Memorandum  for 200,000
shares of common stock for cash at $0.25 per share, or $50,000.

On  September  21,  1998,  the  Company  completed  an Offering  Memorandum  for
2,000,000  shares of common stock for cash at $.05 per share, or $100,000.  Each
share has a warrant attached  entitling the holder to acquire  additional common
stop at $0.05 per share until September 18, 2001.

The  financial  statements  have  been  prepared  on  the  basis  of  accounting
principles  applicable to a going concern.  Accordingly,  they do not purport to
give effect to adjustments,  if any, that may be necessary should the Company be
unable to  continue as a going  concern.  The  continuation  of the Company as a
going concern,  is dependent upon the Company's ability to establish itself as a
profitable business. The Company's ability to achieve these objectives cannot be
determined  at this time.  It is the  Company's  belief that it will continue to
incur  losses  for at least the next 12  months,  and as a result  will  require
additional  funds to be obtained  from private or public equity  investments  to
meet such needs.

NOTE 2- SIGNIFICANT ACCOUNTING POLICIES
- ---------------------------------------

A. Accounting Method
- --------------------

The Company's  financial  statements  are prepared  using the accrual  method of
accounting.

B. Revenue Recognition
- ----------------------

Revenues are primarily recognized as products are shipped and services rendered.
Accounts receivable are shown net of allowance for doubtful accounts,  which are
estimated as a percent of accounts receivable and sales, respectively,  based on
prior years experience.

                                      F-9


<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                       NOTES TO THE FINANCIAL STATEMENTS
                           DECEMBER 31,1998 AND 1997

NOTE 2- SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
- ---------------------------------------------------

C.Cash and Cash Equivalents
- ---------------------------

The Company  considers  all highly  liquid debt  instruments  with a maturity of
three months or less to be cash and cash equivalents.

D. Use of Estimates
- -------------------

Management uses estimates and assumptions in preparing  financial  statements in
accordance with generally accepted  accounting  principles.  Those estimates and
assumptions  affect  the  reported  amounts  of  assets  and  liabilities,   the
disclosure of contingent  assets and liabilities,  and the reported revenues and
expenses.  Actual  results  could vary from the  estimates  that were assumed in
preparing the financial statements.

E. Income Taxes
- ---------------

The Company  accounts  for income  taxes under the  provisions  of  Statement of
Financial  Accounting Standards ("SFAS") No. 109, "Accounting for Income Taxes."
Under SFAS No. 109,  deferred tax liabilities and assets are determined based on
the  difference  between  the  financial  statement  and tax bases of assets and
liabilities,  using  enacted  tax  rates in  effect  for the  year in which  the
differences are expected to reverse. See Note 4.

F. Earnings or Loss Per Share
- -----------------------------

Basic earnings or loss per share has been computed based on the weighted average
number of common shares and common share equivalents  outstanding.  All earnings
or loss per share amounts in the financial statements are basic earnings or loss
per share, as defined by SFAS No. 128, "Earnings Per Share." Diluted earnings or
loss per share does not differ  materially from basic earnings or loss per share
for all  periods  presented.  The number of shares  used in  computing  earnings
(loss)  per  common  share at  December 3 1, 1998 and 1997 was 3,3 00,000 and 3,
100,000, respectively.

G. Business Segment Information
- -------------------------------

The  Company  implemented  SFAS No.  131,  "Disclosures  about  Segments  of an
Enterprise and Related Information," on January 1, 1998. The Company operates in
one industry  segment,  that being the development of Internet  related products
and  services.  There  were no  material  amounts  of sales or  transfers  among
geographic areas or major customers within the United States.

                                      F-10

<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                       NOTES TO THE FINANCIAL STATEMENTS
                           DECEMBER 31, 1998 AND 1997

NOTE 2- SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
- ---------------------------------------------------

H. Pending Accounting Pronouncements
- ------------------------------------

It is anticipated that current pending accounting  pronouncements  will not have
an adverse impact on the financial statements of the Company.

NOTE 3 -STOCK SUBSCRIPTION RECEIVABLE
- --------------------------------------

Stock  Subscription  Receivable at December 31, 1998, of $50,500  represents the
balance of funds due for a 504 Offering  Memorandum  completed on September  21,
1998.  The  entire  balance  was  collected  during  1999,  prior to the date of
issuance of the financial statements.

NOTE 4 - INCOME TAXES
- ---------------------

There is no current or deferred  tax expense  for the years ended  December  31,
1998 and 1997,  due to the  Company's  loss  position.  The  benefits  of timing
differences have not been previously recorded.

The deferred tax  consequences  of temporary  differences in reporting items for
financial  statement  and income tax purposes are  recognized,  as  appropriate.
Realization  of the future tax  benefits  related to the  deferred tax assets is
dependent on many factors,  including the Company's  ability to generate taxable
income  within  the net  operating  loss  carryforward  period.  Management  has
considered  these  factors  in  reaching  its  conclusion  as to  the  valuation
allowance for financial reporting  purposes.  The income tax effect of temporary
differences  comprising the deferred tax assets and deferred tax  liabilities on
the accompanying balance sheet is a result of the following:

<TABLE>
<CAPTION>

Deferred Taxes                               1998            1997
- --------------                               ----            ----
<S>                                          <C>             <C>
NOL Carryforwards                            $ (35,022)      $  (5,740)
Total                                          (35,022)         (5,740)
Valuation Allowance                             35,022           5,740
Net Deferred Tax Assets                      $       0       $       0

</TABLE>

A  reconciliation  between the statutory  federal  income tax rate (34%) and the
effective  rate of income tax  expense  for each of the years  during the period
ended December 31 follows:

<TABLE>
<CAPTION>
                                             1998           1997
                                             ----           ----
<S>                                          <C>            <C>
Statutory Federal Income Tax Rate            (34.0%)        (15.0%)
Increase in Valuation Allowance               34.0           15.0
Effective Income Tax Rate                      0.0%           0.0%

</TABLE>

                                      F-11


<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
                         (A Development Stage Company)
                       NOTES TO THE FINANCIAL STATEMENTS
                           DECEMBER 31, 1998 AND 1997

NOTE 4 - INCOME TAXES (CONTINUED)
- ---------------------------------

The Company has available  net operating  loss  carryforwards  of  approximately
$103,000  for  tax  purposes  to  offset  future  taxable  income,   and  expire
principally in the year 2012,

NOTE 5 - STOCK OPTIONS
- ----------------------

The Company has authorized the 1998 Employee Stock Option Plan that provides for
the granting of stock options to officers and key  employees.  The objecti " ves
of this plan include attracting and retaining the best personnel,  providing for
additional performance  incentives,  and promoting the success of the Company by
providing employees the opportunity to acquire common stock. The plan authorizes
the Company to grant up to 1,000,000  shares.  No shares have been granted as of
April 30, 1999.

NOTE 6 - SUBSEQUENT EVENTS
- --------------------------

On April 15, 1999, the Company changed its name to CancerOption.com, Inc.

                                      F-12

<PAGE>


<TABLE>
<CAPTION>

                             CANCEROPTION.COM, INC.
                           CONSOLIDATED BALANCE SHEET
                    SEPTEMBER 30, 1999 AND DECEMBER 31, 1998
<S>                                                                                     <C>                 <C>

                                                                                                                             1998
                                                                                         1999 (Unaudited)               (audited)
                                                                                         ----------------               ---------
                                            ASSETS

Current Assets

   Cash and Cash Equivalents                                                               $       81,547              $     244

   Other Receivable                                                                                     0                      0
   Stock Subscription Receivable                                                                  140,000                 50,500
   Inventory                                                                                       18,607                      0

Property and Equipment, Net                                                                        22,253                      0



Other Assets
   Prepaid Expenses                                                                                26,774                      0
   Trademarks                                                                                       7,685                      0
Total Assets                                                                               $      296,866              $  50,744
                                                                                        =================   ====================


                                            LIABILITIES AND STOCKHOLDERS' EQUIITY


 Current Liabilities
     Accounts Payable                                                                      $        5,122              $     750
     Payroll Taxes Withheld                                                                         1,080                      0

   Total Current Liabilities                                                               $        6,202              $     750

Stockholders' Equity

    Common Stock: Authorized $0.001 Par Value, 100,000,000 shares;

      Issued and Outstanding, 7,494,600 and 5,200,000                                             317,495                  5,200
        at September 30, 1999 and December 1998 respectively

         Additional Paid In Capital                                                               567,775                147,800
         Loss Accumulated During the Development Stage                                           (284,606)              (103,006)





     Total Stockholder's Equity                                                                   290,664                 49,994





     Total Liabilities and Stockholder's Equity                                            $      296,866              $  50,744
                                                                                        =================   ====================

</TABLE>


                                      F-13

<PAGE>

<TABLE>
<CAPTION>


                             CANCEROPTION.COM, INC.
                      CONSOLIDATED STATEMENT OF OPERATIONS
             FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1999 AND 1998
                                  (Unaudited)

<S>                              <C>                <C>               <C>                <C>


                                      The Three          The Three        The Nine             The Nine
                                         Months             Months          Months               Months
                                   Period Ended       Period Ended     Period Ended        Period Ended
                                 Sept. 30, 1999     Sept. 30, 1998    Sept. 30 1999      Sept. 30, 1998





Revenues                         $       1,427      $           0     $      1,427       $           0


Operating Expenses
 General and Administrative      $     102,147      $         750     $    183,770       $      52,116

Operating Loss                   $    (100,720)     $        (750)    $   (182,343)      $     (52,116)

Other Income
 Interest Income                           102                  0              743       $           0

Net Loss Available to            $    (100,618)     $        (750)    $   (181,600)      $     (52,116)
  Common Stockholders            ==============     ==============    =============      ==============


Loss Per Weighted Average
   Share of Common Stock                 (0.01)           (0.0003)           (0.03)              (0.02)
                                 ==============     ==============    =============      ==============


Weighted Average Number of
Common Shares Outstanding            7,430,600          2,600,000        6,347,300           2,600,000
                                 ==============     ==============    =============      ==============

</TABLE>

                                      F-14

<PAGE>

<TABLE>
<CAPTION>


                             CANCEROPTION.COM, INC.
                 CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
   FOR THE PERIOD FROM INCEPTION (APRIL 17, 1997) THROUGH SEPTEMBER 30, 1999


<S>                                    <C>         <C>       <C>          <C>      <C>          <C>           <C>


                                                                                                       Loss
                                                                                                Accumulated
                                                                                   Additional    During the
                                       Preferred     Stock      Common      Stock     Paid In   Development
                                          Shares   Amounts      Shares    Amounts     Capital         Stage        Total

Common Stock Issued For Services
  Rendered at $0.001 Per Share,
     April 17, 1997                            0   $     0   3,000,000    $ 3,000  $        0   $         0   $    3,000

Issuance of Common Stock for
  Cash at $.25 Per Share                                       200,000         20  $   49,800                     50,000

Net Loss From Inception
  (April 17, 1997)
   Through December 31, 1997
                                                                                                    (38,268)     (38,268)
Balance, December 31, 1997                     0         0   3,200,000      3,200      49,800       (38,268)      14,732

Issuance of Common Stock for                                 2,000,000      2,000      98,000                    100,000
  Cash at $.05 per Share

Net Loss, Year Ended
  December 31, 1998                                                                                 (64,738)     (64,738)

Balance, December 31, 1998                     0         0   5,200,000      5,200     147,800      (103,006)      49,994

Issuance of Common Stock for
  Cash at $.60 per share                                       166,600        167      99,833                    100,000


Issuance of Common Stock for                                 2,000,000      2,000                                  2,000
  Services at $0.001 per share

Issuance of Common Stock for
  Cash at $2.50 per Share                                      128,000         12     320,142                    320,270

Net Loss, Nine Months Ended
  September 30, 1999                                                                               (181,600)    (181,600)



Balance, September 30, 1999                    0         0   7,494,600    $ 7,495  $  567,775      (284,606)     290,664
                                       =========   =======   =========    =======  ==========   ============  ===========

</TABLE>

                                      F-15
<PAGE>

<TABLE>
<CAPTION>


                             CANCEROPTION.COM, INC.
                      CONSOLIDATED STATEMENT OF CASH FLOWS
          FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 1999 AND 1998
           AND FROM INCEPTION (APRIL 17, 1997) TO SEPTEMBER 30, 1999

<S>                                                              <C>                 <C>                 <C>



                                                                   (Unaudited)         (Unaudited)          (Unaudited)
                                                                   Nine Months         Nine Months       From Inception
                                                                         Ended               Ended           To Sept 30
                                                                 Sept 30, 1999       Sept 30, 1998                 1999

Cash Flows From Operating Activities:

  Net Loss                                                       $   (181,600)       $     (52,116)      $    (284,606)

  Adjustments to Reconcile Net Loss to Net Cash

    Changes in Assets and Liabilities

            Depreciation & Amortization                                 1,660                    0               1,660
            (Increase) Decrease in Receivables                        (89,500)             (50,500)           (140,000)
            (Increase) Decrease in Inventory                          (18,607)                   0             (18,607)
            (Increase) Decrease in Prepaid Expense                    (26,773)                   0             (26,773)
            Increase (Decrease) in Accounts Payable                     4,372                    0               5,122
            Increase (Decrease) in Payroll Taxes W/H                    1,080                    0               1,080
            Common Stock Issued for Services                            2,000                    0               5,000

   Total Adjustments                                                 (125,768)             (50,500)           (172,518)

Net Cash Used In Operating Activities                                (307,368)            (102,616)           (457,124)



Cash Flows From Investing Activities
   Purchase of Property and Equipment                                 (23,871)                   0             (23,871)
   Trademark Registration                                              (7,728)                   0              (7,728)
Net Cash Flows Used In Investing Activities                           (31,599)                   0             (31,599)



Cash Flows From Financing Activities

   Proceeds From the Issuance of Common Stock                         420,270              100,000             570,270
   Proceeds From Stock Options Exercised                                    0                    0                   0

Net Cash Provided By Financing Activities                             420,270                    0             570,270



Increase (Decrease) in Cash and Cash Equivalents                       81,303               (2,616)             81,547



Cash and Cash Equivalents at Beginning of Period                          244                2,732                   0



Cash and Cash Equivalents at End of Period                       $     81,547        $         116       $      81,547
                                                                 =============       ==============      ==============

</TABLE>

                                      F-16

<PAGE>

<TABLE>
<CAPTION>

                             CANCEROPTION.COM, INC.
                CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)
          FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 1999 AND 1998
           AND FROM INCEPTION (APRIL 17, 1997) TO SEPTEMBER 30, 1999

<S>                                                              <C>                 <C>                 <C>



                                                                    Nine Months         Nine Months              From
                                                                          Ended               Ended      Inception to
                                                                 Sept. 30, 1999      Sept. 30, 1998      Sept 30 1999


Supplemental Disclosure of Cash Flow Information:

Cash paid for:

     Interest                                                    $            0      $            0      $          0
                                                                 ===============     ===============     =============
     Income Taxes                                                $            0      $            0      $          0
                                                                 ===============     ===============     =============


Noncash Investing and Financing Activities:

     Issuance of Common Stock for Services                       $        2,000      $            0      $      5,000
                                                                 ===============     ===============     ==================
</TABLE>

                                      F-17


<PAGE>

                             CANCEROPTION.COM, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                          SEPTEMBER 30, 1999 AND 1998

The accompanying  unaudited interim consolidated  financial statements have been
prepared  in  accordance  with Form 10SB and in the  opinion  of  management  of
CancerOption.Com,  Inc.  (formerly Pantheon  Technologies,  Inc.) (the Company),
include  all normal  adjustments  considered  necessary  to  present  fairly the
financial  position as of September 30, 1999,  and the results of operations for
the nine months  ended  September  30, 1999 and 1998.  These  results  have been
determined  on  the  basis  of  generally  accepted  accounting  principles  and
practices and applied  consistently  with those used in the  preparation  of the
Company's audited consolidated financial statements and notes for the year ended
December 31, 1998.


                                      F-18

<PAGE>

<TABLE>
<CAPTION>
<S>      <C>               <C>

                                    PART III
                                INDEX TO EXHIBITS

         Exhibit 3
                  (i)      Articles of Incorporation and Amendments
                  (ii)     Bylaws

         Exhibit 23        Consent of Independent Auditor
         Exhibit 27        Financial Data Schedule
         Exhibit 99
                  .1      Private Placement Memorandum dated June 1, 1997
                  .2      Private Placement Memorandum dated September 18, 1998
                  .3      Private Placement Memorandum dated March 1, 1999
                  .4      Private Placement Memorandum dated August 18, 1999
                  .5      Investor Relations Agreement with Thor Equity Group,
                             dated October 13, 1998

                  .6      Investor Relations Agreement with Thor Equity Group,
                             dated August 31, 1999

                  .7      Block Time Agreement with ProNet, Inc.
                  .8      Contract with AdNet International
                  .9      Sublease of Office
                  .10     Shareholders List
                  .11     Written Profile of New Auditors

</TABLE>


                                   SIGNATURES

     In accordance  with Section 12 of the Securities  Exchange Act of 1934, the
registrant caused this registration  statement to be signed on its behalf by the
undersigned, who is duly authorized.

                                              Registrant: CANCEROPTION.COM, INC.
                                               Date: ___________________________


                                               By /S/ Arnold Takemoto
                                                 -------------------------------
                                                 Arnold Takemoto, President,
                                                 CEO and Director

                                               By /s/ Michael Quel
                                                 -------------------------------
                                                 Michael Quel, CPA,
                                                 Chief Financial Officer and
                                                 Director

                                               By /s/ Douglas Brodie
                                                 -------------------------------
                                                 Douglas Brodie, MD, Director



                                       10

<PAGE>

                          Pantheon Technologies, Inc.
                               Formed in Florida

                Federal Employer Identification Number (Tax ID):
                                   65-0744370

                              Corporate Creations@
                                 (305) 672-0686
                                  (856)487-6013

                          FLORIDA DEPARTMENT OF STATE
                                Katherine Harris
                               Secretary of State

April 15, 1999

CANCEROPTION.COM, INC.
7332 E. BUTHERUS DRIVE, SUITE 101
SCOTTSDALE, AZ 85260

Re: Document Number P97000-034687

     The Articles of Amendment  to the  Articles of  Incorporation'  of PANTHEON
TECHNOLOGIES,  INC. which changed its name to CANCEROPTION.COM,  INC., a Florida
corporation, were filed on April 15, 1999.

     This document was electronically  received and filed under FAX audit number
E99000008760.

     Should you have any questions regarding this matter, please telephone (B50)
487-6050, the Amendment Filing Section.

Darlene Connell
Corporate Specialist
Division of Corporations        Letter Number: 099AO0019098

Division of Corporations
P.O. BOX 6327
Florida 32314

<PAGE>

H99000008760
ARTICLES OF AMENDMENT

Article 1. Name
- ---------------

The name of this Florida corporation is: Pantheon Technologies, Inc.

Article 11. Amendment
- ---------------------

The Articles of Incorporation of the Corporation are amended as follows: Article
I. Name

The name of this Florida Corporation is CancerOption.Com, Inc.

Article V.  Capital  Stock

The Corporation shall have the authority to issue  100,000,000  shares of common
stock,  par value $.001 per share;  and 1,000,000 shares of preferred stock, par
value $.0001 per share.

Article 111. Date Amendment Adopt
- ---------------------------------

The amendment set forth in these  Articles of Amendment was adopted on April 14,
1999.

Article IV. Shareholder Approval of Amendment
- ---------------------------------------------

The  amendment  set forth in these  Articles of  Amendment  was  proposed by the
Corporation's  Board of  Directors  and approved by the  shareholders  by a vote
sufficient for approval of the amendment.

The undersigned executed this document on the date shown below.

Pantheon Technologies, Inc.

By: /s/ G.K. Kuroda
  ----------------------------
by G.K. da as attorney-in-fact

Name: Arnold Takemoto
      ---------------
Title: President
      -----------
Date: 4/14/00
     ----------

Corporate Creations International Inc.
941 Fourth Street #200
Miami Beach FL 33139
(305) 672-0686

H99000008760
                                                         Copyright@ 1993-1999 CC

<PAGE>

                                     [SEAL]
                          FLORIDA DEPARTMENT OF STATE
                                Katherine Harris
                               Secretary of State

April 14, 1999

PANTHEON TECHNOLOGIES, INC.
7332 E. BUTHERUS DRIVE, SUITE 101
SCOTTSDALE, AZ 85260

Re: Document Number P97000034687

This will  acknowledge your  reinstatement  for PANTHEON  TECHNOLOGIES,  INC., a
Florida Corporation, which wa6 filed on April 14, 1999.

This  document  was  electronically  received  and filed under FAX aduit  number
H99000008727.

Should you have any questions  regarding  this matter,  please  telephone  (850)
487-6059.

Trevor Brumbley
Document Specialist
Division of Corporations                             Letter Number: 599AO0018732


      Division of Corporations - P.O. BOX 6327-Tallahassee, Florida 32314

<PAGE>

This will  acknowledge your  reinstatament  for PANTHEON  TECHNOLOGIES,  INC., a
Florida Corporation, which.was filed on April 14, 1999.

This  document  was  electronically  received  and filed under FAX audit  number
H99000008727.

Should you have any questions  regarding  this matter,  please  telephone  (850)
487-6059.

Trevor Brumb1sy
Document Specialist
Division of  Corporations                            Letter Number: 599AO0018732


      Division of Corporations - P.O. BOX 6327-Tallahassee, Florida 32314

<PAGE>

ARTICLES OF INCORPORATION

Article 1. Name
- ---------------

The name of this Florida corporation is: Pantheon Technologies, Inc.

Article 11. Address
- -------------------

The mailing  address of the Corporation  is:  Pantheon  Technologies,  Inc. 2455
Hollywood Boulevard Hollywood Fl, 33020

Article Ill. Registered Agen
- ----------------------------

The name and address of the registered  agent of the Corporation  is:  Corporate
Creations Enterprises, Inc. 4521 PGA Boulevard #211 Palm Beach Gardens FL 33418

Article IV. Board of Directors
- ------------------------------

The name of each member of the Corporation's Board of Directors is:

Ken H. Finkelstein

The  affairs  of the  Corporation  shall  be  managed  by a Board  of  Directors
consisting  of no less  than  one  director.  The  number  of  directors  may be
increased or decreased  from time to time in  accordance  with the Bylaws of the
Corporation.  The election of  directors  shall be done in  accordance  with the
Bylaws.  The directors shall be protected from personal liability to the fullest
extent permitted by applicable law.


Corporate Creations International Inc.
401 Ocean Drive #312 (Door Code 125)
Miami Beach FL 33139-6629
(305) 672-0686

H97000006240

<PAGE>

Article V. Capital Stock
- ------------------------

The Corporation shall have the authority to issue  100,000,000  shares of common
stock, par value $.001 per share.

Article VI. Incorporator
- ------------------------

The name and address of the incorporator is: Corporate  Creations  International
Inc. 401 Ocean Drive #312 (Door Code 125) Miami Beach FL

Article VII. Corporate Existence
- --------------------------------

The corporate existence of the Corporation shall begin effective April 16, 1997

The undersigned  incorporator  executed these Articles of Incorporation on April
16, 1997

Corporat Creations International Inc.

By: /s/ Brian R. Fons
- ----------------------------
Brian R. Fons Vice President


Corporate Creations International Inc.
401 Ocean Drive #312 (Door Code 125)
Miami Beach FL 33139-6629
(305) 672-0686

H97000006240

<PAGE>


CERTIFICATE OF DESIGNATION
REGISTERED AGENT/OFFICE

CORPORATION:
- ------------
Pantheon Technologies, Inc.

REGISTERED AGENT/OFFICE:
- ------------------------
Corporate Creations Enterprises, Inc.
4521 PGA Boulevard #211
Palm Beach Gardens FL 33418

I agree  to act as  registered  agent  to  accept  service  of  process  for the
corporation named above at the place designated in this Certificate.  I agree to
comply with the  provisions of all statutes  relating to the proper and complete
performance  of the registered  agent duties.  I am familiar with and accept the
obligations of the registered agent position.

/s/ Brian R. Fons
- -----------------
Corporate Creations Enterprises, Inc.
Brian R. Fons, Vice President

Date: April 16, 1997

Corporate Creations International Inc.
401 Ocean Drive #312 (Door Code 125)
Miami Beach FL 33139-6629
(305) 672-0686

H97000006240

<PAGE>

                                     [SEAL]
                          FLORIDA DEPARTMENT OF STATE
                               Sandra B. Mortham
                               Secretary of State

April 17, 1997

PANTHEON TECHNOLOGIES, INC.
2455 HOLLYWOOD BLVD.
HOLLYWOOD, FL 33020

The Articles of  Incorporation  for PANTHEON  TECHNOLOGIES,  INC. were filed on
April  17,  1997,  effective  April  16,  1997,  and  assigned.document   number
P97000034687.  Please  refer to this  number  whenever  corresponding  with this
office.

Enclosed is the certification requested. To be official, the certification for a
certified copy must be attached to the original document that was electronicallv
submitted and filed under FAX audit number H97000006240.

A corporation  annual report will be due this office between January 1 and May 1
of the year  following  the  calendar  year of the file  date  year.  A  Federal
Employer  Identification (FBI) number will be required before this report can be
filed.   Please  apply  NOW  with  the  Internal   Revenue  Service  by  calling
1-800-829-3676 and requesting form SS-4.

Please be aware if the corporate  address changes,  it is the  responsibility of
the corporation to notify this office.

Should you have questions regarding corporations,  please contact this office at
the address given below.

Agnes Lunt
Corporate Specialist
New Filings Section
Division of Corporations                             Letter Number: 997AC0019613

      Division of Corporations - P.O. BOX 6327-Tallahassee, Florida 32314

<PAGE>

                                     [SEAL]
                              Department of State

I certify from the records of this office that PANTHEON  TECHNOLOGIES,  INC is a
corporation organized under the laws of the State of Florida, filed on April 17,
1997, effective April 16, 1997.

The document number of,this corporation is P97000034687.

I further certify that said corporation has paid all fees and penalties due this
office through Dece.mber 31, 1997, and its status is active.

I further certify that said corporation has not filed Articles of Dissolution.

I  further  certify  that  this  is an  electronically  transmitted  certificate
authorized by section 15.16, Florida Statutes, and authenticated by the L' code,
997AO0019613-041797-P97000034687-1/1, noted below.

          Given  under my hand and the Great  Seal of the State of  Florida,  at
          Tallahassee, the Capital, this the Seventeenth day of April, 1997

Authentication Code: 997AO0019613-041797-P97000034687-1/1


[SEAL]                                                     /s/ Sandra B. Mortham
- ------                                                     ---------------------
                                                               Sandra P. Mortham
                                                              Secretary of State


                                     Bylaws
                                       of
                          Pantheon Technologies, Inc.

                              ARTICLE I. DIRECTORS
                              --------------------

Section 1. Function.
- --------------------

All  corporate  powers shall be exercised by or under the authority of the Board
of Directors. The business and affairs of the Corporation shall be managed under
the direction of the Board of Directors.  Directors must be natural  persons who
are at least 18 years of age but need not be  shareholders  of the  Corporation.
Residents of any state may be directors.

Section 2. Compensation.
- ------------------------

The  shareholders  shall have  authority to fix the  compensation  of directors.
Unless  specifically  authorized  by  a  resolution  of  the  shareholders,  the
directors shall serve in such capacity without compensation.

Section 3. Presumption of Assent.
- ---------------------------------

A director  who is present at a meeting of the Board of Directors or a committee
of the Board of Directors at which action on any corporate matter is taken shall
be  presumed  to have  assented  to the  action  taken  unless he objects at the
beginning  of the  meeting (or  promptly  upon  arriving)  to the holding of the
meeting or transacting the specified business at the meeting, or if the director
votes  against the action taken or abstains  from voting  because of an asserted
conflict of interest.

Section 4. Number.
- ------------------

The Corporation shall have at least the minimum number of directors  required by
law. The number of directors may be increased or decreased  from time to time by
the Board of Directors.

Section 5. Election and Term.
- -----------------------------

At each annual meeting of shareholders,  the shareholders  shall elect directors
to hold office until the next annual meeting or until their earlier resignation,
removal from office or death.  Directors  shall be elected by a plurality of the
votes cast by the shares  entitled to vote in the election at a meeting at which
a quorum is present.

Section 6. Vacancies.
- ---------------------

Any vacancy occurring in the Board of Directors,  including a vacancy created by
an increase in the number of directors,  may be filled by the shareholders or by
the affirmative vote of a majority of the remaining directors though less than a
quorum of the Board of  Directors.  A director  elected to fill a vacancy  shall
hold office only until the next  election of directors by the  shareholders.  If
there  are  no  remaining  directors,   the  vacancy  shall  be  filled  by  the
shareholders. Section 7. Removal of Directors. At a meeting of shareholders, any
director or the entire Board of Directors may be removed, with or without cause,
provided  the  notice of the  meeting  states  that one of the  purposes  of the
meeting is the removal of the  director.  A director  may be removed only if the
number of votes cast to remove  him  exceeds  the  number of votes cast  against
removal.

<PAGE>

Section 8. Quorum and Voting.
- -----------------------------

A majority of the number of directors  fixed by these Bylaws shall  constitute a
quorum for the  transaction  of  business.  The act of a majority  of  directors
present at a meeting at which a quorum is present  shall be the act of the Board
of Directors.

Section 9. Executive and Other Committees.
- ------------------------------------------

The Board of Directors, by resolution adopted by a majority of the full Board of
Directors,  may designate from among its members one or more  committees each of
which must have at least two members.  Each committee  *shall have the authority
set forth in the resolution designating the committee.

Section 10. Place of Meeting.
- -----------------------------

Regular and  special  meetings  of the Board of  Directors  shall be held at the
principal place of business of the Corporation or at another place designated by
the person or persons giving notice or otherwise calling the meeting.

Section 11. Time, Notice and Call of Meetings.
- ----------------------------------------------

Regular  meetings of the Board of Directors  shall be held without notice at the
time and on the date designated by resolution of the Board of Directors. Written
notice of the time, date and place of special meetings of the Board of Directors
shall be given to each  director  by mail  delivery at least two days before the
meeting.

Notice of a meeting  of the Board of  Directors  need not be given to a director
who signs a waiver of notice either before or after the meeting. Attendance of a
director at a meeting  constitutes a waiver of notice of that meeting and waiver
of all objections to the place of the meeting,  the time of the meeting, and the
manner in which it has been called or  convened,.  unless a director  objects to
the transaction of business  (promptly upon arrival at the meeting)  because the
meeting  is  not  lawfully  called  or  convened.  Neither  the  business  to be
transacted  at, nor the purpose of, any regular or special  meeting of the Board
of Directors must be specified in the notice or waiver of notice of the meeting.

A majority of the directors present, whether or not a quorum exists, may adjourn
any meeting of the Board of Directors  to another  time and place.  Notice of an
adjourned  meeting  shall be given to the  directors who were not present at the
time of the adjournment and, unless the time and place of the adjourned  meeting
are announced at the time of the adjournment,  to the other directors.  Meetings
of the Board of Directors  may be called by the President or the Chairman of the
Board of Directors.  Members of the Board of Directors and any committee' of the
Board  may  participate  in  a  meeting  by  telephone   conference  or  similar
communications  equipment if all persons  participating  in the meeting can hear
each other at the same time.  Participation by these means constitutes  presence
in person at a meeting.

<PAGE>

Section 12. Action By Written Consent.
- --------------------------------------

Any action  required or permitted  to be taken at a meeting of directors  may be
taken  without a meeting if a consent in writing  setting forth the action to be
taken  and  signed  by all of the  directors  is  filed  in the  minutes  of the
proceedings  of the Board.  The action taken shall be deemed  effective when the
last director signs the consent, unless the consent specifies otherwise.

                      ARTICLE II. MEETINGS OF SHAREHOLDERS
                      ------------------------------------

Section 1. Annual Meeting.
- --------------------------

The annual meeting of the  shareholders  of the  corporation for the election of
officers  and for such other  business as may properly  come.before  the meeting
shall be held at such time and place as designated by the Board of Directors.

Section 2. Special Meeting.
- ---------------------------

Special  meetings  of the  shareholders  shall  be  held  when  directed  by the
President or when requested in writing by  shareholders  holding at least 10% of
the Corporation's stock having the right and entitled to vote at such meeting. A
meeting  requested by  shareholders  shall be called by the President for a date
not less than 10 nor more than 60 days after the request is made.  Only business
within the  purposes  described  in the  meeting  notice may be  conducted  at a
special shareholders, meeting.

Section 3. Place.
- -----------------

Meetings of the shareholders  will be held at the principal place of business of
the  Corporation  or at such  other  place  as is  designated  by the  Board  of
Directors.

Section 4. Notice.
- ------------------

A  written  notice  of each  meeting  of  shareholders  shall be  mailed to each
shareholder  having the right and entitled to vote at the meeting at the address
as it appears on the records of the  Corporation.  The meeting  notice  shall be
mailed  not  less  than 10 nor  more  than 60 days  before  the date set for the
meeting.  The record date for determining  shareholders  entitled to vote at the
meeting will be the close of business on the day before the notice is sent.  The
notice  shall state the time and place the meeting is to be held.  A notice of a
special  meeting  shall  also state the  purposes  of the  meeting.  A notice of
meeting shall be  sufficient  for that meeting and any  adjournment  of it. If a
shareholder  transfers  any  shares  after the  notice is sent,  it shall not be
necessary  to notify the  transferee.  All  shareholders  may waive  notice of a
meeting at any time.

<PAGE>

Section 5. Shareholder Quorum.
- ------------------------------

A majority of the shares  entitled to vote,  representeT  in person or by proxy,
shall  constitute  a  quorum  at  a  meeting  of  shareholders.  Any  number  of
shareholders,  even if less than a  quorum,  may  adjourn  the  meeting  without
further notice until a quorum is obtained.

Section 6. Shareholder Voting.
- ------------------------------

If a quorum  is  present,  the  affirmative  vote of a  majority  of the  shares
represented  at the meeting and entitled to vote on the subject  matter shall be
the act of the  shareholders.  Each  outstanding  share shall be entitled to one
vote  on each  matter  submitted  to a vote at a  meeting  of  shareholders.  An
alphabetical  list  of  all  shareholders  who  are  entitled  to  notice  of  a
shareholders,  meeting along with their  addresses and the number of shares held
by each shall be produced  at a  shareholders'  meeting  upon the request of any
shareholder.

Section 7. Proxies.
- -------------------

A shareholder entitled to vote at any meeting of.shareholders or any adjournment
thereof  may vote in person or by proxy  executed  in writing  and signed by the
shareholder or his attorney-in-fact.  The appointment of proxy will be effective
when  received  by the  Corporation's  officer or agent  authorized  to tabulate
votes.  No proxy  shall be  valid  more  than 11  months  after  the date of its
execution unless a longer term is expressly stated in the proxy.

Section 8. Validation.
- ----------------------

If  shareholders  who hold a majority of the voting stock  entitled to vote at a
meeting are present at the meeting, and sign a written consent to the meeting on
the record,  the acts of the meeting shall be valid, even if the meeting was not
legally called and noticed.

Section 9. Conduct of Business By Written Consent.
- --------------------------------------------------

Any  action  of the  shareholders  may be taken  without a  meeting  if  written
consents,  setting forth the action taken,  are signed by at least a majority of
shares  entitled  to vote  and are  delivered  to the  officer  or  agent of the
Corporation having custody of the Corporation's records within 60 days after the
date that the  earliest  written  consent  was  delivered.  Within 10 days after
obtaining  an  authorization  of an action by written  consent,  notice shall be
given to those  shareholders  who have not  consented  in writing or who are not
entitled to vote on the action.  The notice shall fairly  summarize the material
features of the authorized action. If the action creates dissenters' rights, the
notice shall contain a clear  statement of the right of dissenting  shareholders
to be paid the fair value of their shares upon  compliance  with and as provided
for by the state law governing corporations.

                             ARTICLE III. OFFICERS
                             ---------------------

<PAGE>

Section 1. Officers; Election; Resignation; Vacancies.
- ------------------------------------------------------

The Corporation shall have the officers and assistant officers that the Board of
Directors  appoint  from  time to  time.  Except  as  otherwise  provided  in an
employment  agreement which the  Corporation  has with an officer,  each officer
shall serve until a successor is chosen by the directors at a regular or special
meeting of the directors or until removed.  officers and agents shall be chosen,
serve for the terms, and have the duties  determined by the directors.  A person
may hold two or more offices.

Any officer may resign at any time upon written notice to the  Corporation.  The
resignation shall be effective upon receipt, unless the notice specifies a later
date.  If the  resignation  is  effective  at a later  date and the  Corporation
accepts the future  effective  date, the Board of Directors may fill the pending
vacancy before the effective  date provided the successor  officer does not take
office until the future  effective date. Any vacancy  occurring in any office of
the  Corporation by death,  resignation,  removal or otherwise may be filled for
the  unexpired-portion  of the term by the Board of  Directors at any regular or
special meeting.

Section 2. Powers and, Duties of Officers.
- ------------------------------------------

The  officers  of the  Corporation  shall  have such  powers  and  duties in the
management  of the  Corporation  as may be  prescribed by the Board of Directors
and, to the extent not so  provided,  as generally  pertain to their  respective
offices, subject to the control of the Board of Directors.

Section 3. Removal of Officers.
- -------------------------------

An officer or agent or member of a committee elected or appointed by the Board
of Directors may be removed by the Board with or without  cause  whenever in its
judgment the best interests of the Corporation will be served thereby,  but such
removal shall be without prejudice to the contract rights, if any, of the person
so  removed.  Election  or  appointment  of an  officer,  agent or  member  of a
committee shall not of itself create contract rights. Any officer,  if appointed
by another-officer, may be removed by that officer.

Section 4. Salaries.
- --------------------

The Board of  Directors  may  cause the  Corporation  to enter  into  employment
agreements  with any  officer  of the  Corporation.  Unless  provided  for in an
employment agreement between the Corporation and an officer, all officers of the
Corporation serve in their capacities without compensation.

Section 5. Bank Accounts.
- -------------------------

The Corporation shall have accounts with financial institutions as determined by
the Board of Directors.

<PAGE>

                           ARTICLE IV. DISTRIBUTIONS
                           -------------------------

The Board of Directors  may,  from time to time,  declare  distributions  to its
shareholders in cash, property, or its own shares, unless the distribution would
cause (i) the  Corporation  to be unable to pay its debts as they  become due in
the usual course of business,  or (ii) the Corporation's  assets to be less than
its liabilities plus the amount necessary,  if the Corporation were dissolved at
the time of the distribution, to satisfy the preferential rights of shareholders
whose rights are superior to those receiving the distribution.  The shareholders
and the  Corporation may enter into an agreement  requiring the  distribution of
corporate profits, subject to the provisions of law.

                          ARTICLE V. CORPORATE RECORDS
                          ----------------------------

Section 1. Corporate Records.
- -----------------------------

The  corporation  shall  maintain its records in written form or in another form
capable  of  conversion  into  written  form  within  a  reasonable   time.  The
Corporation  shall keep as  permanent  records  minutes of all  meetings  of its
shareholders  and  Board of  Directors,  a record  of all  actions  taken by the
shareholders  or Board of  Directors  without  a  meeting,  and a record  of all
actions  taken  by a  committee  of the  Board of  Directors  on  behalf  of the
Corporation.  The Corporation shall maintain accurate  accounting  records and a
record of its  shareholders in a form that permits  preparation of a list of the
names and addresses of all shareholders in alphabetical order by class of shares
showing the number and series of shares held by each.

The  Corporation  shall keep a copy of its  articles  or  restated  articles  of
incorporation  and all amendments to them  currently in effect;  these Bylaws or
restated Bylaws and all amendments  currently in effect;  resolutions adopted by
the Board of  Directors  creating  one or more  classes  or series of shares and
fixing their relative rights,  preferences,  and  limitations,  if shares issued
pursuant to those resolutions are outstanding;  the minutes of all shareholders'
meetings and records of all actions taken by shareholders  without a meeting for
the past three years;  written  communications to all shareholders  generally or
all shareholders of a class of series within the past three years, including the
financial  statements  furnished  for the last three years;  a list of names and
business street  addresses of its current  directors and officers;  and its most
recent annual report delivered to the Department of State.

Section 2. Shareholders' Inspection Rights.
- -------------------------------------------

A shareholder is entitled to inspect and copy,  during regular business hours at
a reasonable location specified by the Corporation, any books and records of the
Corporation.  The shareholder  must give the Corporation  written notice of this
demand at least five business days before the date on which he wishes to inspect
and copy the  record(s).  The demand must be made in good faith and for a proper
purpose. The shareholder must describe with reasonable particularity the purpose
and the  records  he  desires  to'inspect,  and  the  records  must be  directly
connected  with  this  purpose.  This  Section  does not  affect  the right of a
shareholder to inspect and copy the shareholders, list described in this Article
if the  shareholder is in litigation with the  Corporation.  In such a case, the
shareholder  shall  have the same  rights as any other  litigant  to compel  the
production of corporate records for examination.

<PAGE>

The Corporation may deny any demand for inspection if the demand was made for an
improper  purpose,  or if the  demanding  shareholder  has  within the two years
preceding his demand,  sold or offered for sale any list of  shareholders of the
Corporation  or of any other  corporation,  has aided or  abetted  any person in
procuring any list of shareholders for that purpose,  or has improperly used any
information  secured  through  any  prior  examination  of the  records  of this
Corporation or any other corporation.

Section 3. Financial Statements for Shareholders.
- -------------------------------------------------

Unless  modified by  resolution  of the  shareholders  within 120 days after the
close of each fiscal year, the Corporation  shall furnish its shareholders  with
annual financial  statements which may be consolidated or combined statements of
the  Corporation  and one or  more of its  subsidiaries,  as  appropriate,  that
include a balance  sheet as of the end of the fiscal year,  an income  statement
for that  year,  and a  statement  of cash  flows for that  year.  If  financial
statements are prepared for the  Corporation on the basis of generally  accepted
accounting principles,  the annual financial statements must also be prepared on
that basis.

If the annual financial statements are reported upon by a public accountant, his
report must  accompany  them. If not, the  statements  must be  accompanied by a
statement  of the  President  or the person  responsible  for the  Corporation's
accounting  records  stating his reasonable  belief whether the statements  were
prepared on the basis of generally accepted  accounting  principles and, if not,
describing  the basis of  preparation  and  describing any respects in which the
statements  were not  prepared  on a basis  of  accounting  consistent  with the
statements  prepared for the  preceding  year.  The  Corporation  shall mail the
annual financial  statements to each shareholder within 120 days after the close
of each fiscal year or within such  additional  time thereafter as is reasonably
necessary  to enable  the  Corporation  to  prepare  its  financial  statements.
Thereafter,  on  written  request  from a  shareholder  who was not  mailed  the
statements,   the  Corporation  shall  mail  him  the  latest  annual  financial
statements.

Section 4. Other Reports to Shareholders.
- -----------------------------------------

If the Corporation  indemnifies or advances  expenses to any director,  officer,
employee or agent otherwise than by court order or action by the shareholders or
by an insurance carrier pursuant to insurance maintained by the Corporation, the
Corporation  shall  report  the  indemnification  or  advance  in writing to the
shareholders with or before the notice of the next annual shareholders, meeting,
or prior to the  meeting  if the  indemnification  or advance  occurs  after the
giving of the  notice but prior to the time the  annual  meeting  is held.  This
report shall include a statement  specifying the persons paid, the amounts paid,
and the  nature  and status at the time of such  payment  of the  litigation  or
threatened litigation.

<PAGE>

If the  Corporation  issues or authorizes the issuance of shares for promises to
render services in the future,  the  Corporation  shall report in writing to the
shareholders the number of shares  authorized or issued,  and the  consideration
received by the corporation, with or before the notice of the next shareholders'
meeting.

                         ARTICLE VI. STOCK CERTIFICATES
                         ------------------------------

Section 1. Issuance.
- --------------------

The Board of Directors  may  authorize the issuance of some or all of the shares
of any,or all of its classes or series without  certificates.  Each  qertificate
issued shall be signed by the President  and the  Secretary (or the  Treasurer).
The rights and  obligations of shareholders  are identical  whether or not their
shares are represented by certificates.

Section 2. Registered Shareholders.
- -----------------------------------

No certificate  shall be issued for any share until the share is fully paid. The
Corporation  shall be  entitled  to treat the  holder of record of shares as the
holder in fact and,  except as otherwise  provided by law, shall not be bound to
recognize any equitable or other claim to or interest in the shares.

Section 3. Transfer of Shares.
- ------------------------------

Shares of the  Corporation  shall be  transferred  on its books  only  after the
surrender to the  Corporation  of the share  certificates  duly  endorsed by the
holder  of record  or  attorney-in-fact.  If the  surrendered  certificates  are
canceled,  new certificates  shall be issued to the person entitled to them, and
the transaction recorded on the books of the Corporation.

Section 4. Lost, Stolen or Destroyed Certificates.
- --------------------------------------------------

If a shareholder claims to have lost or destroyed a certificate of shares issued
by the Corporation,  a new certificate  shall be issued upon the delivery to the
Corporation of an affidavit of that fact by the person  claiming the certificate
of stock to be lost, stolen or destroyed, and, at the discretion of the Board of
Directors, upon the deposit of a bond or other indemnity as the Board reasonably
requires.

<PAGE>

                          ARTICLE VII. INDEMNIFICATION
                          ----------------------------

Section 1. Right to Indemnification.
- ------------------------------------

The Corporation hereby indemnifies each person (including the heirs,  executors,
administrators, or estate of such person) who is or was a director or officer of
the  Corporation  to the fullest  extent  permitted or  authorized by current or
future  legislation or judicial or  administrative  decision  against all fines,
liabilities,  costs and expenses,  including attorneys, fees, arising out of his
or her status as a director,  officer,  agent,  employee or representative.  The
foregoing  right of  indemnification  shall not be  exclusive of other rights to
which those seeking an  indemnification  may be entitled.  The  Corporation  may
maintain  insurance,  at its  expense,  to protect  itself and all  officers and
directors  against fines,  liabilities,  costs and expenses,  whether or not the
Corporation  would have the legal power to indemnify them directly  against such
liability.

Section 2. Advances.
- --------------------

Costs,  charges and expenses  (including  attorneys'  fees) incurred by a person
referred  to in  Section 1 of this  Article  in  defending  a civil or  criminal
proceeding shall be paid by the Corporation in advance of the final  disposition
thereof upon receipt of an undertaking  to repay all amounts  advanced if. it is
ultimately  determined  that the person is not entitled to be indemnified by the
Corporation  as  authorized  by this  Article,  and upon  satisfaction  of other
conditions required by current or future legislation.

Section 3. Savings Clause.
- --------------------------

If this Article or any portion of it is  invalidated on any ground by a court of
competent  Jurisdiction,  the Corporation  nevertheless  indemnifies each person
described  in Section 1 of this Article to the fullest  extent  permitted by all
portions  of this  Article  that have not been  invalidated  and to the  fullest
extent permitted by law.

                            ARTICLE VIII. AMENDMENT
                            -----------------------

     These Bylaws may be altered,  amended or repealed,  and new Bylaws adopted,
by a majority vote of the directors or by a vote of the  shareholders  holding a
majority of the shares.

     I certify that these are the B~:4ws adopted by the Board n. of Directors of
the Corporation.

/s/  F. Muller
- ---------------
Secretary

Date: April 17, 1997
     ---------------

CERTIFIED PUBLIC ACCOUNTANTS

                                September 3, 1999

CancerOption.com, Inc.
(formerly Pantheon Technologies, Inc.)
7332 E. Butherus Drive, Suite 101
Scottsdale, AZ 85260

Dear Sirs:

This   is   to   confirm   that   the   client-auditor    relationship   between
CancerOption.com,  Inc. (formerly Pantheon Technologies, Inc.) (The Company) and
Clancy and Co., P.L.L.C., has ceased.

The opinions of Clancy and Co.,  P.L.L.C.,  on the balance  sheet of the Company
for the years ended  December 31, 1998 and 1997,  the  statement of  operations,
stockholders'  equity,  and cash flows for the Company for the period from April
17,  1997 to  December  31,  1998,  did not  contain  any  adverse  opinions  or
disclaimers  of opinion , or  modifications  as to  uncertainty,  audit scope or
accounting  principals.  There were no  disagreements  between  the  Company and
Clancy and Co., P.L.L.C.,  on any matter of accounting  principals or practices,
financial  statement  disclosure,   or  auditing  scope  of  procedures,   which
disagreements,  if not resolved to the satisfaction of Clancy and Co., P.L.L.C.,
would  have  caused  it  to  make   reference  to  the  subject  matter  of  the
disagreements in connection with its report.


                               Sincerely,


                               /s/ Clancy and Co., P.L.L.C.
                               ----------------------------
                               Clancy and Co., P.L.L.C.


<TABLE> <S> <C>

<ARTICLE> 5

<S>                                        <C>                     <C>                     <C>
<PERIOD-TYPE>                               9-MOS                   12-MOS                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1999             DEC-31-1998             DEC-31-1997
<PERIOD-END>                               SEP-30-1999             DEC-31-1998             DEC-31-1997
<CASH>                                          81,547                     244                   2,732
<SECURITIES>                                         0                       0                       0
<RECEIVABLES>                                        0                  50,500                  12,000
<ALLOWANCES>                                         0                       0                       0
<INVENTORY>                                     18,607                       0                       0
<CURRENT-ASSETS>                               100,154                  50,744                  14,732
<PP&E>                                           6,373                       0                       0
<DEPRECIATION>                                       0                       0                       0
<TOTAL-ASSETS>                                 156,866                  50,744                  14,732
<CURRENT-LIABILITIES>                            6,202                     750                       0
<BONDS>                                              0                       0                       0
                                0                       0                       0
                                          0                       0                       0
<COMMON>                                         5,440                   5,200                   3,200
<OTHER-SE>                                           0                       0                       0
<TOTAL-LIABILITY-AND-EQUITY>                   156,866                       0                       0
<SALES>                                          1,427                       0                       0
<TOTAL-REVENUES>                                 1,427                       0                       0
<CGS>                                              714                       0                       0
<TOTAL-COSTS>                                      714                       0                       0
<OTHER-EXPENSES>                               181,013                       0                       0
<LOSS-PROVISION>                                     0               (103,006)                (38,268)
<INTEREST-EXPENSE>                                   0                       0                       0
<INCOME-PRETAX>                                      0                       0                       0
<INCOME-TAX>                                         0                       0                       0
<INCOME-CONTINUING>                                  0                       0                       0
<DISCONTINUED>                                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0
<CHANGES>                                            0                       0                       0
<NET-INCOME>                                 (179,556)                       0                       0
<EPS-DILUTED>                                        0                       0                       0
<EPS-BASIC>                                          0                       0                       0



</TABLE>

                              OFFERING MEMORANDUM

                          Pantheon Technologies, Inc.
                            (A Florida Corporation)

                    Offering Memorandum Dated June 1st, 1997

                                 200,000 Shares

     Pantheon  Technologies,  Inc. (the "Company'),  a Florida  corporation,  is
offering on a "best efforts, no minimum basis" up to a maximum of 200,000 shares
of common stock ('Common  Stock'),  $.001 par value,  at $0.25 per Share.  Since
there is no minimum,  no proceeds  will be held in escrow  account and all funds
will be immediately available to the Company.

     The Company  intends to apply for inclusion of the Common Stock on the Over
the Counter Electronic Bulletin Board. There can be no assurances that an active
trading market will develop,  even if the securities are accepted for quotation.
Additionally,  even if the Company's  securities  are accepted for quotation and
active  trading  develops,  the Company is still  required  to maintain  certain
minimum criteria  established by NASDAQ, of which there can be no assurance that
the Company will be able to continue to fulfill such criteria.

     Prior to this offering there has been no public market for the common stock
of the  Company.  The  price  of  the  Shares  offered  hereby  was  arbitrarily
determined  by the Company and does not bear any  relationship  to the Company's
assets,  book value,  net worth,  results of operations or any other  recognized
criteria of value. For additional  information  regarding the factors considered
in determining  the offering price of the Shares,  see "Risk Factors - Arbitrary
Offering Price", "Description of Securities".

     The Company does not presently file reports or other  information  with the
Securities and Exchange Commission CCommission).   However, following completion
of this  offering,  the Company  intends to furnish its  security  holders  with
annual reports containing audited financial statements and such interim reports,
in each case as it may determine to furnish or as may be required by law.

THESE  SECURITIES  HAVE NOT BEEN APPROVED OR  DISAPPROVED  BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE COMMISSION OF
ANY STATE  SECURITIES  COMMISSION  PASSED UPON THE  ACCURACY OR ADEQUACY OF THIS
PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

THE SECURITIES ARE OFFERED BY THE COMPANY  SUBJECT TO PRIOR SALE,  ACCEPTANCE OR
AN OFFER TO PURCHASE,  WITHDRAWAL,  CANCELLATION  OR  MODIFICATION OF THE OFFER,
WITHOUT NOTICE.  THE COMPANY RESERVES THE RIGHT TO REJECT ANY ORDER, IN WHOLE OR
IN PART, FOR THE PURCHASE OF ANY OF THE SECURITIES OFFERED HEREBY.

     This  offering  involves  special risks  concerning  the Company (see "Risk
Factors").  Investors should  carefully review the entire  Memorandum and should
not  invest  any funds in this  Offering  unless  they can  afford to lose their
entire  investment.  In making an investment  decision,  investors  must rely on
their own examination of the issuer and the terms of the Offerin&  including the
merit and risks involved.

                                        1

<PAGE>

                                OFFERING SUMMARY

Thefollowing  summary  information  is qualified in its entirety by the detailed
information and financial  statements and notes thereto  appearing  elsewhere in
this Memorandum.

The Company is involved in the  development  of internet  related  products  and
services.  The Company was incorporated in the state of Florida,  it's principal
executive  office is  located at 2455  Hollywood  Blvd,  Suite  495,  Hollywood,
Florida 33020, and it's telephone number is (954)-453-1195.

                                  RISK FACTORS

THE SECURITIES OFFERED HEREBY ARE SPECULATIVE AND INVOLVE A HIGH DEGREE OF RISK.
ONLY THOSE PERSONS ABLE TO LOSE THEIR ENTIRE  INVESTMENT  SHOULD  PURCHASE THESE
SECURITIES.  PROSPECTIVE  INVESTORS,  PRIOR TO  MAKING AN  INVESTMENT  DECISION,
SHOULD  CAREFULLY READ THIS  PROSPECTUS  AND CONSIDER,  ALONG WITH OTHER MATTERS
REFERRED TO HEREIN, THE FOLLOWING RISK FACTORS:

Risk Factors Relating to the Business of the Company

Start-up or Development Stage Company.   The Company has had no operations since
its  organization  and  is  a  "start-up  or  "development  stage"  company.  No
assurances  can be given that the  Company  will be able to  compete  with other
companies in its industry. The purchase of the securities offered hereby must be
regarded as the placing of funds at a high risk in a new or  "start-up"  venture
with all the unforeseen  costs,  expenses,  problems,  and difficulties to which
such ventures are subject.  See "Use of Proceeds to Issuer" and  "Description of
Business."

No  Assurance  of   Profitability.   To  date,   the  Companyhas  not  generated
anysigaificant  revenues from  operations.The  Company does not  anticipate  any
significant  revenues in the near future.  The Company's ability to successfully
implement  its business plan is dependent on the  completion  of this  Offering.
There  can be no  assurance  that the  Company  will be able to  develop  into a
successfiil or profitable business.

No Assurance  ofPayment of  Dividends.No  assurances can be made that the future
operations  of the  Company  will  result  in  additional  revenues  or  will be
profitable. Should the operations of the Company become profitable, it is likely
that the Company  would  retain much or all of its  earnings in order to finance
future growth and expansion. Tberefore, the Company does not presently intend to
pay  dividends,  and it is not  likely  that any  dividends  will be paid in the
foreseeable future. See "Dividend Policy."

Possible  Need for  Additional  Financing.  The  Company  intends  to fiind  its
operations and other capital needs for the next 12 months substantially from the
proceeds of this Offerin& but there can be no assurance  that such funds will be
sufficient for these  purposes.  The Company may require  additional  amounts of
capital  for its future  reasearch  and  deveolpment  of Internet  services  and
products,  operating  costs  and  working  capital.  The  Company  has  made  no
arrangements to obtain fiiture additional firiancin& and if required,  there can
be no assurance that such  financing  will be available,  or that such financing
will be available on acceptable terms. See "Use of Proceeds"

Dependence on Management.  The Company's success is principally dependent on its
current management personnel for the operation of its business.

Broad  Discretion in Application of Proceeds.  The management of the Company has
broad discretion to adjust the application and allocation of the net proceeds of
this offering, in order to address changed circumstances and opportunities. As a
result  of the  foregoin&  the  success  of the  Company  will be  substantially
dependent upon the discretion and judgment of the management of the Company with
respect to the application and allocation of the

                                       2

<PAGE>

net  proceeds  hereof  Pending use of such  proceeds,  the net  proceeds of this
offering   will  be   invested   by  the   Company  in   temporary,   short-term
interest-bearing obligations. See "Use of Proceeds."

Arbitrary  Offering  Price.  There  has  been no  prior  public  market  for the
Company's  securities.  The price to the public of the Shares offered hereby has
been  arbitrarily  determined  by the Company and bears no  relationship  to the
Company's earnings, book value or any other recognized criteria of value.

Immediate  and  Substantial  Dilution.    An  investor  in  this  offering  will
experience immediate and substantial dilution.

Lack of Prior Market for Securities of the Company.  No prior market has existed
for the  securities  being  offered  hereby and no assurance can be given that a
market will develop subsequent to this offering.

No Escrow of Investors'  Funds - This offering is being made on a "best efforts,
no minimum  basis" As such, all the funds from this Offering will be immediately
available to the Company.

                                USE OF PROCEEDS

The proceeds from this Offering will be used for the research and development of
internet related products and services.

                                DIVIDEND POLICY

Holders of the Company's  Common Stock are entitled to dividends when, as and if
declared by the Board of Directors out of funds legally available therefor.  The
Company does not anticipate  the  declaration or payment of any dividends in the
foreseeable  future. Ile Company intends to retain earnings,  if any, to finance
the  development  and expansion of its business.  Future dividend policy will be
subject to the discretion of the Board of Directors and will be contingent  upon
future   earnings,   if  any,  the  Company's   financial   condition,   capital
requirements,  general business conditions and other factors.  Therefore,  there
can be no assurance that any dividends of any kind will ever be paid.

                                  THE COMPANY

The Company's  inital primary  service will consist of deveolping web home pages
for small businesses.  These services will include developing  graphical display
text, video files, sound clips and graphics.  The Company plans to use the fully
interactive  capabilities of the current  available web technology to create web
sites of home pages of content  which any  internet  user with a web browser can
access.  A summary of the  Company's  planned  services  and  products  include:
advising  clients on information to be communicated and links to be established,
write promotional copy, prepare story boards and graphics design,  create images
using audio, video and multimedia designs, prepare content in internet languages
for placement on the net and provide technical service for web maintance.  There
is no assurance that the Company will be able to achieve these goals, or even if
it does achieve these goals, that the Company will be profitable.

Management

The following sets forth the names of the Company's officers and directors:

Timothy Bullinger: is a Director of the Company.  Mr.Bullinger has over 15 years
of  experience in design and  architecture.  He heads a design firm that creates
designs for homes,  products and fashion on a international level. Mr. Bullinger
also has extensive  technical  experience  in audio  recording  engineering  and
computer generated multimedia design.

                                       3
<PAGE>

Lance  Dusanj:  is a Director  of the  Company.  Mr.  Dusanj has over 7 years of
industrial  experience working at White Pine Division of MacMillan Bloedel Ltd.,
and  brings to the  Company a  tremendous  wealth of  contacts  in the  industrW
sector.. In addition,  Mr. Dusanj has extensive  experience in corporate finance
and personnel management.

Arian Soheili : is a Director of the Company. Mr. Sobel has extensive experience
in the  computer  technology  fields such as interne%  intranet  and  electronic
commerce.  The Company also benefits  from his many years of personell,  finance
and accounting skills.

                             EXECUTIVE COMPENSATION

Since the Company was recently  incorporated,  it has no historical  information
with respect to executive  compensation.  At the conclusion of the Offering, the
Company does not intend to  compensate  its officers for services to the Company
from the  proceeds of this  Offering and will only do so when and if the Company
generates profits.

Compensation of Directors  ------------------------- Directors are not paid fees
for their services nor reimbursed for expenses of attending board meetings.

                           DESCRIPTION OF SECURITIES

Shares

The Company is offering hereby a "best efforts,  no minimum basis" up to 200,000
shares of Common Stock at $0.25 per Share.

Common Stock

The authorized  capital stock of the Company  consists of 100,000,000  shares of
Common  Stock,  $.001  par  value,  Holders  of the  Common  Stock  do not  have
preemptive  rights  to  purchase  additional  shares  of  Common  Stock or other
subscription  rights.  The Common Stock carries no conversion  rights and is not
subject to  redemption or to any sinking fund  provisions.  All shares of Common
Stock are entitled to share equally in dividends from sources legally  available
therefor  when,  as  and if  declared  by  the  Board  of  Directors  and,  upon
liquidation or dissolution of the Company, whether voluntary or involuntary,  to
share  equally  in the  assets of the  Company  available  for  distribution  to
stockholders.  All outstanding shares of Common Stock are validly authorized and
issued,  fally paid and  nonassessable,  and all shares to be sold and issued as
contemplated  hereby,  will be validly  authorized  and issued,  fiffly paid and
nonassessable.  The Board of Directors is authorized to issue additional  shares
of  Common  Stock,  not  to  exceed  the  amount  authorized  by  the  Company's
Certificate  of  Incorporation,  on such  terms  and  conditions  and  for  such
consideration  as the Board may deem  appropriate  without  further  stockholder
action.  The above  description  concerning die Common Stock of the Company does
not purport to be complete.  Reference is made to the Company's  Certificate  of
Incorporation  and Bylaws which are available for inspection  upon proper notice
at the Company's offices,  as well as to the applicable statutes of the State of
Florida for a more complete description concerning the rights and liabilities of
stockholders.

Prior to this  offerin&  there has been no market  for the  Common  Stock of the
Company, and no predictions can be made of the effect, if any, that market sales
of shares or the  availability  of shares for sale will have on the market price
prevailing from time to time. Nevertheless,  sales of significant amounts of the
Common Stock of the Company in the public market may adversely affect prevailing
market  prices,  and may impair the  Company's  ability to raise capital at that
time through the sale of its equity securities.

                                       4
<PAGE>

Each holder of Common  Stock is entitled to one vote per share on all matters on
which such  stockholders  are entitled to vote. Since the shares of Common Stock
do not have cumulative voting rights, the holders of more than 50 percent of the
shares  voting for the election of directors can elect all the directors if they
choose to do so and, in such event, the holders of the remaining shares will not
be able to elect any person to the Board of Directors.

                              PLAN OF DISTRIBUTION

The Company has no underwriter  for this  Offering.  The Offering is therefore a
self-underwriting.  The Shares  will be offered by the  Company at the  offering
price of $0.25 per Share.

Price of the Offering.
- ----------------------

There is no,  and never  has  been,  a market  for the  Shares,  and there is no
guaranty that a market will ever develop for the Company's shares. Consequently,
the  offering  price has been  determined  by the Company.  Among other  factors
considered in such  determination  were estimates of business  potential for the
Company,  the  Company's  financial  condition,  an  assessment of the Company's
management  and the general  condition of the  securities  market at the time of
this Offering. However, such price does not necessarily bear any relationship to
the assets, income or net worth of the Company.

The offering price should not be considered an indication of the actual value of
the Shares. Such price is subject to change as a result of market conditions and
other  factors,  and no assurance  can be given that the Shares can be resold at
the Offering Price.

There can be no  assurance  that an active  trading  market  will  develop  upon
completion of this Offerin& or if such market  develops,  that it will continue.
Consequently,  purchasers  of the  Shares  offered  hereby  may not find a ready
market for Shares.

                             ADDITIONAL INFORMATION

Each investor  warrants and  represents to the Company that,  prior to making an
investment in the Company,  that he has had the opportunity to inspect the books
and records of the Company and that he has had the opportunity to make inquiries
to the  officers  and  directors  of the Company  and  further  that he has been
provided full access to such information.

                                       5
<PAGE>
                       _____________________________________

                       INVESTOR SUITABILITY STANDARDS AND

                             INVESTMENT RESTRICTIONS
                       _____________________________________

                                  Suitability

Shares will be offered and sold pursuant an exemption  under the Securities Act,
and exemptions  under  applicable  state securities and Blue Sky laws. There are
different  standards under these federal and state  exemptions which must be met
by prospective investors in the Company.

The Company will sell Shares only to those Investors it reasonably believes meet
certain suitability requirements described below.

Each prospective Investor must complete a Confidential  Purchaser  questionnaire
and  each   Purchaser   Representative,   if  any,  must  complete  a  Purchaser
Representative Questionnaire.

EACH INVESTOR MUST BE RESPONSIBLE FOR DETERMINING THAT IT IS PERMITTED TO INVEST
IN THE COMPANY,  THAT ALL  APPROPRIATE  ACTIONS TO AUTHORIZE  SUCH AN INVESTMENT
HAVE BEEN TAKEN, AND THAT ANY  REQUIREMENTS  THAT ITS INVESTMENTS BE DIVERSIFIED
OR SUFFICIENTLY LIQUID HAVE BEEN MET.

An investor will qualify as an accredited Investor if it falls within any one of
the following categories at the time of the sale of the Shares to that Investor:

(1) A bank as defined in Section 3(a)(2) of the Securities Act, or a savings and
loan  association or other  institution as defined in Section  3(a)(5)(A) of the
Securities Act, whether acting in its individual or fiduciary capacity; a broker
or dealer  registered  pursuant to Section 15 of the Securities  Exchange Act of
1934; an insurance company as defined in Section 2(13) of the Securities Act; an
investment  company  registered  under the  Investment  Company Act of 1940 or a
business development company as defined in Section 2(a)(48) of that Act; a Small
Business  Investment  Company  licensed  by the  United  States  Small  Business
Administration under Section 301 (c) or (d) of the Small Business Investment Act
of  1958;  a  plan   established  and  maintained  by  a  state,  its  political
subdivisions,  or any  agency  or  instrumentality  of a state or its  political
subdivisions, for the benefit of its employees, if such plan has total assets in
excess of  $5,000,000;  an  employee  benefit  plan  within  the  meaning of the
Employee  Retirement Income Security Act of 1974, if the investment  decision is
made by a plan  fiduciary,  as defined in  Section  3(21) of that Act,  which is
either a bank, savings and loan association,  insurance  company,  or registered
investment  adviser,  or if the employee benefit plan has total assets in excess
of $5,000,000,  or, if  aself-directed  plan with the investment  decisions made
solely by persons that are accredited investors;

(2) A private business  development company as defined in Section 202(a) (22) of
the Investment Advisers Act of 1940;

(3) An organization  described in Section 501(c)(3) of the Internal Revenue Code
with total assets in excess of $5,000,000;

(4) A director or executive officer of the Company.

(5) A natural person whose  individual  net worth,  or joint net worth with that
person's  spouse,  at the time of such person's  purchase of the Shares  exceeds
$1,000,000;

                                       6
<PAGE>

(6) A natural person who had an individual  income in excess of $200,000 in each
of the two most recent years or joint income with that person's spouse in excess
of $300,000 in each of those years and has a reasonable  expectation of reaching
the same income level in the current year;

(7) A trust  with  total  assets in excess of  $5,000,000,  not  formed  for the
specific purpose of acquiring the securities offered, whose purchase is directed
by a sophisticated person as describe in Rule 506(b)(2)(ii) of Regulation D; and

(8) An entity in which all of the equity  owners are  accredited  investors  (as
defined above).

As used in this  Memorandum,  the term "net  worth"  means  the  excess of total
assets over total  liabilities.  In  computing  net worth for the purpose of (5)
above, the principal residence of the investor must be valued at cost, including
cost of improvements,  or at recently appraised value by an institutional lender
making a secured loan, net of  encumbrances.  In determining  income an investor
should add to the investor's  adjusted gross income any amounts  attributable to
tax exempt income  received,  losses claimed as a limited partner in any limited
partnership,  deductions claimed for depletion, contributions to an IRA or KEOGH
retirement plan, alimony payments, and any amount by which income form long-term
capital gains has been reduced in arriving at adjusted gross income.

In order to meet the conditions for exemption from the registration requirements
under the securities laws of certain jurisdictions,  investors who are residents
of  such   jurisdiction   may  be  required  to  meet   additional   suitability
requirements.

An Investor that does not qualify as an accredited  Investor is a  nonaccredited
Investor and may acquire Shares only if

(1) The Investor is knowledgeable and experienced with respect to investments in
limited partnerships either alone or with its Purchaser Representative,  if any;
and

(2) The Investor has been provided  access to all relevant  documents it desires
or needs; and

(3) The  Investor is aware of its limited  ability to sell and/or  transfer  its
Shares in the Company; and

(4) The  Investor  can bear the  economic  risk  (including  loss of the  entire
investment) without impairing its ability to provide for its financial needs and
contingencies in the same manner as it was prior to making such investment.

THE COMPANY  RESERVES  THE RIGHT IN ITS  ABSOLUTE  DISCRETION  TO DETERMINE IF A
POTENTIAL INVESTOR MEETS OR FAILS TO MEET THE SUITABILITY STANDARDS SET FORTH IN
THIS SECTION.

Additional Suitability Requirements for Benefit Plan Investor:

In addition to the foregoing  suitability  standards generally applicable to all
Investors,  the Employee  Retirement  Income  Security  Act of 1934,  as amended
("ERISA"), and the regulations promulgated thereunder by the Department of Labor
impose certain additional suitability standards for Investors that are qualified
pension,  profit-sharing  or stock bonus plans  ('Benefit  Plan  Investor").  In
considering  the purchase of Shares,  a fiduciary  with respect to a prospective
Benefit Plan  Investor  must  consider  whether an investment in the Shares will
satisfy the prudence  requirement of Section  404(a)(1)(B) of ERISA, since there
is not expected to be any market  created in which to sell or otherwise  dispose
of the Shares.  In addition,  the fiduciary must consider whether the investment
in Shares will satisfy the diversification  requirement of Section  404(a)(1)(C)
of ERISA.

                                       7
<PAGE>

Restrictions on Transfer or Resale of Shares

The  Availability of Federal and state exemptions and the legality of the offers
and sales of the Shares are conditioned upon, among other things,  the fact that
the purchase of Shares by all Investors are for investment purposes only and not
with a view to resale or distribution.  Accordingly,  each prospective  Investor
win be required to represent in the Subscription Agreement that it is purchasing
the Shares for its own account and for the purpose of investment  only, not with
a view to, or in accordance  with,  the  distribution  of sale of the Shares and
that it will not sell,  pledge,  assign or  transfer  or offer to sell,  pledge,
assign or transfer any of its Shares without an effective registration statement
under the Securities  Act, or an exemption  there from and an opinion of counsel
acceptable  to the Company that  registration  under the  Securities  Act is not
required and that the transaction complies with all other applicable Federal and
state securities or Blue Sky laws.

                                       8
<PAGE>

                          PANTHEON TECHNOLOGIES, INC.
             SUBSCRIPTION AGREEMENT SIGNATURE PAGE FOR INDIVIDUALS

Number of Shares Subscribed for:           ____________________

Amount tendered at $0.25 per Share:        ____________________

___________________________     ______________________________________________
(Signature of Subscriber)       (Signature of Spouse, or joint tenant, if any)

___________________________     ___________________________________________
(Printed Name of Subscriber)    (Printed Name of Spouse, or
                                other joint tenant, if any)

___________________________     ___________________________________________
(Address)                       (Address)

___________________________     ___________________________________________
(Social Security Number)        (Social Security Number)

     APPROVED AND  ACCEPTED in  accordance  with the terms of this  Agreement on
this ___ day of __________,1997.



                                    PANTHEON TECHNOLOGIES, INC.


                                    By: ______________________________________
                                                  DIRECTOR

                                       9

                                  CONFIDENTIAL

                      NOT TO BE REPRODUCED OR DISTRIBUTED

                                 Memorandum No.

                                Name of Offeree:

                     PRIVATE PLACEMENT MEMORANDUM OF UNITS
                                       OF

                          Pantheon Technologies, Inc.
                      (a Florida Corporation) ("Company")

2,000,000 Common Shares and 2,000,000  Common Share Purchase  Warrants $.001 Par
Value  $0.05 Per Share  Warrants  exerciseable  at $0.05 per Share  expiring  on
September 18th, 2001.

                               MINIMUM INVESTMENT
                                  2,500 Shares
                                    $125.00

                          Principal Executive Offices:
                          1628 West 1st Ave, Suite 219
                             Vancouver, BC, V6J-1G1
                                 (604) 739-7911

              The date of this Memorandum is September 18th, 1998
<PAGE>

                          PANTHEON TECHNOLOGIES, INC.

Type of securities  offered : Shares of the Company's  common stock,  $0.001 par
value.

Number of Units offered: 2,000,000 Shares and 2,000,000 Warrants

Price per security:  $0.05  per  Share.  Warrant exerciseable at $0.05 per Share
up until September 18th, 2001.

Total proceeds:If all shares sold:$100,000.If all Warrants exercised $200,000.00

Is a commissioned selling agent selling the securities in this offering?
Yes     [XI No

If yes, what percent is commission of price to public?

Is there other compensation to selling agent(s)?
Yes     [X] No

Is there a finder's fee or similar payment to any person?
Yes     [X] No

Is there an escrow of proceeds until minimum is obtained?
[ ] Yes         [X] No

Is this offering limited to members of a special group, such as employees of the
Company or individuals?
[ ] Yes         [X] No

Is transfer of the securities restricted?
[ ] Yes         [X] No

THIS OFFERING OF SECURITIES HAS NOT BEEN  REGISTERED  UNDER  THE  SECURITIES ACT
OF 1933 OR APPROVED OR  DISAPPROVED  BY THE SECURITIES  AND EXCHANGE  COMMISSION
NOR HAS THE COMMISSION  PASSED UPON THE ACCURACY OR ADEQUACY OF THIS  MEMORANDUM
ANY  REPRESENTATION  TO THE CONTRARY IS A CRIMINAL  OFFENSE.  THE  OFFERING WILL
TERMINATE  UPON THE EARLIER OF ALL OF  THE SHARES OR  DECEMBER  31,  1998.   THE
COMPANY IS NOT REQUIRED  TO SELL ANY  MINIMUM  NUMBER OF SHARES IN ORDER TO SELL

                                       2
<PAGE>

SHARES IN THE OFFERING. THE COMPANY  MAY  IN  ITS  DISCRETION  CONDUCT  MULTIPLE
CLOSINGS.  ( SEE " DESCRIPTION  OF  THE OFFERING. ") THIS  MEMORANDUM  HAS  BEEN
PREPARED SOLELY FOR USE IN  CONNECTION  WITH THE PRIVATE PLACEMENT OF THE SHARES
OFFERED HEREBY AND MAY NOT BE REPRODUCED  OR  USED  FOR  ANY  OTHER  PURPOSE THE
OFFEREE  AGREES TO RETURN TO THE COMPANY THIS  MEMORANDUM  AND  ALL  ATTACHMENTS
AND  RELATED.  DOCUMENTATION  IF  THE  OFFEREE  DOES  NOT  SUBSCRIBE TO PURCHASE
SHARES IN THE OFFERING.

THESE  SECURITIES  ARE BEING OFFERED ONLY TO INVESTORS WHO THE OFFEROR  BELIEVES
HAVE THE  QUALIFICATIONS  NECESSARY TO PERMIT THE  SECURITIES  TO BE OFFERED AND
SOLD UNDER APPLICABLE  EXEMPTIONS FROM REGISTRATION  UNDER THE ACT AND QUALIFICA
TION UNDER  APPLICABLE  STATE  STATUTES,  THE OFFEROR  WILL BE THE SOLE JUDGE OF
WHETHER AN INVESTOR POSSESSES SUCH  QUALIFICATIONS  NOTWITHSTANDING  DELIVERY OF
THIS  MEMORANDUM  AND ASSOCIATED  DOCUMENTATION,  THE OFFEROR DOES NOT INTEND TO
EXTEND AN OFFER TO SELL OR TO SOLICIT AN OFFER TO BUY THESE SECURITIES UNTIL THE
OFFEROR   DETERMINES  THAT  THE  OFFEREE  IS  QUALIFIED  AND  COMMUNICATES  SUCH
DETERMINATION  TO INVESTORS IN WRITING THE SHARES ARE BEING OFFERED IN A PRIVATE
PLACEMENT TO A LIMITED NUMBER OF INVESTORS THIS  MEMORANDUM  DOES NOT CONSTITUTE
AN  OFFER  OR  SOLICITATION   IN  ANY   JURISDICTION  IN  WHICH  SUCH  OFFER  OR
SOLICITATIONS  NOT PERMITTED UNDER  APPLICABLE LAW OR ANY FIRM OR INDIVIDUAL WHO
DOES NOT POSSESS THE QUALIFICATIONS DESCRIBED IN THIS MEMORANDUM

THE SHARES OFFERED HEREBY HAVE NOT BEEN  REGISTERED  UNDER THE SECURITIES ACT OF
1933 (THE "ACT'),  OR THE  SECURITIES  LAWS OF FLORIDA OR OTHER STATES,  AND ARE
BEING  OFFERED  AND  SOLD  IN  RELIANCE  ON  EXEMPTIONS  FROM  THE  REGISTRATION
REQUIREMENTS OF THE ACT AND SUCH LAWS THERE IS A PUBLIC MARKET FOR SECURITIES OF
THE COMPANY  EVEN IF SUCH A MARKET DID NOT EXIST,  PURCHASERS  OF SHARES WILL BE
REQUIRED TO REPRESENT THAT THE SHARES ARE BEING ACQUIRED FOR INVESTMENT PURPOSES
AND NOT WITH A VIEW TO SALE OR DISTRIBUTION,  AND PURCHASERS WlLL NOT BE ABLE TO
RESELL THE SHARES UNLESS THE SHARES ARE  REGISTERED  UNDER THE ACT AND QUALIFIED
UNDER THE APPLICABLE STATE STATUTES (UNLESS AN EXEMPTION FROM SUCH  REGISTRATION
AND QUALIFICATION IS AVAILABLE).  PURCHASERS OF THE SHARES SHOULD BE PREPARED TO
BEAR THE ECONOMIC RISK OF THEIR INVES7MENT FOR AN INDEFINITE PERIOD OF TIME

THE  PURCHASE  OF THESE  SECURITIES  WILL  ENTAIL A HIGH  DEGREE  OF RISK  THESE
SECURITIES  ARE  SUITABLE  ONLY  FOR  PERSONS  WHO  HAVE  SUBSTANTIAL  FINANCIAL
RESOURCES AND HAVE NO LIQUIDITY IN THIS INVESTMENT NO ONE

                                       3
<PAGE>

SHOULD INVEST IN THE SHARES WHO IS NOT PREPARED TO LOSE THEIR ENTIRE  INVESTMENT
PROSPECTIVE  INVESTORS  SHOULD  CONSIDER  CAREFULLY THE RISK TA CTORS INDICATED
UNDER  "RISK FACTORS."

INVESTORS   SHOULD  NOT  CONSTRUE  THE  CONTENTS  OF  THIS   MEMORANDUM  OR  ANY
COMMUNICATION,  WHETHER  WRITTEN  OR  ORAL,  FROM  THE  COMPANY,  ITS  FOUNDERS,
MANAGEMENT,  EMPLOYEES  OR AGENTS,  AS LEGAL,  TAX,  ACCOUNTING  OR OTHER EXPERT
ADVICE EACH  INVESTOR  SHOULD  CONSULT THEIR OWN COUNSEL,  ACCOUNTANT  AND 0THER
PROFESSIONAL  ADVISORS  AS  TO  LEGAL,  TAX,  ACCOUNTING,  AND  RELATED  MATTERS
CONCERNING HIS INVESTMENT AND ITS SUITABILITY FOR THEM.

NO PERSON  (OTHER THAN OFFICERS OF THE COMPANY TO WHOM REQUESTS ARE DIRECTED FOR
ADDITIONAL  INFORMATION  CONCERNING  THIS  OFFERING) IS  AUTHORIZED  TO GIVE ANY
INFORMATION OR MAKE ANY REPRESENTATIONS  (WHETHER ORAL OR WRITTEN) IN CONNECTION
WITH THIS  OFFERING  EXCEPT SUCH  INFORMATION  AS IS  CONTAINED  IN THIS PRIVATE
PLACEMENTMEMORANDUMAND THE ATTACHMENTS THERETO AND DOCUMENTS REFERRED TO HEREIN.
ONLY INFORMATION OR  REPRESENTATIONS  CONTAINED HEREIN AND THEREIN MAY BE RELIED
UPON AS HAVING BEEN AUTHORIZED.

THE   SECURITIES   OFFERED   HEREBY  WILL  BE  SOLD  TO  SUBJECT  TO  THE  STOCK
SUBSCRIPTIONAGREEMENTATTACHED  AS ATTACHMENT OF THIS MEMORANDUM,  WHICH CONTAINS
CERTAIN  REPRESENTATIONS  WARRANTIES,  TERMS AND CONDITIONS EACH INVESTOR SHOULD
CAREFULLY REVIEW THE PROVISIONS OF THE SUBSCRIPTION A GREEMENT BEFORE INVESTING.

This Company:

[   ] Has never conducted operations.
[ x ] Is in the development stage.
[   ] Is currently conducting operations.
[   ] Has shown a profit in the last fiscal year.
[   ] Other( Specify) __________________________

(Check at one, as appropriate)

This offering has been registered for offer and sale in the following states:

State             State File No               Effective Date
- -----             -------------               --------------

                                       4
<PAGE>

                               TABLE OF CONTENTS

Cover Page                                                                     1
Disclosure Statements                                                          2
Table of Contents                                                              5
Summary of the Offering                                                        6
The Company                                                                    6
Risk Factors                                                                   7
Use of Proceeds                                                                9
Description of Securities                                                     10
Terms of the Offering                                                         11
Directors, Officers and key Personnel of the Company                          12
Principal Stockholders                                                        13
Remuneration of Directors and Officers                                        13
Reports                                                                       14
Legal Matters                                                                 14
Litigation                                                                    14
Additional Information                                                        14
State Restrictions                                                         14-16

EXHIBITS

Exhibit A       Subscription Agreement                                     17-21


This is an original  unpublished  work  protected  under  copyright  laws of the
United  States and other  countries.  All Rights  Reserved.  Should  publication
occur,   then  the  following  notice  shall  apply:   Copyright  1998  Pantheon
Technologies,  Inc.  All  Rights  Reserved.  No  part of  this  document  may be
reproduced,  stored in a  retrieval  system or  transmitted,  in any form or any
means, electronic, mechanical, photocopying, recording or otherwise, without the
prior written permission of Pantheon Technologies, Inc.

                                       5
<PAGE>

                            SUMMARY OF THE OFFERING

The following material is intended to summarize  information contained elsewhere
in this  Memorandum.  This  summary  is  qualified  in its  entirety  by express
reference  to  the  Memorandum  and  the  exhibits  referred  to  therein.  Each
prospective investor is urged to read this Memorandum in its entirety.

Pantheon  Technologies,  Inc, a Florida  corporation  (the " Company  "), is the
issuer of the Shares.  The  address of the  Company is 1628 West lst Ave,  Suite
216, Vancouver, BC, V6J-lGl.

The Offering. The Company is offering up to 2,000,000 of its common stock units,
par value $.001 per share (the "Shares"). The Minimum investment for an Investor
is 2,500 Shares,  or $125.00.  The Company,  in its sole discretion,  may accept
subscriptions  for up to an aggregate of 2,000,000 or $100,000.00 until December
31st,  1998,  or until such  earlier  date as the Company  determines  that this
Offering shall be terminated.  In its sole discretion,  the Company may elect to
terminate this Offering even if subscriptions  for Shares have been received and
accepted by the  Company.  See "Terms of the  Offering"  and  "Subscription  for
Shares".

Company's  Business:  The  Company is involved  in the  development  of internet
related products and services

Risk Factors:  The offering  involves  speculative  investment with  substantial
risks, including those risks associated with the industry.  Although the Company
will use its best efforts to protect the investments of the Investors,  there is
no assurance  that the  Company's  efforts will be  successful.  Accordingly,  a
prospective  Investor  should not view the Company or its  Officers,  Directors,
employees or agents as guarantors  of the financial  success of an investment in
the Shares. See "Risk Factors".

Limited Transferability of the Shares. The Shares have not been registered under
the 1933 Act or the  securities  laws of any state.  The Shares of common  stock
purchased pursuant to this Offering will not be "restricted"  shares because the
shares  are  offered  under  Rule 504 and this  offering  is  excluded  from the
provisions of Regulation D pertaining to restricted shares.  This does not mean,
however,  that a public market does exist for the Shares.  Currently  there is a
market for the Shares on NASDAQ - OTC  Bulletin  Board.  See "Risk  Factors" and
"Terms of the Offering".

Limitation  of  Liability.  Except for the amounts paid by  Investors  for their
purchase of any Shares,  and as required by Florida  State law, no investor will
be  liable  for any debts of the  Company  or be  obligated  to  contribute  any
additional capital or funds to the Company. See " Risk Factors".

Suitability  Standards.  Each Investor must meet certain  eligibility  standards
established  by the  Company for the  purchase of the Shares.  See "Terms of the
Offering" and "Subscription for Shares".

                                       6
<PAGE>

Use of Proceeds.  The Company plans to use the money received from this offering
to cover the costs involved in the development of Internet  related products and
services.  The funds  will not be  deposited  in an escrow  account  and will be
available to the Company immediately. No minimum amount of Shares is required to
be sold.

                                  THE COMPANY

Exact corporate name:                           Pantheon Technologies, Inc.

State and date of incorporation:                Florida State
                                                April 17, 1997.

Street address of principal office:             1628 West 1st Ave, Suite 219
                                                Vancouver, BC, V6J-1GI
                                                (604) 739-7911

Fiscal Year:                                    December 31 st.

PRODUCTS

The Company is engaged in the  development  of  Internet  related  products  and
services.

MATERIAL CONTRACTS

The Company has no contracts.

MARKETING APPROACHES

The Company intends to establish a commerce based business through the Internet.

                                  RISK FACTORS

An  investment  in the Shares  involves a high  degree of risk.  No  prospective
Investor  should  acquire the Shares unless he can afford a complete loss of his
investment.  The risks  described  below are those which the Company  deems most
significant  as of the date  hereof.  Other  factors  which may have a  material
impact on the operations of the Company may not be foreseen.  In addition to the
other  factors set forth  elsewhere in this  Memorandum,  prospective  Investors
should carefully consider the following specific risk factors:

                                       7

<PAGE>

A.   OPERATING RISKS

     General.  The economic success of an investment in the Shares depends, to a
large  degree,  upon many factors  over which the Company has no control.  These
factors  include  general  economic,  industrial and  international  conditions;
inflation or deflation;  fluctuation in interest rates; the availability of, and
fluctuations in the money supply.  The extent,  type and  sophistication  of the
Company's competition; and government regulations.

     Operations. The Company has no operations.

     Dependence on Key Personnel.  The Company's  success will depend,  in large
part,  upon the talents and skills of key  management  personnel.  To the extent
that  any  of  its  management  personnel  is  unable  or  refuses  to  continue
association  with the Company,  a suitable  replacement  would have to be found.
There  is no  assurance  that  the  Company  would  be  able  to  find  suitable
replacements for such personnel, or that suitable person.

     Lack of  Adequate  Capital,  Additional  capital  will be  required  in the
Company's  future  operations.  In the absence of any  additional  funding,  the
Company's  operations  may be  affected  negatively.  Therefore,  the  Company's
management will be careful and use its best judgment in directing the affairs of
the Company in a manner that maximizes its chances of success and,  accordingly,
the best chances of raising future funding.

     Inherent  Business  Risks.  The  business  that the  Company  is engaged in
involves substantial and inherent risks associated with an emerging company with
limited financial resources.

B.   INVESTMENT RISKS

     Speculative Investment, The Shares are a very speculative investment. There
can be no assurance  that the Company will attain its  objective  and it is very
likely that the Company will not be able to advance any business  activities and
Investors could lose their entire investments.

     Arbitrary  Purchase Price; No Market. The purchase price for the Shares has
been arbitrarily determined by the Company, and is not necessarily indicative of
their  value.  No  assurance  is or can  be  given  that  the  Shares,  although
transferable,  could be sold for the purchase  price,  or for any amount.  There
currently is a market for resale of the Shares.

     Restriction  of  Transferability.   While  the  Company  believes  that  no
restriction  exists for the transfer of the Shares being offered by the Company,
an investment in the Shares may be a long term investment.  Investors who do not
wish or who are not financially able to hold the Shares for a substantial period
of time are advised  against  purchasing  Shares.  The Shares are not registered
under  the 1933 Act or under the  securities  laws of any  state,  but are being
offered by the Company under the exemption  from  registration  provided by Rule
504 under Regulation D and related state and foreign exceptions.

                                       8

<PAGE>

     "Best  Efforts"  Offers , The Shares are being offered on a "best  efforts"
basis by the Company.  No person or entity is committed to purchase or take down
any of the  Shares  offered  pursuant  to this  Offering.  No escrow  account is
maintained and no minimum amount is required to be sold. Funds will be available
to the Company upon receipt.

     Management and Operation Experience. The Company's officers,  directors and
other  personnel  have engaged in a variety of businesses and have been involved
in business financing,  operations and marketing,  but their experience in these
fields is limited. There is no assurance that such experience will result in the
success of the Company.

     Other Risks.  No assurance can be given that the Company will be successful
in achieving its stated objectives, that the Company's business is undertaken by
the  Company,  will  generate  cash  sufficient  to operate the  business of the
Company or that other parties entering into agreements relating to the Company's
business will meet their respective obligations.

     Dividends,  The Company's Board of Directors presently intends to cause the
Company to follow a policy of  retaining  earnings,  if any,  for the purpose of
increasing the net worth and reserves of the Company. Therefore, there can be no
assurance that any holder of Common Stock will receive any cash,  stock or other
dividends on his shares of Common Stock.  Future  dividends on Common Stock,  if
any,  will  depend on the  future  earnings,  financing  requirements  and other
factors.

     Additional Securities Available for Issuance.  The Company's Certificate of
Incorporation  authorizes the issuance of 100,000,000 shares of Common Stock. At
this  time,  3,200,000  shares of common  stock have been  issued.  Accordingly,
including  those  purchasing  the shares  offered  with the sale of these units,
investors will be dependent  upon the judgment of management in connection  with
the future  issuance and sale of shares of the Company's  capital stock,  in the
event purchasers can be found for such securities.

                                USE OF PROCEEDS

     The Company  will incur  expenses  in  connection  with the  Offering in an
amount  anticipated  not to exceed  $3,500.00 for legal fees,  accounting  fees,
filing fees, printing costs and other expenses.  If the maximum number of Shares
are sold, the Company  anticipates that the net proceeds to it from the Offering
will be as  follows:

     Item                                    Maximum Shares Sold
     ----                                    --------------------
Offering Expenses                            $100,000.00


Offering Expenses
- -----------------

                                       9

<PAGE>

Offering Expenses
- -----------------

   Cost of Offering                                 $3,500.00
                                                    ---------

          TOTAL PROCEEDS RECEIVED:                $ 96,500.00

Operating Expenses
- ------------------
Working capital                                   $ 50,000.00
Development of Internet products and Services     $ 46,500.00
                                                  -----------
          TOTAL                                   $ 96,500.00

     NET FUNDS AVAILABLE TO COMPANY

     The Company  estimates  that the costs of the Offering  will be as follows:
(i) legal fees of approximately $1,500.00, (ii) accounting fees of approximately
$1,000 and (iii) printing and other miscellaneous costs of approximately $1,000.
A sales commissions will be paid only to NASD  broker/dealer and no other person
will receive any commissions or remuneration from the Company.

     The net proceeds of this offering, assuming all the Units are sold, will be
sufficient  to sustain the  planned  marketing  activities  of the Company for a
period of 6 months,  depending upon the number of Units sold in the offering and
other  factors.  Even if all the Units offered  hereunder are sold,  the Company
will  require  additional  capital  in  order  to  fund  continued   development
activities and capital  expenditures  that must be made. The Company's  business
plan is based on the premise that  additional  funding will be obtained  through
funds generated from operations, the exercising of the warrants by shareholders,
additional offerings of its securities,  or other arrangements.  There can be no
assurance that any securities  offerings will take place in the future,  or that
funds sufficient to meet any of the foregoing needs or plans will be raised from
operations or any other source.

                           DESCRIPTION OF SECURITIES

     The following  discussion  describes the stock and other  securities of the
Company.

     General.  The Company  currently has 100,000,000  authorized common shares,
par value  $.001 per share,  of which  3,200,000  common  shares were issued and
outstanding  as of the date of this  Placement.  All of the  outstanding  common
shares of the Company are fully paid for and nonassessable.

     Voting Rights.  Each share of the 3,200,000  shares of the Company's common
stock held by its current  shareholders  is entitled to one vote at shareholders
meetings.

                                       10
<PAGE>

     Dividends.  The Company has never paid a dividend  and does not  anticipate
doing so in the near future.

     Options. The Company does not have any outstanding Stock Option's.

     Miscellaneous  Rights and Provisions.  Shares of the Company's common stock
have no pre-emptive  rights.  The Shares do not have any conversion  rights,  no
redemption  or sinking  fund  provisions,  and are not liable to further call or
assessment.  The  Shares,  when paid for by  Investors,  will be fully  paid and
nonassessable.  Each share of the  Company's  common shares is entitled to a pro
rata  share in any  asset  available  for  distribution  to  holders  of  equity
securities upon the liquidation of the Company.

                             TERMS OF THE OFFERING

     The Company is offering to qualified investors a maximum of 2,000,000 Share
(Units) at a purchase  price of $0.05 per share of the  Company's  common stock,
with a warrant that  entitles  the  purchaser  an  additional  common share when
exercised at $0.05 per share on or before September 18th, 2001. The Company may,
in its sole  discretion,  terminate the offering at any time.  The Offering will
close on the earliest of December 31st, 1998 or the election of the Company when
all of the Shares are sold,  in no event later than  December 3 1 st, 1998.  The
minimum  subscription  is $125.00  (2,500  Shares) per  Investor,  although  the
Company, in its sole discretion, may accept subscriptions for lesser amounts.

     Terms of Sale:  The Company  hereby agrees to sell to the purchaser and the
purchaser  hereby  agrees to  subscribe  for 2,500  units in the  capital of the
Company  (the  "Units")  for a  purchase  of $0.05 US per Unit for an  aggregate
purchase of $125.00 US (the "Purchase Funds" ).

     Constitution  of  Shares:  Each Unit  will  consist  of one fully  paid and
non-assessable  common share in the capital stock ( the "Share" ) of the Company
and the right to purchase one share purchase warrant (the "Warrants") with terms
as described below.

     Terms of Warrants: All Warrants will

(a)  be comprised in one warrant  certificate  ( the  "Warrant  Certificate"  ),
     registered in the name of the purchaser,  representing an aggregate  number
     of Warrants which be equal to the number of Units being acquired  hereunder
     by the Purchaser;

(b)  be non-transferable;

(c)  will be  subject  to the terms and  conditions  which  are  adopted  by the
     Company for the Warrants,  which terms and conditions  will,  amongst other
     things,

                                       11
<PAGE>


     (i)  provide  for an  adjustment  in class and  number  of shares  issuable
          pursuant  to any  exercise  thereof  upon the  occurrence  of  certain
          events, including any subdivision,  consolidation or re-classification
          of the shares, and

     (ii) not  provide  for any  adjustment  in the  number of  shares  issuable
          pursuant to any exercise  thereof in the event of the Company  issuing
          any other  shares,  warrants  or options  to acquire  shares at prices
          either above, at or below the exercise price of the Warrants;

(d)  and each  Warrant  will  provide for the right to purchase  one  additional
     Share.  The Warrant will be  exerciseabel  in whole or in part from time to
     time at any time prior to 4:30 p.m.  (P.S.T)  on  September  18th,  2001 at
     $0.05 per Share.

     The Shares are being  offered and sold by the Company  under the  exemption
from  registration  contained  in  Rule  504  under  Regulation  D  and  related
exemptions from state registration requirements. Rule 504 permits the Company to
offer and sell its stock in an amount not  exceeding  $1,000,000 to an unlimited
number of persons.  Until 1992, Rule 504(b)(2)(ii)  imposed a limited disclosure
obligation  of all issuers such as the Company which was intended to ensure that
investors  in a Rule 504  transaction  were  clearly  advised of the  restricted
character  of the  securities  being  offered  for sale.  This  requirement  was
eliminated in July,  1992 at which time the Securities  and Exchange  Commission
adopted an amendment to Rule 504 that  eliminated all  limitations on the manner
of offering of stock  under that rule  and/or the resale of stock  purchased  in
reliance on that rule. Therefore,  following adoption of the 1992 amendment, the
securities  being  offered  and  sold by the  Company  pursuant  to the  present
Offering are available for immediate resale by nonaffiliates of the issuer.

     The Shares are being offered on a "best  efforts"  basis by the Company and
certain expenses of the Offering will be paid from the proceeds of the Offering.
The Company anticipates that such expenses will not exceed $3,500.00 as detailed
in the Use of Proceeds.

              DIRECTORS, OFFICERS AND KEY PERSONNEL OF THE COMPANY

     Officers and Directors.  The following  information sets forth the names of
the officers  and  directors of the Company,  their  present  position  with the
Company and biographic information:

NAME                  POSITION                                     HELD SINCE
- ----                  --------                                     ----------
Timothy Bulliger      President and Director                   April 17th 1997
Arian Soheili         Director, Secretary and Treasurer        April 18th 1997
Lance Dusarj          Director                                 April 17th 1997

                                       12

<PAGE>

Timothy Bullinger:  is the President and Director of the Company.  Mr. Bullinger
has over fifteen (15) years of experience in design and architecture. He heads a
design  firm  that  creates  designs  for  homes,  products  and  fashion  on  a
international  level. Mr. Bullinger also has extensive  technical  experience in
audio recording engineering,  computer generated multimedia design and extensive
knowledge of the Internet.

Arian  Soheili : is a Director,  Secretary  and  Treasurer of the  Company.  Mr.
Soheili  brings many years of extensive  experience  in the computer  technology
fields such as Internet,  Intranet  and  electronic  commerce.  The Company aslo
gains the  benefit of Mr.  Soheili's  many years of  personell,  accounting  and
finance skills.

Lance Dusanj: is a Director of the Company.  Mr. Dusanj has over seven (7) years
of industrial  experience  working at White Pine  Division of MacMillan  Bloedel
Ltd,,  and brings the Company a tremendous  wealth of contacts in the industrial
sector.  In addition,  Mr. Dusnaj has extensive  experience in corporate finance
and personnel management.

                             PRINCIPAL STOCKHOLDERS

     The following table sets forth information  concerning the shares of Common
Stock of the  Company  owned of record and  beneficially  held as of the date of
this  Memorandum  by (i) each  person  known to the  Company to own of record or
beneficially 5% or more of the 3,200,000  outstanding  shares of Common Stock of
the  Company,  (ii) each  Director of the  Company,  and (iii) all  officers and
directors  of the  Company  as a group,  as of the date of this  Memorandum  and
adjusted  to reflect  share  holdings  after the sale of the  maximum  number of
Shares offered hereby.

Ownership                  No Shares       %       No Shares               %
Name & Position            Pre Issue               Post Issue
- ---------------            ---------               ----------
Timothy Bullinger          3,000,000    93.75%      3,000,000            73.3%

                     REMUNERATION OF DIRECTORS AND OFFICERS

     Directors of the Company who are also  employees of the Company  receive no
additional compensation for their services as Directors. The Company intends, in
the future, to pay Directors who are not employees of the Company,  compensation
of $500 per Director's  Meeting,  as well as reimbursements of any out of pocket
expenses incurred in the Company's behalf

                                    REPORTS

     The books and records of the Company will be maintained by the Company. The
books of account and records shall be kept at the principal place of business of
Pantheon Technologies,

                                       13

<PAGE>


Inc., and each shareholder, or his duly authorized  representatives,  shall have
upon giving ten (10) days prior notice,  access during reasonable business hours
to such books and  records,  and the right to inspect and copy them.  Within 120
days after the close of each fiscal  year,  reports will be  distributed  to the
shareholders which will include financial statements  (including a balance sheet
and  statements of income,  shareholder's  equity,  and cash flows)  prepared in
accordance with generally accepted accounting principals,  with a reconciliation
to the tax  information  supplementary  supplied,  accompanied  by a copy of the
accountant's report.

                                 LEGAL MATTERS

     Gary R.  Blume,  Esquire,  11801  North  Tatum  Blvd,  Suite 108,  Phoenix,
Arizona, 85028 will pass upon certain matters for the Company.

                                   LITIGATION

     The Company is not presently  involved in any material  litigation or other
legal proceedings.

                             ADDITIONAL INFORMATION

     In the opinion of the Board of Directors of the  Company,  this  memorandum
contains  a fair  presentation  of the  subjects  discussed  herein and does not
contain  a  misstatement  of  material  fact or fail to  state a  material  fact
necessary to make any  statements  made herein not  misleading.  Persons to whom
offers are made will be furnished with such  additional  information  concerning
the Company  and other  matters  discussed  herein as they,  or their  purchaser
representative or other advisors,  may reasonably request. The Company shall, to
the extent such information is available or can be acquired without unreasonable
effort or expense,  endeavour to provide the  information  to such persons.  All
offeree's  are  urged  to make  such  personal  investigations,  inspections  or
inquiries as they deem appropriate.

     Questions or requests  for  additional  information  may be directed to Mr.
Timothy Bullinger by calling (604) 73 9-7911.  Requests for additional copies of
this  Memorandum  or  assistance  in  executing  subscription  documents  may be
directed to the Company.

                       STATE RESTRICTIONS AND DISCLOSURES
                     FOR UNREGISTERED SECURITIES OFFERINGS

NOTICE TO ARIZONA RESIDENTS:

     These securities are being sold in reliance upon Arizona!s Limited Offering
exemption from registration pursuant to ARS. 44-1844.

                                       14
<PAGE>

     THE  SHARES  OFFERED  HEREBY  HAVE NOT BEEN  REGISTERED  UNDER THE  ARIZONA
SECURITIES  ACT, AS AMENDED,  AND  THEREFORE,  CANNOT BE  TRANSFERRED  OR RESOLD
UNLESS  THEY  ARE  REGISTERED  UNDER  SUCH  ACT  OR AN  EXEMPTION  THEREFROM  IS
AVAILABLE.

     As a purchaser of such securities  hereby represent that I understand these
securities cannot be resold without  registration  under the Arizona  Securities
Act or an exemption therefrom. I am not an underwriter within the meaning of ARS
44-1801(17),  and I am  acquiring  these  securities  for myself,  not for other
persons.  If qualifying as a non-accredited  investor,  I further represent that
this  investment  does  not  exceed  20% of my net  worth  (excluding  principal
residence, furnishings therein and personal automobiles).

NOTICE TO CALIFORNIA RESIDENTS:

     These  securities  are being sold in  reliance  upon  California's  Limited
Offering Exempti on. 25102(f) of the California Code, as amended.

     THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS MEMORANDUM HAS NOT
BEEN QUALIFIED WITH THE  COMMSSIONER OF  CORPORATIONS OF THE STATE OF CALIFORNIA
AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE
CONSIDERATION  THEREFROM PRIOR TO SUCH  QUALIFICATIONS  IS UNLAWFUL,  UNLESS THE
SALE OF SECURITIES IS' EXEMPT FROM THE QUALIFICATIONS BY SECTION 25100, 25102 OR
26105 OF THE  CALIFORNIA  CORPORATIONS  CODE.  THE  RIGHTS  OF ALL  PARTIES  ARE
EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS
SO EXEMPT.

     THE  COMMISSIONER  OF  CORPORATIONS  OF THE  STATE OF  CALIFORNIA  DOES NOT
RECOMMEND OR ENDORSE THE PURCHASE OF THESE SECURITIES.

NOTICE TO COLORADO RESIDENTS:

     THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS  AMENDED,  OR THE  COLORADO  SECURITIES  ACT OF 1981 BY  REASON  OF  SPECIFIC
EXEMPTIONS  THEREUNDER  RELATING TO THE LIMITED  AVAILABILITY  OF THE  OFFERING.
THESE SECURITIES CANNOT BE SOLD,  TRANSFERRED,  OR OTHERWISE  DISPOSED OF TO ANY
PERSON OR ENTITY UNLESS  SUBSEQUENTLY  REGISTERED  UNDER THE  SECURITIES  ACT OF
1933, AS AMENDED,  OR THE COLORADO  SECURITIES ACT OF 1981, IF SUCH REGISTRATION
IS REQUIRED.

                                       15
<PAGE>

NOTICE TO NEW YORK RESIDENTS:

     THIS PRIVATE  PLACEMENT  MEMORANDUM  HAS NOT BEEN FILED WITH OR REVIEWED BY
THE ATTORNEY  GENERAL PRIOR TO ITS ISSUANCE AND USE. THE ATTORNEY GENERAL OF THE
STATE OF NEW YORK HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY
REPRESENTATION OF THE CONTRARY IS UNLAWFUL.

     THIS PRIVATE  PLACEMENT  MEMORANDUM DOES NOT CONTAIN AN UNTRUE STATEMENT OF
MATERIAL  FACT  AND  DOES  NOT OMIT  ANY  MATERIAL  FACT  NECESSARY  TO MAKE THE
STATEMENTS MADE, IN LIGHT OF THE  CIRCUMSTANCES  UNDER WHICH THEY WERE MADE, NOT
MISLEADING.  IT.  CONTAINS A FAIR  SUMMARY OF THE MATERIAL  TERMS AND  DOCUMENTS
PURPOSED TO BE SUMMARIZED HEREIN.

     Purchaser Statement:

     I  understand  that this  Offering  of Shares has not been  reviewed by the
Attorney   General  of  the  State  of  New  York   because  of  the   Offeror's
representations  that this intended to be a non-public  Offering pursuant to the
Regulation D Rule 504 or 505, and that if all of the conditions and  limitations
of Regulation D are not complied  with,  the Offering will be resubmitted to the
Attorney General for amended exemption. I understand that any literature used in
connection  with this Offering has not been  previously  filed with the Attorney
General and has not been reviewed by the Attorney General.  This Investment Unit
is being purchased for my own account for investment,  and not for  distribution
or resale to others.  I agree that I will not sell or otherwise  transfer  these
securities  unless they are registered under the Federal  Securities Act of 1933
or unless an exemption from such  registration is available.  I represent that I
have  adequate  means of providing  for my current  needs and possible  personal
contingencies  of financial  problems,  and that I have no need for liquidity of
this investment.

     It is understood that all documents,  records and books  pertaining to this
investment have been made available to my attorney, my accountant, or my offeree
representative  and myself,  and that,  upon  reasonable  notice,  the books and
records  of the  issuer  will be  available  for  inspection  by  investors,  at
reasonable hours at the principal place of business.

                                       16
<PAGE>

                                    EXHIBITS

                          Pantheon Technologies, Inc.
                          ---------------------------

                             SUBSCRIPTION DOCUMENT

1. The undersigned hereby subscribes for common stock (hereinafter "Shares"), as
described  in  the  Private  Offering  Memorandum  dated  September  18th,  1998
("Memorandum"),  of Pantheon  Technologies,  Inc.,  a Florida  corporation  (the
"Company"),  being offered by the Company for a purchase price of $0.05 per Unit
and tenders herewith the sum of $ in payment  therefor,  together with tender of
this Subscription Document.

2. The  undersigned  represents  and warrants that he is a bona fide resident of
the State of _____________________.

3. The undersigned acknowledges:

     a.   Receipt of a copy of the  Private  Offering  Memorandum;

     b.   That this subscription, if accepted by the Company, is legally binding
          and irrevocable;

     c.   The Company has over 19 years of financial and operating  history;

     d.   That the Shares have not been  registered  under the Securities Act of
          1933, as amended,  in reliance upon exemptions  contained in that Act,
          and that the Shares have not been registered under the securities acts
          of any state in reliance upon exemptions  contained in certain state's
          securities laws; and

     e.   That the  representations and warranties provided in this Subscription
          Document  are being  relied  upon by the  Company as the basis for the
          exemption from the registration  requirements of the Securities Act of
          1933 and of the applicable state's securities laws.

4. The undersigned represents and warrants as follows:

     a.   That the  undersigned  subscriber  is  purchasing  said  Shares  as an
          investment and said Shares are purchased solely for the  undersigned's
          own account.

     b.   That  the   undersigned   subscriber  has  sufficient   knowledge  and
          experience  in financial  and business  matters to evaluate the merits
          and risks of an investment in the Shares;

                                       17
<PAGE>

     c.   That the  undersigned  subscriber is able to bear the economic risk of
          an investment in the Shares;

     d.   That the  undersigned  subscriber has read and is thoroughly  familiar
          with the Private Offering  Memorandum and represents and warrants that
          he is aware of the high degree of risk  involved in making  investment
          in the Shares;

     e.   That the undersigned  subscriber's  decision to purchase the Shares is
          based  solely on the  information  contained  in the Private  Offering
          Memorandum  and on written  answers to such questions as he has raised
          concerning the transaction;

     f.   That the undersigned subscriber is purchasing the Shares directly from
          the Company and understands  that neither the Company nor the Offering
          is  associated  with;  endorsed  by nor  related  in any way  with any
          investment company, national or local brokerage firm or broker dealer.
          The  undersigned  subscriber's  decision to purchase the Shares is not
          based in whole or in part on any assumption or  understanding  that an
          investment  company,  national or local brokerage firm or other broker
          dealer is  involved  in any way in this  Offering  or has  endorsed or
          otherwise recommended an investment in these Shares.

     g.   That  the  undersigned  subscriber  has  an  investment  portfolio  of
          sufficient  value that he could  suitably  absorb a high risk illiquid
          addition such as an investment in the Shares.

     h.   The  undersigned   further   represents   that  (INITIAL   APPROPRIATE
          CATEGORY):

          [   ]  I am a natural  person  whose  individual  net worth,  or joint
                 worth with my spouse at the time of purchase, exceeds $200,000;

          [   ]  I am a natural person who had an individual income in excess of
                 $50,000 or joint income with my suppose in excess of $50,000 in
                 each of the two most recent years and who reasonably expects an
                 income in excess of those amounts in the current year;

     i.   That  Regulation D requires the Company to conclude that each investor
          has  sufficient  knowledge  and  experience  in financial and business
          matters  as to be  capable  of  evaluating  the merits and risks of an
          investment in the shares,  or to verify that the investor has retained
          the services of one or more purchaser  representatives for the purpose
          of  evaluating  the  risks of  investment  in the  shares  and  hereby
          represents  and warrants that he has such  knowledge and experience in
          financial and business  matters that he is capable of  evaluating  the
          merits  and  risks of an  investment  in the  shares  and of making an
          informed   investment  decision  and  will  not  require  a  purchaser
          representative.

                                       18
<PAGE>

5. The undersigned understands and agrees that this subscription is made subject
to each of the following terms and conditions:

     a.   The   Company   shall  have  the  right  to  accept  or  reject   this
          subscription,  in whole or part, for any reason.  Upon receipt of each
          Subscription  Document,  the Company shall have until December 3 1 st,
          1998 in which to  accept  or  reject  it. If no action is taken by the
          Company within said period,  the subscription  shall be deemed to have
          been accepted.  In each case where the  subscription is rejected,  the
          Company  shall return the entire  amount  tendered by the  subscriber,
          without interest;

     b.   That the undersigned  subscriber will, from time to time,  execute and
          deliver such documents or other instruments as may be requested by the
          Company  in  order  to aid  the  Company  in the  consummation  of the
          transactions contemplated by the Memorandum.

6. The undersigned hereby constitutes and appoints the Company,  with full power
of  substitution,   as  attorney-in-fact   for  the  purpose  of  executing  and
delivering,  swearing to and filing, any documents or instruments  related to or
required  to  make  any  necessary  clarifying  or  conforming  changes  in  the
Subscription Document so that such document is correct in all respects.

7. As used herein, the singular shall include the plural and the masculine shall
include the feminine where necessary to clarify the meaning of this Subscription
Document.  All terms not defined  herein shall have the same  meanings as in the
Memorandum.

IN WITNESS WHEREOF, the undersigned has executed this Subscription Document this
____ day of _______, 1998.

Number of Shares           ___________________
Total amount tendered      $__________________

INDIVIDUAL OWNERSHIP:       ____________________________________________________
                            Name (Please type or Print)

                            ____________________________________________________
                            Signature

                            ____________________________________________________
                            Social Security Number

                                       19
<PAGE>


JOINT OWNERSHIP:            ____________________________________________________
                            Name (Please Type or Print)


                            ____________________________________________________
                            Signature


                            ____________________________________________________
                            Social Security Number



OTHER OWNERSHIP             ____________________________________________________
                            Name (Please Type or Print)

                            By: ________________________________________________
                                 (Signature)

                            ____________________________________________________
                            Title

                            ____________________________________________________
                            Employer Identification Number


ADDRESS:  ______________________________________________________________________
          Street              City                State                    Zip

Phone (Residence) _____________________; Phone (Business)_______________________


     I do hereby  certify that the  representations  made herein  concerning  my
financial  status are true, and that all other  statements  contained herein are
true, accurate and complete to the best of my knowledge.

Date:   ___________________________, 1998.



                                    Signature _______________________________

                                       20

<PAGE>

                            CERTIFICATE OF DELIVERY

     I hereby acknowledge that I delivered the foregoing  Subscription  Document
to _____________ on the _____ day of ________________, 1998.


                                        ________________________________________
                                        Signature

                                   ACCEPTANCE


     This Subscription is accepted by PANTHEON TECHNOLOGIES, INC., as of the ___
day of _______________________, 1998.


                                        PANTHEON TECHNOLOGIES, INC.



                                        By: ____________________________________
                                        Director

                                       21

                                  CONFIDENTIAL
                      NOT TO BE REPRODUCED OR DISTRIBUTED

                                 Memorandum No.
                                Name of Offeree:

                          PRIVATE PLACEMENT MEMORANDUM

                          Pantheon Technologies, Inc.
                       (a Florida Corporation) ("Company")

        166,600 Common Shares and 166,600 Common Share Purchase Warrants
                                 $.001 Par Value
                                $0.60 Per Share
        Warrant exercisable at $0.65 per Share expiring on March 1st, 2003

                               MINIMUM INVESTMENT
                                  1,666 SHARES
                                   $1,000.00

                          Principal Executive Offices:
                          1628 West St. Ave, Suite 237
                             Vancouver, BC, V6J-lG1

                                 (604) 739-7911

                  The date of this Memorandum is March 1, 1999
<PAGE>
                           PANTHEON TECHNOLOGIS, INC.

Type of  securities  offered  Shares of the Company's  common stock,  $0.001 par
value.

Number of Securities offered : 166,600 Shares.

Price per security : $0.60 per share.

Total proceeds : If all shares sold : $100,000.00

Is a commissioned selling agent selling the securities in this offering ?
Yes [ ]     [X] No

If yes, what percent is commission of price to public ?

Is there other compensation to selling agent(s) ?
Yes [ ]     [X] No

Is there a finder's fee or similar payment to any person ?
Yes [ ]    [X] No

Is there an escrow of proceeds until minimum is obtained ?
Yes [ ]    [X] No

Is this offering limited to members of a special group, such as employees of the
Company or individuals ?
Yes [ ]    [X] No

Is transfer of the securities restricted ?

Yes [ ]    [X] No

THIS OFFERING OF SECURITIES HAS NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF
1933 OR APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE  COMMISSION,  NOR
HAS THE  COWISSION  PASSED UPON THE ACCURACY OR ADEQUACY&  THIS  MFMORAND UW ANY
REPRESENTATION  TO  THE  CONTRARY  IS A  CRIMINAL  OFFENCE.  THE  OFFERING  97LL
TERMINATE UPON THE EARLIER OF ALL OF THE S8ARES OR MARCH 31st, 1999. THE COMPANY
IS NOT REQUIRED TO SELL  ANYM?N1MUM  NUMBER OF SHARESIN  ORDER TO SELL SHARES IN
THE OFFERING THE COMPANY MA Y, IN ITS  DISCRETION,  CONDUCT  MULTIPLE  CLOSINGS.
(SEE DESCRIPT~ON OF THE OFFERING.

                                       2
<PAGE>

THIS  MEMORANDUM HAS BEEN PREPARED SOLELY FOR USE IN CONVECTION WITH THE PRIVATE
PLACEMENT~  OF THE SHARES  OFFERED  HEREBY AND MAY NOT BE REPRODUCED OR USED FOR
ANY OTHER  PURPOSE THE OFFEREE  AGREES TO RETURN TO THE COMPANY THIS  MEMORANDUM
AND ALL ATTACHMENTS AND RELATED DOCUMENTATIONIF THE OFFEREE DOES NOTSUBSCRIBE TO
PURCHASE SHARES IN THE OFFERING.

THESE  SECURITIES  ARE BEING OFFERED ONLY TO INVESTORS WHO THE OFFEROR  BELIEVES
HAVE THE QUAL)TICA  TIONS  NECESSARY TO PERMIT THE  SECURITIES TO BE OFFERED AND
SOLD  UNDER  APPLICABLE   EXEMPTIONS  FROM   REGISTRATION   UNDER  THE  ACT  AND
QUALIFICATION  UNDER  APPLICABLE  STATE  STATUTES.  THE OFFEROR WILL BE THE SOLE
JUDGE OF WHETHER AN  INVESTOR  POSSESSES  SUCH  UNDERSTANDING  DELIVERY  OF THIS
MEMORANDUM AND ASSOCIATED  DOCUMENTATION,  THE OFFEROR DOES NOT INTEND TO EXTEND
AN AN OFFER TO BUY THESE  SECURITIES  UNTIL THE THE  OFFEREE  IS  QUALIFIED  AND
COMMUNICATES  SUCH  DETERMINATION TO INVESTORS IN WRITING.  THE SHARES ARE BEING
OFFERED IN A PRIVATE PLACEMENT TO A LIMITED NUMBER OF INVESTORS. THIS MEMORANDUM
DOES NOT CONSTITUTE AN OFFER OR SOLICITATION  IN ANY  JURISDICTION IN WHICH SUCH
OFFER OR  SOLICITATION  IS NOT  PERMITTED  UNDER  APPLICABLE  LAW OR ANY FIRM OR
INDIVIDUAL WHO DOES NOT POSSESS THE QUALIFICATIONS DESCRIBED IN THIS MEMORANDUM

THE SHARES OFFERED HEREBY HAVE NOT BEEN  REGISTERED  UNDER THE SECURITIES ACT OF
1933 (THE "ACT"),  OR THE  SECURITIES  LAWS OF FLORIDA OR 0THER STATES,  AND ARE
BEING  OFFERED  AND  SOLD  IN  RELIANCE  ON  EXEMPTIONS  FROM  THE  REGISTRATION
REQUIREMENTS  OF THE ACT AND SUCH LAWS THERE IS NO PUBLIC MARKET FOR  SECURITIES
OF THE  COMPANY  EVEN IF SUCH  MARKET  EXISTED,  PURCHASERS  OF  SHARES  WILL BE
REQUIRED TO REPRESENT THAT THE SHARES ARE BEING ACQUIRED FOR INVESTMENT PURPOSES
AND NOT WITH A VIEW TO SALE OR DISTRIBUTION,  AND PURCHASERS WILL NOT BE ABLE TO
RESELL THE SHARES UNLESS THE SHARES ARE  REGISTERED  UNDER THE ACT AND QUALIFIED
UNDER THE APPLICABLE STATE STATUTES (UNLESS AN EXEMPTION FROM SUCH  REGISTRATION
AND QUALIFICATION IS AVAILABLE).  PURCHASERS OF THE SHARES SHOULD BE PREPARED TO
BEAR THE ECONOMIC RISK OF THEIR INVESTMENT FOR AN INDEFINITE PERIOD OF TIME

THE  PURCHASE OF THESE  SECURITIES  SHALL  ENTAIL A HIGH  DEGREE OF RISK.  THESE
SECURITIES  ARE  SUITABLE  ONLY  FOR  PERSONS  WHO  HAVE  SUBSTANTIAL  FINANCIAL
RESOURCES  AND HAVE NO LIQUIDITY IN THIS  INVESTMENT NO ONE SHOULD INVEST IN THE
SHRES WHO IS NOT PREPARED TO LOSE THEIR ENTIRE INVESTMENT  PROSPECTIVE INVESTORS
SHOULD CONSIDER CAREFULLY THE RISK FACTORS INDICATED UNDER "RISK FACTORS."

                                       3
<PAGE>


INVESTORS  SHOULD NOT CONSTRUE THE CONTENTS OF THIS  MEMORANDUM OR ETHER WRITTEN
OR ORAL, FROM THE COMPANY, ITS EMPLOYEES OR AGENTS, AS LEGAL, TAX, ACCOUNTING OR
OTHER EXPERT ADVICE. EACH INVESTOR SHOULD CONSULT THEIR OWN COUNSEL,  ACCOUNTANT
AND OTHER PROFESSIONAL ADVISORS AS TO LEGAL, TAX ACCOUNTING, AND RELATED MATTERS
CONCERNING HIS INVESTMENT AND ITS SUITABILITY FOR THEM.

NO PERSON  (OTHER THAN OFFICERS OF THE COMPANY TO WHOM REQUESTS ARE DIRECTED FOR
ADDITIONAL  INFORMATION  CONCERNING  THIS  OFFERING) IS  AUTHORIZED  TO GIVE ANY
INFORMATION OR MAKE ANY  REPRESENTATIONS  (WHETHER ORAL OR WRITTEN IN CONNECTION
WITH THIS  OFFERING  EXCEPT SUCH  INFORMATION  AS IS  CONTAINED  IN THIS PRIVATE
PLACEMENT  MEMORANDUM  AND THE  ATTACHMENTS  THERETO AND  DOCUMENTS  REFERRED TO
HEREIN.  ONLY INFORMATION OR REPRESENTATIONS  CONTAINED HEREIN AND THEREIN MAYBE
RELIED UPON AS HAVING BEEN AUTHORIZED.

THE SECURITIES  OFFERED HEREBY WILL BE SOLD TO SUBJECT TO THE STOCK SUBSCRIPTION
AGREEMENT  ATTACHED AS ATTACHMENT A OF THIS  MEWORANDUM,  WHICH CONTAINS CERTAIN
REPRESENTATIOM WARRANTIES,  TERMS AND CONDITIONS. EACH INVESTOR SHOULD CAREFULLY
REVIEW THE PROVISIONS OF THE SUBSCRIPTION AGREEMENT BEFORE INVESTING.

This Company:

[ ] Has never conducted operations.
[X ] Is in the development stage,~
[ ] Is currently conducting operations.
[ ] Has shown a profit in the last fiscal year.
[ ] Other( Specify)

(Check at one, as appropriate )

This offering has been registered for offer and sale in the following states :

State                State File No              Effective Date
- -----                -------------              --------------

                                       4
<PAGE>

TABLE OF CONTENTS

Cover Page                                                                     1
Disclosure Statements                                                          2
Table of Contents                                                              5
Summary of the Offering:                                                       6
The Company                                                                    6
Risk Factors                                                                   7
Use of Proceeds                                                                9
Description of Securities                                                     10
Terms of the Offering                                                         11
Directors, Officers and key Personnel of the Company                          12
Principal Stockholders                                                        13
Remuneration of Director s and Officers                                       13
Reports                                                                       14
Legal Matters                                                                 14
Litigation                                                                    14
Additional Information                                                        14
State Restrictions                                                         14-16

EXHIBITS

Exhibit A                Subscription Agreement                            17-21


This is an original  unpublished  work  protected  under  copyright  laws of the
United  States and other  countries.  All Rights  Reserved.  Should  publication
occur,   then  the  following  notice  shall  apply:   Copyright  1999  Pantheon
Technologies,  Inc.  All  Rights  Reserved.  No  part of  this  document  may be
reproduced,  stored in a  retrieval  system or  transmitted,  in any form or any
means, electronic, mechanical, photocopying, recording or otherwise, without the
prior written permission of Pantheon Technologies, Inc.

                                       5
<PAGE>
                            SUMMARY OF THE OFFERING

The following material is intended to summarize  information contained elsewhere
in this  Memorandum.  This  summary  is  qualified  in its  entirety  by express
reference  to  the  Memorandum  and  the  exhibits  referred  to  therein.  Each
prospective investor is urged to read this Memorandum in its entirety.

Pantheon  Technologies,  Inc, a Florida  corporation  (the " Company  "), is the
issuer of the Shares.  The  address of the Company is 1~628 West St. Ave,  Suite
237, Vancouver, BC, V6J- 1Gl.

The  Offering.  The Company is Offering up to 166,600 of its common  stock,  par
value $.001 per share (the "Shares").  The Minimum investment for an Investor is
1,666  Shares,  or $1,000.00  The Company,  in its sole  discretion ~ may accept
subscriptions  for up to an  aggregate  of 166,600 or  $100,000.00  until  March
31st,)999,  or until  such  earlier  date as the  Company  determines  that this
Offering shall be terminated.  In its sole discretion,  the Company may elect to
terminate this Offering even if subscriptions  fi' Shares have been received and
accepted by the Company.  S*ee "Terms of the  Offering"  and  "Subscription  for
Shares".

Company's  Business:  The  Company is involved  in the  development  of Internet
related products and services.

Risk Factors:  The offering  invo'ves  speculative  investment with  substantial
risks,  including those associated with an unproven  startup venture,  and risks
associated with the industry. Although the Company will use its best efforts, to
protect  the  investments  of the  Investors,  there  is no  assurance  that the
Company's efforts will b successful.  Accordingly, a prospective Investor should
not view the  Company  or its  officers,  dire  tors,  employees  or  agents  as
guarantors  of the financial  success of an investment in the Shares.  See "Risk
Factors".

Limited  Transferability  of the Sh alres.  The Shares have not been  registered
under the 1933 Act or the  securities  laws of any  state.  the Shares of common
stock  purchased  pursuant  to this  Offering  will not be  "restricted"  shares
because the shares are offered under Rule 504 and this offering is excluded from
the  provisions of Regulation D pertaining to restricted  shares.  This does not
mean, however,  that a public market does exist for the Shares. No market exists
now and none is foreseen. See "Risk Factors" and "Terms of the Offering".

Limitation  of  Liability.  Except for the amounts paid by  Investors  for their
purchase of any Shares,  and as required by Florida State ]law, no investor will
be  liable  for any debts of the  Company  or be  obligated  to  contribute  any
additional capital or funds to the Company. See " Risk Factors".

Suitability  Standards.  Each Investor must meet certain  eligibility  standards
established  by the  Company for the  purchase of the Shares.  See "Tenns of the
Offering" and "Subscription for Shares".

                                       6
<PAGE>

Use of Proceeds.  The Company plans to use the money received from this offering
to cover the costs involved with promoting and marketing the Company's  products
and  services  and public  relations.  The funds will not be  deposited  into an
escrow  account and will be  available  to the Company  immediately.  No minimum
amount of Shares is required to be sold.

                                  THE COMPANY

Exact corporate name:                     Pantheon Technologies, Inc.
State and date of incorporation:          Florida State
                                          April 17th, 1997.

Street address of principal office:       1628 West St. Ave, Suite 237
                                          Vancouver, BC, V6J-1G1
                                          (604) 739-7911

Fiscal Year:                              December 31.

PRODUCTS

The Company is engaged in the  development  of  Internet  related  products  and
services.

MATERIAL CONTRACTS

The  Company  has a  contract  with  Thor  Equity  Group for  investor  relation
services.

MARKETING APPROACHES

The  Company  intends to  establish  a  e-commerce  based  business  through the
Internet.

                                  RISK FACTORS

An  investment  in the Shares  involves a high  degree of risk.  No  prospective
Investor  should  acquire the Shares unless he can afford a complete loss of his
investment.  The risks  described  below are those which the Com! any deems most
significant  as of the date  hereof.  Other  factors  which may have a  material
impact on the operations of the Company may not be foreseen.  In addition to the
other  factors set forth  elsewhere in this  Memorandum,  prospective  Investors
should carefully consider the following specific risk factors:

                                       7

<PAGE>

A. OPERATING RISKS

     General.  The economic success of an investment in the Shares depends, to a
large  degree,  upon many factors  over which the Company has no control.  These
factors  include  general  economic,  industrial and  international  conditions;
inflation or deflation;  fluctuation in interest rates; the availability of, and
fluctuations in the money supply.  The extent,  type and  sophistication  of the
Company's competition; and government regulations.

     Development  Stage  Company,  The  Company  was  organized  in 1997 and has
engaged  in  minimal  business  operations.   Accordingly,   the  Company  is  a
development  stage  company as  defined by  Statement  of  Financial  Accounting
Standards No. 7.

     Dependence on Key Personnel.  The Company's  success will depend,  in large
part, upon the talents and skills of key nt personnel. To the extent that any of
its management  personnel is unable or refuses to: continue association with the
Company,  a suitable  replacement would have to be found.  There is no assurance
that  the  Company  ,  would  be able to find  suitable  replacements  for  such
personnel, or that suitable person.

        Lack of Adequate  Capital,  Additional  capital  will be required in the
Company's  future  operations.  In the absence of any  additional  funding,  the
Company's  operations  may be  affected  negatively.  Therefore,  the  Company's
management  will be careful and use its best  judgement in directing the affairs
of  the  Company  in a  manner  that  maximizes  its  chances  of  success  and,
accordingly, the best chances of raising future funding.

     Inherent  Business  Risks~ The business that the Company plans to engage in
involves   substantial  and  inherent  risks  associated  with  a  start-up  and
development company with limited financial resources.

B. INVESTMENT RISKS

     Speculative Investment. The Shares are a very speculative investment. There
can be no assurance that the Company will ~i attain its objective and it is very
likely that the Company will not be able to advance any business  activities and
Investors could lose their entire investments.

     Arbitrary  Purchase Price; No Market. The purchase price for the Shares has
been arbitrarily determined by the Company, and is not necessarily indicative of
their  value.  No  assurance  is or can  be  given  that  the  Shares,  although
transferable,  could be sold for the purchase  price,  or for any amount.  There
currently is no market for resale of the Shares.

     Restriction  of  Transferability.   While  the  Company  believes  that  no
restriction  exists for the transfer of the Shares being offered by the Company,
an investment in the Shares may be a long term investment.  Investors who do not
wish or who are not financially able to hold the Shares for a substantial period
of time are advised against purchasing Shares. The Shares are not

                                       8

<PAGE>

registered under the 1933 Act or under the securities laws of any state, but are
being offered by the Company under the exemption from  registration  provided by
Rule 504 under Regulation D and related state and foreign exceptions.

     "Best Efforts"  Offering:  The Shares are being offered on a "best efforts"
basis by the Company.  No person or entity is committed to purchase or take down
any of the  Shares  offered  pursuant  to this  Offering.  No escrow  account is
maintained and no minimum amount is required to be sold. Funds will be available
to the Company upon receipt.

     Management and Operation Experience. The Company's officers,  directors and
other  personnel have engaged in a varliety of businesses and have been involved
in business financing,  operations and marketing,  but their experience in these
fields is limited. There is no assurance that such experience will result in the
success of the Company.

     Other Risks.  No assurance can be given that the Company will be successful
in achieving its stated objectives, that the Company's business is undertaken by
the  Company,  will  generate  cash  sufficient  to operate the  business of the
Company or that other parties entering into agreements relating to the Company's
business will meet their respective obligations.

     Dividends.  The Company's Board of Directors presently intends to cause the
Company to follow a policy of  retaining  earnings,  if any,  for the purpose of
increasing the net worth and reserves of the Company. Theref~re, there can be no
assurance that any holder of Common Stock will receive any cash,  stock or other
dividends on his shares of Common Stock.  Future  dividends on Common Stock,  if
any,  will  depend on the  future  earnings,  financing  requirements  and other
factors.

     Additional Securities Available for Issuance.  The Company's Certificate of
Incorporation  authorizes the issuance of 100,000,000 shares of Common Stock. At
this  time,  7,200,000  shares of common  stock have been  issued.  Accordingly,
including  those  purchasing  the shares  offered  with the sale of these units,
investors will be dependent upon the judgement of management in connection  with
the future  issuance and sale of shares of the Company's  capital stock,  in the
event purchasers can be found for suchl~ securities.

                                USE OF PROCEEDS

     The Company  will incur  expenses  in  connection  with the  Offering in an
amount  anticipated  not to exceed  $3,500.00 for I:gal fees,  accounting  fees,
filing fees, printing costs and other expenses.  If the maximum number of Shares
are sold, the Company  anticipates that the net proceeds to it from the Offering
Will be as  follows:

Item                                    Maximum Shares Sold
- ----                                    -------------------

Gross Proceeds of Offering              $100,000.00

                                       9
<PAGE>

Offering Expenses
- -----------------

Cost of Offering                                         $  3,500.00
                                                         -----------

               TOTAL PROCEEDS RECEIVED:                  $ 96,500.00

Operating Expenses
- ------------------

Development of Internet products and services            $ 96,500.00
                                                         -----------
              TOTAL                                      $ 96,500.00

NET FUNDS AVAILABLE TO COMPANY

     The Company  estimates  that the costs of the Offering  will be as follows:
(i) legal fees of approximately $1,500.00, (ii) accounting fees of approximately
$1,000.00  and (iii)  printing and other  miscellaneous  costs of  approximately
$1,000.00.  A sales commissions will be paid only to NASD  broker/dealers and no
other person will receive any commissions or remuneration from the Company.

     The net proceeds of this offering,  assuming all the Shares are sold,  will
be sufficient to sustain the planned marketing and development activities of the
Company  for a period of 6 months,  depending  upon the number of Shares sold in
the offering and other  factors.  Even if all the Shares  offered  hereunder are
sold,  the Company will require  additional  capital in order to fund  continued
development activities and capital expenditures that must be made. The Company's
business plan is based on the premise that  additional  funding will be obtained
through  funds  generated  from  operations,  the ~ xercising of the options and
warrants by  shareholders,  additional  offerings  of its  securities,  or other
arrangements.  There can be no assurance that any securities offerings will take
place in the future, or that funds sufficient to meet any of the foregoing needs
or plans will be raised from operations or any other source.

                           DESCRIPTION OF SECURITIES

     The following  discussion  describes the stock and other  securities of the
Company.

     General.  The Company  currently has 100,000,000  authorized common shares,
par value  $.001 per share,  of which  7,200,000  common  shares were issued and
outstanding  as of the date of this  Placement.  All of the  outstanding  common
shares of the Company are fully paid for and nonassessable.

     Voting Rights.   Each share of the 7,200,000 shares of the Company's common
stock held by its current  shareholders  is entitled to one vote at shareholders
meetings.

                                       10

<PAGE>

        Dividends, The Company has never paid a dividend and does not anticipate
doing so in the near future.

     Options.  The Company  currently has no options  outstanding in relation to
its common stock.

     Miscellaneous  Rights and Provisions.  Shares of the Company's common stock
have no pre-emptive  rights.  The Shares Oo not have any conversion  rights,  no
redemption  or sinking  fund  provisions,  and are not liable to further call or
assessment.  The  Shares,  when paid for by  Investors,  will be fully paid and!
nonassessable.  Each share of the  Company's  common shares is entitled to a pro
rata  share in any  asset  available  for  distribution  to  holders  of  equity
securities upon the liquidation of the Company.

                             TERMS OF THE OFFERING

     The Company is offering' to qualified  investors a maximum of 166,600 Share
(Units) at a purchase  price of $0.60 per share of the  Company's  common stock,
with a warrant that  entitles  the  purchaser  an  additional  common share when
exercised at $0.65 per share on or before March 31st., 2003. The Company may, in
its sole discretion, terminate the offering at any time. The Offering will close
on the  earliest of March 31st,  1999 or the election of the Company when all of
the  Shares are sold,  in no event  later than March  31st,  1999.  The  minimum
subscription is $1,000.00 (1,666 Shares) per Investor,  although the Company, in
its sole discretion, may accept subscriptions for lesser amounts.

     Terms of Sale:  The Company  hereby agrees to sell to the purchaser and the
purchaser  hereby  agrees to  subscribe  for 11,666  units in the capital of the
Company  (the  "Units")  for a  purchase  price  of  $0.60  USD per  Unit for an
aggregate purchase of $ 1,000.00 USD (the "Purchase Fund").

     Constitution  of  Shares : Each  Unit will  consist  of one fully  paid and
non-assessable  common share in the capital stock ( the "Share" ) of the Company
and the right to purchase  one share  purchase  warrant ( the  "Warrants" ) with
terms as described below.

     Terms of Warrants: All Warrants will;

(a)  be comprised in one warrant  certificate  ( the  "Warrant  Certificate"  ),
     registered in the name of the purchaser,  representing an aggregate  number
     of Warrants which be equal to the number of Units being acquired  hereunder
     by the purchaser;

(b)  be non-transferabte;

(c)  will be  subject  to the terms and  conditions  which  are  adopted  by the
     Company for the Warrants,  which terms and conditions  will,  amongst other
     things.

                                       11
<PAGE>

     (i)  provide  for an  adjustment  in class and  number  of shares  issuable
pursuant  to any  exercise  thereof  upon the:  occurrence  of  certain  events,
including any subdivision, consolidation or re-classification of the shares, and

     (ii) not  provide  for any  adjustment  in the  number of  shares  issuable
pursuant  to any  exercise  thereof in event~ of the  Company  issuing any other
shares,  warrants or options to acquire  shares at prices  either  above,  at or
below the exercise price of Warrants;

(d)  and each  Warrant  will  provide for the right to purchase  one  additional
     Share.  The Warrant will be exercised in whole or in part from time to time
     at any time prior to 4:30 p.m. (PST) on March St., 2003 at $0.65 per Share.

     The Shares are being  offered and sold by the Company  under the  exemption
from  registration  contained  in  Rule  504  under  Regulation  D  and  related
exemptions from state registration requirements. Rule ~04 permits the Company to
offer and sell its stock in an amount  not  exceeding  $1,000,000  to  unlimited
number of persons.  Until 1992, Rule 504(b)(2)(ii)  imposed a limited disclosure
obligation  of all issuers such as the Company which was intended to ensure that
investors  in a Rule 04  transaction  were  clearly  advised  of the  restricted
character  of the  securities  being  offered  for sale.  This  requirement  was
eliminated in July,  1992 at which time the Securities  and Exchange  Commission
adopted an amendment to Rule 504 that  eliminated all  limitations on the manner
of offering of stock  under that rule  and/or the resale of stock  purchased  in
reliance on that rule. There~bre,  following adoption of the 1992 amendment, the
securities  being  offered  and  sold by the  Company  pursuant  to the  present
Offering are available for immediate resale by nonaffiliates of the issuer.

     The Shares are being offered on a "best  efforts"  basis by the Company and
certain expenses of the Offering will be Paid from the proceeds of the Offering.
The Company anticipates that such expenses will not exceed $3,500.00 as detailed
in the Use of Proceeds.

              DIRECTORS, OFFICERS AND KEY PERSONNEL OF THE COMPANY

     Officers and Directors,  The following  information sets forth the names of
the officers  and  directors of the Company,  their  present  position  with the
Company and biographic information:

NAME                         POSITION                                 HELD SINCE
- ----                         --------                                 ----------
Timothy Bullinger            President & Director                     April 1997
Arian Soheili                Secretary, Treasurer & Director          April 1997
Lance Dusanj                 Director                                 April 1997

                                       12
<PAGE>


Timothy Bullinger:  is the President and Director has over fifteen (15) years of
experience  indesign  and  architecture.  He heads a design  firm  that  creates
designs for homes,  products,  furniture and fashion on an international  level.
Mr.  Bullinger  also has  extensive  technical  experience  in  audio  recording
engineering, computer generated multimedia design and extensive knowledge of the
Internet.

Arian  Soheili : is a Director,  Secretary  and  Treasurer of the  Company.  Mr.
Soheili  brings many years of extensive  experience  in the computer  technology
fields such as Internet,  Intranet  and  electronic  commerce.  The Company also
gains the  benefit of Mr.  Soheili's  many years of  personnel,  accounting  and
finance skills.

Lance  Duaan is a Director  of  experience  working at White Pine  Company.  Mr.
Dusanj has over seven (7) years of industrial  eexperience working at White Pine
Division of MacMillan  Bloedel Ltd., and brings the Company a tremendous  wealth
of contacts in the  industrial  sector.  In addition,  Mr.  Dusanj has extensive
experience in corporate finance and personnel management.

                             PRINCIPAL STOCKHOLDERS

     The following table sets forth information  concerning the shares of Common
Stock of the  Company  owned of record and  beneficially  held as of the date of
this  Memorandum  by (i) each  person  known to the  Company to own of record or
beneficially  5% or  more of the  7,200,000  Stock  of the  Company,  (ii)  each
Director of the Company,  and (iii) all officers and directors of the Company as
a  group,  as of the date of this  Memorandum  and  adjusted  to  reflect  share
holdings after the sale of the maximum number of Shares offered hereby.

Ownnership                    No Shares      %         No Shares           %
Name & Position               Pre Issue                Post Issue
- ---------------               ---------                ----------

Timothy Bullinger             3,000,000      41.66%    7,366,600          40.7%


                     REMUNERATION OF DIRECTORS AND OFFICERS

     Directors of the Company who are also  employees of the Company  receive no
additional compensation for their services as Directors. The Company intends, in
the future, to pay Directors who are not employees of the Company,  compensation
of $500 per Director's  Meeting,  as well as reimbursements of any out of pocket
expenses incurred in the Company's behalf

                                    REPORTS

     The books and records ofthe Company will be maintained by the Company.  The
books of account and records shall be kept at the principal place of business of
Pantheon Technologies, Inc.

                                       13
<PAGE>


and each shareholder,  or his du1y authorized  representatives,  shall have upon
giving ten (10) days prior notice,  access during  reasonable  business hours to
such books and records,  and the right to inspect and copy them. Within 120 days
after  the  close  of each  fiscal  year,  reports  will be  distributed  to the
shareholders which will include financial statements  (including a balance sheet
and  statements of income,  shareholder's  equity,  and cash flows)  prepared in
accordance with generally accepted accounting principals,  with a reconciliation
to the tax  information  supplementary  supplied  by a copy of the  accountant's
report.

                                 LEGAL MATTERS

     Gary R. Blume, Esquire 11801 North Tatum Blvd, Suite 108, Phoenix, Arizona,
85028 will pass upon certain matters for the Company.

                                   LITIGATION

        The Company is not  presently  involved in any  material  litigation  or
other legal proceedings.

                             ADDITIONAL INFORMATION

     In the opinion of the Board of Directors of the  Company,  this  memorandum
contains  a fair  presentation  of the  subjects  discussed  herein and does not
contain a misstatement  of material fact  necessary to make any statements  made
herein not  misleading  or fail to state a material  fact  necessary to make any
statements made herein not  misleading.  Persons to whom offers are made will be
furnished  with such  additional  information  concerning  the Company and other
matters  discussed  herein as they, or their purchaser  representative  or other
aadvisors,  may  reasonable  request.  The  Company  shall,  to the extent  such
information  is  available  or can be acquired  without  unreasonable  effort or
expense,  endeavour to provide the information to such persons. All offerees are
urged to make such  personal  investigations,  inspections  or inquiries as they
deem appropriate.

     Questions or requests  for  additional  information  may be directed to Mr.
Timothy  Bullinger by calling (604) 739-7911.  Requests for additional copies of
this  Memorandum  or  assistance  in  executing  subscription  documents  may be
directed to the Company.

                        STATE ESTRICTIONS AND DISCLOSURES
                      FOR UNREGISTERED SECURITIES OFFERINGS

NOTICE TO ARIZONA RESIDENTS:

     These securities are being sold in reliance upon Arizona's Limited Offering
exemption from registration pursuant to A.R.S. 44-1844.

                                       14

<PAGE>


     THE SHARES  OFFERED HEREBY HAVE NOT BEEN  REGISTERED  UNDER THE THE ARIZONA
SECURITIES  ACT, AS AMENDED,  AND  THEREFORE,  CANNOT BE  TRANSFERRED  OR RESOLD
UNLESS  THEY  ARE  REGISTERED  UNDER  SUCH  ACT  OR AN  EXEMPTION  THEREFROM  IS
AVAILABLE.

     As a purchaser of such securities  hereby represent that I understand these
securities cannot be resold without  registration  under the Arizona  Securities
Act or an exemption  therefrom.  I am not an  underwriter  within the meaning of
AR.S 44-1801(17),  and I am acquiring these securities for myself, not for other
persons.  If qualifying as a non-accredited  investor,  I further represent that
this  investment  does not  exceed  20% of my net  worth (  excluding  principal
residence, furnishings therein and personal automobiles).

NOTICE TO CALIFORNIA RESIDENTS:

     These  securities  are being sold in  reliance  upon  California's  Limited
Offering Exemption. 25102(f) of the California Code, as amended.


     THE SALE OF THE SECURITIES WHICH ARE RHE SUBJECT OF THIS MEMORANDUM HAS NOT
BEEN QUALIFIED WITH THE  COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA
AND TTHE  ISSUANCE OF SUCH  SECURITIES  OR THE PAYMENT OR RECEIPT OF ANY PART OF
THE CONSIDERATION THEREFROM PRIOR TO SUCH QUALIFICATIONS BY SECTION 25100, 25102
OR 26105 OF THE  CALIFORNIA  CORPORATIONS  CODE.  THE RIGHTS OF ALL  PARTIES ARE
EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS
SO EXEMPT.

     THE  COMMISSIONER  OF  CORPORATIONS  OF THE  STATE OF  CALIFORNIA  DOES NOT
RECOMMEND OR ENDORSE THE PURCHASE OF THESE SECURITIES.

NOTICE TO COLORADO RESIDENTS:

     THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS  AMENDED,  OR THE  COLORADO  SECURITIES  ACT OF 1981 BY  REASON  OF  SPECIFIC
EXEMPTIONS  THEREUNDER  RELATING TO THE LIMITED  AVAILABILITY  OF THE  OFFERING.
THESE SECURITIES CANNOT BE SOLD,  TRANSFERRED,  OR OTHERWISE  DISPOSED OF TO ANY
PERSON OR ENTITY UNLESS  SUBSEQUENTLY  REGISTERED  UNDER THE  SECURITIES  ACT OF
1933, AS AMENDED,  OR THE COLORADO  SECURITIES ACT OF 1981, IF SUCH REGISTRATION
IS REQUIRED.

                                       15
<PAGE>


NOTICE TO NEW YORK RESIDENTS:

     THIS PRIVATE  PLACEMENT  MEMORANDUM  HAS NOT BEEN FILED WITH OR REVIEWED BY
THE ATTORNEY  GENERAL PRIOR TO ITS ISSUANCE AND USE. THE ATTORNEY GENERAL OF THE
STATE OF NEW YORK HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY
REPRESENTATION OF THE CONTRARY IS UNLAWFUL.

     THIS PRIVATE  PLACEMENT  MEMORANDUM DOES NOT CONTAIN AN UNTRUE STATEMENT OF
MATERIAL  FACT  AND  DOES  NOT ONUT  ANY  MATERIAL  FACT  NECESSARY  TO MAKE THE
STATEMENTS MADE, IN LIGHT OF THE  CIRCUMSTANCES  UNDER WHICH THEY WERE MADE, NOT
MISLEADING.  IT  CONTAINS A FAIR  SUMMARY OF THE  MATERIAL  TERMS AND  DOCUMENTS
PURPOSED TO BE SUMMARIZED HEREIN.

Purchaser Statement:

     I  understand  that this  Offering  of Shares has not been  reviewed by the
Attorney   General  of  the  State  of  New  York   because  of  the   Offeror's
representations  that this intended to be a non-public  Offering pursuant to the
Regulation D Rule 504 or 505, and that if all of the conditions and  limitations
of Regulation D'i are not complied with, the Offering will be resubmitted to the
Attorney General for amended exemption. I understand that any literature used in
connection  with this Offering has not been previ olusly filed with the Attorney
General and has not been  reviewed by the Attorney  General.  This 1~ Investment
Unit  is  being  purchased  for my own  account  for  investment,  and  not  for
distribution  or resale to  others.  I agree  that I will not sell or  otherwise
transfer  these  securities   unless  they  are  registered  under  the  Federal
Securities  Act of 1933  or  unless  an  exemption  from  such  registration  is
available.  I represent  that I have adequate  means of providing for my current
needs and possible personal contingencies of financial problems, and that I have
no need for liquidity of this investment.

     It is understood that all documents,  records and books  pertaining to this
investment have been made available to my attorney, my accountant, or my offeree
representative  and myself,  and that,  upon  reasonable  notice,  the books and
records  of the  issuer  will be  available  for  inspection  by  investors,  at
reasonable hours !at the principal place of business.

                                       16
<PAGE>



                                    EXHIBITS

                          Pantheon Technologies, Inc.
                          ---------------------------

                             SUBSCRIPTION DOCUMENT

1.   The  undersigned  hereby  subscribes  for  166,600  shares of common  stock
     (hereinafter  "Shares"),  as described in the Private  Offering  Memorandum
     dated March St., 1999  ("Memorandum"),  of Pantheon  Technologies,  Inc., a
     Florida  corporation  (the  "Company"),  being offered by the Company for a
     purchase  price of $0.60  per Unit  and  tenders  herewith  the sum of $ in
     payment therefor, together with tender of this Subscription Document.

2.   The undersigned  represents and warrants that he is a bona fide resident of
     the State of

3    The undersigned acknowledges:

     a.   Receipt of a copy of the Private Offering Memorandum;

     b.   That this subscription, if accepted by the Company, is legally binding
          and irrevocable;

     c.   That the Company has a very limited financial and operating history;

     d.   That the Shares have not been  registered  under the Securities Act of
          1933, as amended,  in reliance upon exemptions  contained in that Act,
          and that the Shares have not been re istered under the securities acts
          of  any  state  in  reliance  upon  exempt  ~ted  in  certain  state's
          securities laws; and

     e.   That the  representations and warranties provided in this Subscription
          Document  are being  relied  u)on by the  Company as the basis for the
          exemption from the registration  requirements of the Securities Act of
          1933 and of the applicable state's securities laws.

4.   The undersigned represents and warrants as follows:

     a.   That the  undersigned  subscriber  is  purchasing  said  Shares  as an
          investment and said Shares are purchased solely for the  undersigned's
          own account.

                                       17
<PAGE>



     b.   That  the   undersigned   subscriber  has  sufficient   knowledge  and
          experience  in financial  and business  matters to evaluate the merits
          and risks of an investment in the Shares;

     c.   That the  undersigned  subscriber is able to bear the economic risk of
          an investment in the Shares;

     d.   That the  undersigned  subscriber has read and is thoroughly  familiar
          with the Private Offering  Memorandum and represents and warrants that
          he is aware of the high degree of risk  involved in making  investment
          in Shares;

     e.   That the  undersiged  subscriber's  decision to purchase the Shares is
          based  solely on the  information  contained  in the Private  Offering
          Memorandum  and on written  answers to such questions as he has raised
          concerning the transaction;

     f.   That the undersigned subscriber is purchasing the Shares directly from
          the Company and understands  that neither the Company nor the Offering
          is associated with;  endorsed by nor related in any way any investment
          company,  national  or local  brokerage  firm or  broker  dealer.  The
          undersigned  subscriber's decision to purchase the Shares is not based
          in  whole  or in  part  on any  assumption  or  understanding  that an
          investment  company,  national or local brokerage firm or other broker
          dealer is  involved  in any way in this  Offering  or has  endorsed or
          otherwise recommended an investment in these Shares.

     g.   That  the  undersigned  subscriber  has  an  investment  portfolio  of
          sufficient  value that he could  suitably  absorb a high risk illiquid
          addition such as an investment in the Shares.

     h.   The  undersigned   further   represents   that  (INITIAL   APPROPRIATE
          CATEGORY):

          [ ] I am a natural person whose  individual net worth,  or joint worth
          with my spouse at the time of purchase, exceeds $200,000;

          [ ]I am a natural  person  who had an  individual  income in excess of
          $50,000 or joint income with my supose in excess of $50,000 in each of
          the two most  recent  years and who  reasonably  expects  an income in
          excess of those amounts in the current year;

     i.   That  Regulation D requires the Company to conclude that each investor
          sufficient  knowledge and experience in financial and business matters
          as to be capable of  evaluating  the merits and risks of an investment
          in the  shares,  or to  verify  that the  Investor  has  retained  the
          services of one or more purchaser  representatives  for the purpose of
          evaluating the risks of investment in the shares,



                                       18
<PAGE>


          and hereby  represents  and warrants  that he has such  knowledge  and
          experience  in financial  and  business  matters that he is capable of
          evaluating  the merits and risks of an investment in the shares and of
          making  an  informed  investment  decision  and  will  not  require  a
          purchaser representative.

5.   The  undersigned  understands  and agrees  that this  subscription  is made
     subject to each of the following terms and conditions:

     a.   The   Company   shall  have  the  right  to  accept  or  reject   this
          subscription,  in whole or part, for any reason.  Upon receipt of each
          Subscription  Document,  the Company shall have until March 31st, 1999
          in which to accept or reject it. If no action is taken by the  Company
          within  said  period,  the  subscription  shall be deemed to have been
          accepted. In each case where the subscription is rejected, the Company
          shall  return  the the  entire  amount  tendereed  by the  subscriber,
          without interest;

     b.   That the undersigned  subscriber will, from time to time,  execute and
          deliver such documents or other instruments as may be requested by the
          Company  in  order  to aid  the  Company  in the  consummation  of the
          transactions contemplated by the Memorandum.

6.   The  undersigned  hereby  constitutes  and appoints the Company,  with full
     power of substitution, as attorney-in-fact for the purpose of executing and
     delivering, swearing to and filing, any documents or instruments related to
     or required to make any necessary  clarifying or conforming  changes in the
     Subscription Document so that such document is correct in all respects.

7.   As used herein,  the singular  shall  include the plural and the  masculine
     shall include the feminine  where  necessary to clarify the meaning of this
     Subscription  Document.  All terms not defined  herein  shall have the same
     meanings as in the Memorandum.

IN WITNESS WHEREOF, the undersigned has executed this Subscription Document this
day of 1999.

Number of Shares
Total amount tendered    $

INDIVIDUAL OWNERSHIP: _______________________________________________________
                      Name ( Please Type or Print )

                      _______________________________________________________
                      Signature
                      Social Security Number

                                       19
<PAGE>

JOINT OWNERSHIP:      _______________________________________________________
                      Name (Please Type or Print)

                      _______________________________________________________
                      Signature

                      _______________________________________________________

                      Social Security Number


OTHER OWNERSHIP
                      _______________________________________________________

                      Name (Please Type or Print)

                      By: ___________________________________________________
                           (Signature)

                      _______________________________________________________
                      Title


                      _______________________________________________________
                      Employer Identification Number


ADDRESS:       ______________________________________________________________
                Street            City            State                 Zip


Phone (Residence) __________________;       Phone (Business) ___________________

     I, do hereby  certify that the  representations  made herein  concerning my
financial  status are true, and that all other  statements  contained herein are
true, accurate and complete to the best of my knowledge.

Date:    ,1999.

                                             ___________________________________
                                             Signature

                                       20

<PAGE>


                            CERTIFICATE OF DELIVERY

     I hereby acknowledge that I delivered the foregoing  Subscription  Document
to on the day of  ,1999.


                                             ___________________________________
                                             Signature

                                   ACCEPTANCE

     This Subscription is accepted by Pantheon Technologies, Inc., as of the day
of   ,1999. Pantheon Technologies, Inc.


                                             PANTHEON TECHNOLOGIES, INC.



                                             By: _______________________________
                                                 Director

                                       21


                                  CONFIDENTIAL

                       NOT TO BE REPRODUCED OR DISTRIBUTED



                       Memorandum No. ___________________

                  Name of Offeree : __________________________



                          PRIVATE PLACEMENT MEMORANDUM

                             CancerOption.com, Inc.
                      (a Florida Corporation) (" Company ")

        128,000 Common Shares and 128,000 Common Share Purchase Warrants
                                 $.001 Par Value
                                 $2.50 Per Share
      Warrant exercisable at $2.35 per Share expiring on August 18th, 2002



                               MINIMUM INVESTMENT
                                  1,000 SHARES
                                    $2,500.00





                          Principal Executive Offices:
                        7332 E. Butherus Drive, Suite 101
                            Scottsdale, Arizona 85260

                                 (480) 991-8080


                The date of this Memorandum is August 18th, 1999

<PAGE>

                                CancerOption.com

Type of securities  offered : Shares of the Company's  common stock,  $0.001 par
value.

Number of Units offered : 128,000 Shares and 128,000 Warrants

Price per security : $2.50 per share.  Warrant exercisable at $2.35 per Share up
until August 18th, 2002.

Total  proceeds : If all shares sold :  $320,000.00.  If all warrants  exercised
$620,800.00.

Is a  commissioned  selling agent selling the  securities in this offering ?
                  [    ] Yes                         [ X ] No

If yes , what percent is commission of price to public ?

Is there other compensation to selling agent(s) ?
                  [    ]  Yes                        [ X ]  No

Is there a finder's fee or similar payment to any person ?
                  [    ]  Yes                        [ X ]  No

Is there an escrow of proceeds until minimum is obtained ?
                  [    ]  Yes                        [ X ]  No

Is this offering limited to members of a special group, such as employees of the
Company or individuals ?
                  [    ]  Yes                        [ X ]  No

Is transfer of the securities restricted ?

                  [    ]  Yes                        [ X ]  No

THIS OFFERING OF SECURITIES HAS NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF
1933 OR APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE  COMMISSION,  NOR
HAS THE COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS MEMORANDUM.  ANY
REPRESENTATION  TO  THE  CONTRARY  IS A  CRIMINAL  OFFENCE.  THE  OFFERING  WILL
TERMINATE  UPON THE  EARLIER  OF ALL OF THE  SHARES OR AUGUST  31st,  1999.  THE
COMPANY IS NOT  REQUIRED TO SELL ANY  MINIMUM  NUMBER OF SHARES IN ORDER TO SELL
SHARES IN THE OFFERING.  THE COMPANY MAY, IN ITS  DISCRETION,  CONDUCT  MULTIPLE
CLOSINGS. ( SEE " DESCRIPTION OF THE OFFERING." )

<PAGE>

THIS  MEMORANDUM HAS BEEN PREPARED SOLELY FOR USE IN CONNECTION WITH THE PRIVATE
PLACEMENT OF THE SHARES OFFERED HEREBY AND MAY NOT BE REPRODUCED OR USED FOR ANY
OTHER PURPOSE.  THE OFFEREE AGREES TO RETURN TO THE COMPANY THIS  MEMORANDUM AND
ALL ATTACHMENTS AND RELATED  DOCUMENTATION  IF THE OFFEREE DOES NOT SUBSCRIBE TO
PURCHASE SHARES IN THE OFFERING.

THESE  SECURITIES  ARE BEING OFFERED ONLY TO INVESTORS WHO THE OFFEROR  BELIEVES
HAVE THE  QUALIFICATIONS  NECESSARY TO PERMIT THE  SECURITIES  TO BE OFFERED AND
SOLD  UNDER  APPLICABLE   EXEMPTIONS  FROM   REGISTRATION   UNDER  THE  ACT  AND
QUALIFICATION  UNDER  APPLICABLE  STATE  STATUTES.  THE OFFEROR WILL BE THE SOLE
JUDGE OF WHETHER AN  INVESTOR  POSSESSES  SUCH  QUALIFICATIONS.  NOTWITHSTANDING
DELIVERY OF THIS MEMORANDUM AND ASSOCIATED  DOCUMENTATION,  THE OFFEROR DOES NOT
INTEND TO EXTEND AN OFFER TO SELL OR TO SOLICIT AN OFFER TO BUY THESE SECURITIES
UNTIL THE OFFEROR DETERMINES THAT THE OFFEREE IS QUALIFIED AND COMMUNICATES SUCH
DETERMINATION TO INVESTORS IN WRITING. THE SHARES ARE BEING OFFERED IN A PRIVATE
PLACEMENT TO A LIMITED NUMBER OF INVESTORS.  THIS MEMORANDUM DOES NOT CONSTITUTE
AN OFFER OR SOLICITATION IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION
IS NOT PERMITTED  UNDER  APPLICABLE  LAW OR ANY FIRM OR INDIVIDUAL  WHO DOES NOT
POSSESS THE QUALIFICATIONS DESCRIBED IN THIS MEMORANDUM.

THE SHARES OFFERED HEREBY HAVE NOT BEEN  REGISTERED  UNDER THE SECURITIES ACT OF
1933 (THE "ACT"),  OR THE  SECURITIES  LAWS OF FLORIDA OR OTHER STATES,  AND ARE
BEING  OFFERED  AND  SOLD  IN  RELIANCE  ON  EXEMPTIONS  FROM  THE  REGISTRATION
REQUIREMENTS OF THE ACT AND SUCH LAWS.  THERE IS NO PUBLIC MARKET FOR SECURITIES
OF THE  COMPANY.  EVEN IF SUCH  MARKET  EXISTED,  PURCHASERS  OF SHARES  WILL BE
REQUIRED TO REPRESENT THAT THE SHARES ARE BEING ACQUIRED FOR INVESTMENT PURPOSES
AND NOT WITH A VIEW TO SALE OR DISTRIBUTION,  AND PURCHASERS WILL NOT BE ABLE TO
RESELL THE SHARES UNLESS THE SHARES ARE  REGISTERED  UNDER THE ACT AND QUALIFIED
UNDER THE APPLICABLE STATE STATUTES (UNLESS AN EXEMPTION FROM SUCH  REGISTRATION
AND QUALIFICATION IS AVAILABLE).  PURCHASERS OF THE SHARES SHOULD BE PREPARED TO
BEAR THE ECONOMIC RISK OF THEIR INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

THE  PURCHASE  OF THESE  SECURITIES  WILL  ENTAIL A HIGH  DEGREE OF RISK.  THESE
SECURITIES  ARE  SUITABLE  ONLY  FOR  PERSONS  WHO  HAVE  SUBSTANTIAL  FINANCIAL
RESOURCES AND HAVE NO LIQUIDITY IN THIS INVESTMENT.  NO ONE SHOULD INVEST IN THE
SHARES  WHO IS  NOT  PREPARED  TO  LOSE  THEIR  ENTIRE  INVESTMENT.  PROSPECTIVE
INVESTORS  SHOULD  CONSIDER  CAREFULLY THE RISK FACTORS  INDICATED  UNDER " RISK
FACTORS."

<PAGE>

INVESTORS   SHOULD  NOT  CONSTRUE  THE  CONTENTS  OF  THIS   MEMORANDUM  OR  ANY
COMMUNICATION,  WHETHER  WRITTEN  OR  ORAL,  FROM  THE  COMPANY,  ITS  FOUNDERS,
MANAGEMENT,  EMPLOYEES  OR AGENTS,  AS LEGAL,  TAX,  ACCOUNTING  OR OTHER EXPERT
ADVICE.  EACH INVESTOR  SHOULD  CONSULT THEIR OWN COUNSEL,  ACCOUNTANT AND OTHER
PROFESSIONAL  ADVISORS  AS  TO  LEGAL,TAX,   ACCOUNTING,   AND  RELATED  MATTERS
CONCERNING HIS INVESTMENT AND ITS SUITABILITY FOR THEM.

NO PERSON  (OTHER THAN OFFICERS OF THE COMPANY TO WHOM REQUESTS ARE DIRECTED FOR
ADDITIONAL  INFORMATION  CONCERNING  THIS  OFFERING) IS  AUTHORIZED  TO GIVE ANY
INFORMATION OR MAKE ANY REPRESENTATIONS  (WHETHER ORAL OR WRITTEN) IN CONNECTION
WITH THIS  OFFERING  EXCEPT SUCH  INFORMATION  AS IS  CONTAINED  IN THIS PRIVATE
PLACEMENT  MEMORANDUM  AND THE  ATTACHMENTS  THERETO AND  DOCUMENTS  REFERRED TO
HEREIN . ONLY INFORMATION OR REPRESENTATIONS CONTAINED HEREIN AND THEREIN MAY BE
RELIED UPON AS HAVING BEEN AUTHORIZED.

THE SECURITIES  OFFERED HEREBY WILL BE SOLD TO SUBJECT TO THE STOCK SUBSCRIPTION
AGREEMENT  ATTACHED AS ATTACHMENT A OF THIS  MEMORANDUM,  WHICH CONTAINS CERTAIN
REPRESENTATIONS,   WARRANTIES,   TERMS  AND  CONDITIONS.  EACH  INVESTOR  SHOULD
CAREFULLY REVIEW THE PROVISIONS OF THE SUBSCRIPTION AGREEMENT BEFORE INVESTING.

This Company :

[    ]  Has never conducted operations.
[  X ]  Is in the development stage.
[    ]  Is currently conducting operations.
[    ]  Has shown a profit in the last fiscal year.
[    ]  Other ( Specify )  ______________________

 ( Check at one , as appropriate )

This offering has been registered for offer and sale in the following states :

State                      State File No                         Effective  Date

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                           Page
                                                                           ----
<S>                                                                        <C>
Cover Page                                                                    1
Disclosure Statements                                                         2
Table of Contents                                                             5
Summary of the Offering                                                       6
The Company                                                                   6
Risk Factors                                                                  7
Use of Proceeds                                                               9
Description of Securities                                                    10
Terms of the Offering                                                        11
Directors, Officers and key Personnel of the Company                         12
Principal Stockholders                                                       13
Remuneration of Directors and Officers                                       13
Reports                                                                      14
Legal Matters                                                                14
Litigation                                                                   14
Additional Information                                                       14
State Restrictions                                                        14-16
EXHIBITS
   Exhibit A            Subscription Agreement                            17-22

</TABLE>

This is an original  unpublished  work  protected  under  copyright  laws of the
United  States and other  countries.  All Rights  Reserved.  Should  publication
occur, then the following notice shall apply:  Copyright 1999  CancerOption.com,
Inc. All Rights Reserved. No part of this document may be reproduced,  stored in
a  retrieval  system  or  transmitted,  in any  form or any  means,  electronic,
mechanical,  photocopying,  recording or  otherwise,  without the prior  written
permission of CancerOption.com, Inc.

<PAGE>

                             SUMMARY OF THE OFFERING

The following material is intended to summarize  information contained elsewhere
in this  Memorandum.  This  summary  is  qualified  in its  entirety  by express
reference  to  the  Memorandum  and  the  exhibits  referred  to  therein.  Each
prospective investor is urged to read this Memorandum in its entirety.

CancerOption.com, Inc, a Florida corporation (the " Company "), is the issuer of
the Shares.  The address of the Company is 7332 E.  Butherus  Drive,  Suite 101,
Scottsdale, Arizona 85260.

The  Offering.  The Company is offering up to 128,000 of its common  stock,  par
value $.001 per share (the "Shares").  The Minimum investment for an Investor is
1,000  Shares,  or $2,500.00  The Company,  in its sole  discretion,  may accept
subscriptions  for up to an  aggregate  of 128,000 or  $320,000.00  until August
31st,  1999,  or until such  earlier  date as the Company  determines  that this
Offering shall be terminated.  In its sole discretion,  the Company may elect to
terminate this Offering even if subscriptions  for Shares have been received and
accepted by the  Company.  See "Terms of the  Offering"  and  "Subscription  for
Shares".

Company's  Business:  The  Company is involved  in the  development  of Internet
related products and services.

Risk Factors:  The offering  involves  speculative  investment with  substantial
risks,  including those associated with an unproven  startup venture,  and risks
associated with the industry.  Although the Company will use its best efforts to
protect  the  investments  of the  Investors,  there  is no  assurance  that the
Company's efforts will be successful. Accordingly, a prospective Investor should
not  view the  Company  or its  officers,  directors,  employees  or  agents  as
guarantors  of the financial  success of an investment in the Shares.  See "Risk
Factors".

Limited Transferability of the Shares. The Shares have not been registered under
the 1933 Act or the  securities  laws of any state.  The Shares of common  stock
purchased  pursuant to this Offering  will be  "restricted"  shares  because the
shares  are  offered  under  Rule 504 and this  offering  is  excluded  from the
provisions of Regulation D pertaining to restricted shares.  This does not mean,
however,  that a public  market does exist for the Shares.  No market exists now
and none is foreseen . See "Risk Factors" and "Terms of the Offering".

Limitation  of  Liability.  Except for the amounts paid by  Investors  for their
purchase of any Shares,  and as required by Florida  State law, no investor will
be  liable  for any debts of the  Company  or be  obligated  to  contribute  any
additional capital or funds to the Company. See " Risk Factors".

Suitability  Standards.  Each Investor must meet certain  eligibility  standards
established  by the  Company for the  purchase of the Shares.  See "Terms of the
Offering" and "Subscription for Shares".

<PAGE>

Use of Proceeds.  The Company plans to use the money received from this offering
to cover the costs involved with promoting and marketing the Company's  products
and  services  and public  relations.  The funds will not be  deposited  into an
escrow  account and will be  available  to the Company  immediately.  No minimum
amount of Shares is required to be sold.

                                   THE COMPANY

<TABLE>
<CAPTION>
<S>                                         <C>
Exact corporate name:                       CancerOption.com, Inc.
State and date of incorporation:            Florida State
                                            April 17th, 1997.

Street address of principal office:         7332 E. Butherus Drive, Suite 101
                                            Scottsdale, Arizona 85260
                                            (480) 991-8080

Fiscal Year:                                December 31.

</TABLE>

PRODUCTS

The  Company  has  an  online  web  site  www.CancerOption.com,   that  provides
educational  information on different  forms of cancer be researched,  targeting
specific  cancers with  guidelines and products for  alternative  and adjunctive
therapies.  It features the latest research and statistics on cancer  treatments
and immunological disorders including traditional and alternative therapies. The
portal  provides  links with  cancer  clinics and  physicians,  books on cancer,
health,  immunological  disorders and general health,  online newsletter,  links
with  medical  sites and  universities  for  educational  purposes  and specific
formulated nutritional supplements.

MATERIAL CONTRACTS

The  Company  has a  contract  with  Thor  Equity  Group for  investor  relation
services.

MARKETING APPROACHES

The Company expects to market it's portal to doctors,  hospitals, cancer clinics
and special care  facilities,  cancer patients,  health related portals,  cancer
survivors and the general public.

                                  RISK FACTORS

An  investment  in the Shares  involves a high  degree of risk.  No  prospective
Investor  should  acquire the Shares unless he can afford a complete loss of his
investment.  The risks  described  below are those which the Company  deems most
significant  as of the date  hereof.  Other  factors  which may have a  material
impact on the operations of the Company may not be foreseen.  In addition to the
other  factors set forth  elsewhere in this  Memorandum,  prospective  Investors
should carefully consider the following specific risk factors:

<PAGE>

OPERATING RISKS
- ---------------

General

     The economic  success of an  investment in the Shares  depends,  to a large
degree,  upon many factors over which the Company has no control.  These factors
include general economic, industrial and international conditions;  inflation or
deflation;  fluctuation in interest rates; the availability of, and fluctuations
in the money  supply.  The  extent,  type and  sophistication  of the  Company's
competition; and government regulations.

Development  Stage  Company

     The  Company  was  organized  in 1997 and has  engaged in minimal  business
operations.  Accordingly,  the Company is a development stage company as defined
by Statement of Financial Accounting Standards No.7.

Dependence on Key Personnel

     The  Company's  success  will depend,  in large part,  upon the talents and
skills of key  management  personnel.  To the extent that any of its  management
personnel  is unable or refuses to  continue  association  with the  Company,  a
suitable  replacement  would have to be found.  There is no  assurance  that the
Company would be able to find suitable replacements for such personnel,  or that
suitable person.

Lack of Adequate Capital

     Additional capital will be required in the Company's future operations.  In
the absence of any additional funding,  the Company's operations may be affected
negatively. Therefore, the Company's management will be careful and use its best
judgement in directing the affairs of the Company in a manner that maximizes its
chances of success and, accordingly, the best chances of raising future funding.

Inherent Business Risks

     The business that the Company plans to engage in involves  substantial  and
inherent risks  associated with a start-up and development  company with limited
financial resources.

INVESTMENT RISKS
- ----------------

Speculative Investment

     The Shares are a very  speculative  investment.  There can be no  assurance
that the  Company  will  attain its  objective  and it is very  likely  that the
Company will not be able to advance any business  activities and Investors could
lose their entire investments.

Arbitrary Purchase Price; No Market

     The purchase  price for the Shares has been  arbitrarily  determined by the
Company,  and is not  necessarily  indicative of their value. No assurance is or
can be  given  that the  Shares,  although  transferable,  could be sold for the
purchase  price,  or for any amount.  There currently is no market for resale of
the Shares.

Restriction of Transferability

     While the Company  believes that no restriction  exists for the transfer of
the Shares being  offered by the Company,  an  investment in the Shares may be a
long term investment.  Investors who do not wish or who are not financially able
to hold  the  Shares  for a  substantial  period  of time  are  advised  against
purchasing Shares. The Shares are not registered under the 1933 Act or under the
securities  laws of any state,  but are being  offered by the Company  under the
exemption from registration  provided by Rule 504 under Regulation D and related
state and foreign exceptions.

"Best Efforts" Offering

     The Shares are being offered on a "best efforts"  basis by the Company.  No
person or entity is committed to purchase or take down any of the Shares offered
pursuant to this Offering. No escrow account is maintained and no minimum amount
is required to be sold. Funds will be available to the Company upon receipt.

Management and Operation Experience

     The Company's  officers,  directors and other  personnel  have engaged in a
variety of businesses and have been involved in business  financing,  operations
and  marketing,  but their  experience  in these fields is limited.  There is no
assurance that such experience will result in the success of the Company.

Other Risks

     No assurance  can be given that the Company will be successful in achieving
its stated objectives, that the Company's business is undertaken by the Company,
will  generate  cash  sufficient  to operate the business of the Company or that
other parties entering into agreements  relating to the Company's  business will
meet their respective obligations.

Dividends

     The Company's Board of Directors  presently intends to cause the Company to
follow a policy of retaining earnings, if any, for the purpose of increasing the
net worth and reserves of the Company. Therefore, there can be no assurance that
any holder of Common  Stock will receive any cash,  stock or other  dividends on
his shares of Common  Stock.  Future  dividends on Common  Stock,  if any,  will
depend on the future earnings, financing requirements and other factors.

Additional Securities Available for Issuance

     The  Company's  Certificate  of  Incorporation  authorizes  the issuance of
100,000,000  shares of Common Stock.  At this time,  9,789,200  shares of common
stock have been  issued.  Accordingly,  including  those  purchasing  the shares
offered  with the sale of these  units,  investors  will be  dependent  upon the
judgement  of  management  in  connection  with the future  issuance and sale of
shares of the Company's  capital stock, in the event purchasers can be found for
such securities.

<PAGE>

                                 USE OF PROCEEDS

     The Company  will incur  expenses  in  connection  with the  Offering in an
amount  anticipated  not to exceed  $2,000.00 for legal fees,  accounting  fees,
filing fees, printing costs and other expenses.  If the maximum number of Shares
are sold, the Company  anticipates that the net proceeds to it from the Offering
will be as follows:

<TABLE>
<CAPTION>
                                                                         Maximum
Item                                                                 Shares Sold
<S>                                                                  <C>
Gross Proceeds of Offering                                           $320,000.00
Offering Expenses
Cost of Offering                                                       $2,000.00
    TOTAL PROCEEDS RECEIVED:                                         $318,000.00
Operating Expenses
Development of Internet products and services                        $318,000.00
    TOTAL                                                            $318,000.00

</TABLE>

                         NET FUNDS AVAILABLE TO COMPANY

     The Company  estimates  that the costs of the Offering  will be as follows:
(i) legal fees of approximately $1,000.00, (ii) accounting fees of approximately
$500.00  and (iii)  printing  and  other  miscellaneous  costs of  approximately
$500.00.  A sales  commissions will be paid only to NASD  broker/dealers  and no
other person will receive any commissions or remuneration from the Company.

     The net proceeds of this offering,  assuming all the Shares are sold,  will
be sufficient to sustain the planned marketing and development activities of the
Company  for a period of 6 months,  depending  upon the number of Shares sold in
the offering and other  factors.  Even if all the Shares  offered  hereunder are
sold,  the Company will require  additional  capital in order to fund  continued
development activities and capital expenditures that must be made. The Company's
business plan is based on the premise that  additional  funding will be obtained
through  funds  generated  from  operations,  the  exercising of the options and
warrants by  shareholders,  additional  offerings  of its  securities,  or other
arrangements.  There can be no assurance that any securities offerings will take
place in the future, or that funds sufficient to meet any of the foregoing needs
or plans will be raised from operations or any other source.

                            DESCRIPTION OF SECURITIES

     The following  discussion  describes the stock and other  securities of the
Company.

General
- -------

     The Company currently has 100,000,000  authorized common shares,  par value
$.001 per share, of which 9,533,200 common shares were issued and outstanding as
of the date of this  Placement.  All of the  outstanding  common  shares  of the
Company are fully paid for and nonassessable.

<PAGE>

Voting Rights
- -------------

     Each share of the 9,533,200  shares of the  Company's  common stock held by
its current shareholders is entitled to one vote at shareholders meetings.

Dividends
- ---------

     The Company has never paid a dividend and does not  anticipate  doing so in
the near future.

Options
- -------

     The Company currently has no options  outstanding in relation to its common
stock.

Miscellaneous Rights and Provisions
- -----------------------------------

     Shares of the Company's common stock have no pre-emptive rights. The Shares
do not have any conversion rights, no redemption or sinking fund provisions, and
are not liable to  further  call or  assessment.  The  Shares,  when paid for by
Investors,  will be fully paid and  nonassessable.  Each share of the  Company's
common  shares  is  entitled  to a pro rata  share in any  asset  available  for
distribution  to  holders  of  equity  securities  upon the  liquidation  of the
Company.

                              TERMS OF THE OFFERING

     The Company is offering to qualified  investors a maximum of 128,000  Share
(Units) at a purchase  price of $2.50 per share of the  Company's  common stock,
with a warrant that  entitles  the  purchaser  an  additional  common share when
exercised at $2.35 per share on or before August 18th, 2002. The Company may, in
its sole discretion, terminate the offering at any time. The Offering will close
on the earliest of August 31st,  1999 or the election of the Company when all of
the Shares are sold,  in no event  later than  August  31st,  1999.  The minimum
subscription is $2,500.00 (1,000 Shares) per Investor,  although the Company, in
its sole discretion, may accept subscriptions for lesser amounts.

     Terms of Sale : The Company  hereby agrees to sell to the purchaser and the
purchaser  hereby  agrees to  subscribe  for 1,000  units in the  capital of the
Company  (the  "Units")  for a  purchase  price  of  $2.50  USD per  Unit for an
aggregate purchase of $2,500.00 USD (the "Purchase Fund").

     Constitution  of  Shares : Each  Unit will  consist  of one fully  paid and
non-assessable  common share in the capital stock ( the "Share" ) of the Company
and the right to purchase  one share  purchase  warrant ( the  "Warrants" ) with
terms as described below.

<PAGE>

          Terms of Warrants : All Warrants will;


     (a)  be comprised in one warrant certificate ( the "Warrant Certificate" ),
          registered  in the name of the  purchaser,  representing  an aggregate
          number  of  Warrants  which  be  equal to the  number  of Units  being
          acquired hereunder by the purchaser;

     (b)  be non-transferable;

     (c)  will be subject to the terms and  conditions  which are adopted by the
          Company for the Warrants,  which terms and  conditions  will,  amongst
          other things.

          (i)  provide for an adjustment in class and number of shares  issuable
               pursuant to any exercise  thereof upon the  occurrence of certain
               events,    including   any    subdivision,    consolidation    or
               re-classification of the shares, and

          (ii) not provide for any  adjustment in the number of shares  issuable
               pursuant to any exercise  thereof in event of the Company issuing
               any other shares, warrants or options to acquire shares at prices
               either above, at or below the exercise price of Warrants;

     (d)  and each Warrant will provide for the right to purchase one additional
          Share.  The Warrant will be exercised in whole or in part from time to
          time at any time  prior to 4:30 p.m.  (PST) on August  18th.,  2002 at
          $2.35 per Share.

     The Shares are being  offered and sold by the Company  under the  exemption
from  registration  contained  in  Rule  504  under  Regulation  D  and  related
exemptions from state registration requirements. Rule 504 permits the Company to
offer and sell its stock in an amount not  exceeding  $1,000,000 to an unlimited
number of persons.  Until 1992, Rule 504(b)(2)(ii)  imposed a limited disclosure
obligation  of all issuers such as the Company which was intended to ensure that
investors  in a Rule 504  transaction  were  clearly  advised of the  restricted
character  of the  securities  being  offered  for sale.  This  requirement  was
eliminated in July,  1992 at which time the Securities  and Exchange  Commission
adopted an amendment to Rule 504 that  eliminated all  limitations on the manner
of offering of stock  under that rule  and/or the resale of stock  purchased  in
reliance on that rule. Therefore,  following adoption of the 1992 amendment, the
securities  being  offered  and  sold by the  Company  pursuant  to the  present
Offering are available for immediate resale by nonaffiliates of the issuer.

     The Shares are being offered on a "best  efforts"  basis by the Company and
certain expenses of the Offering will be paid from the proceeds of the Offering.
The Company anticipates that such expenses will not exceed $2,000.00 as detailed
in the Use of Proceeds.

<PAGE>

              DIRECTORS, OFFICERS AND KEY PERSONNEL OF THE COMPANY

     Officers and Directors.  The following  information sets forth the names of
the officers  and  directors of the Company,  their  present  position  with the
Company and biographic information:

<TABLE>
<CAPTION>
NAME                                        POSITION                                    HELD SINCE
<S>                                         <C>                                         <C>
Arnold Takemoto                             President, CEO & Director                   March 1999
Michael Quel                                Secretary, Treasurer & Director             April 1999
Dr. Douglas Brodie                          Director                                    April 1999

</TABLE>

Arnold  Takemoto : is the  President,  CEO &  Director.  Mr.  Takemoto  has been
recognized  for  developing  a variety of  scientifically  endorsed  nutritional
augmentation  programs and protocol for patients  exhibiting  chronic  ailments,
tenacious viral conditions,  immune defiencies,  rheumatlogic  illnesses and for
those seeking assistance with sports nutrition.

Mr. Takemoto brings to CancerOption.com his unique and innovative  approaches to
cancer therapies and immunological  support.  His detailed  protocols that he is
currently  implementing as a chemist,  biochemist and nutritionist are the basis
of CancerOption.com's proprietary content. Mr. Takemoto is a chief consultant to
physicians  and  cancer  clinics   worldwide  and  attends   workshops  at  many
international  medical  conferences as a keynote speaker or guest lecturer.  Mr.
Takemoto also co-ordinates clinical studies in adjunctive cancer programs and is
a  innovator  in  complementary  approaches  to heart  disease.  Mr.  Takemoto's
personal  mission  statement is to provide strong  clinical  support for cutting
edge complementary  protocols and facilitate  physicians in their implementation
of cancer  therapies.  This  mission  statement  is the  encompassing  vision of
CancerOption.com.

Michael Quel : is the CFO, Director, Secretary and Treasurer of the Company. Mr.
Quel brings over twenty (20) years of  professional  accounting  and  management
expertise to the Company.  As Chief Financial Officer, he is responsible for the
Company's financial  organization,  operations and internal controls, as well as
researching   all   possible    acquisitions   and   developmental   stages   of
CancerOption.com.

Dr. Douglas  Brodie : is a Director.  Dr. Brodie has over twenty five (25) years
of expertise in the field of both allopathic and complementary cancer therapies,
he has also developed several new protocols for the complementary  management of
cancer as well as highly specialized programs for enhancing the effectiveness of
chemotherapy.  His  research  and  protocols  will  supplement  and  support the
therapies  of Mr.  Arnold  Takemoto  to create  more  concise  content for those
researching cancer therapies.

Dr. Brodie has practiced complementary methodologies,  primarily specializing in
cancer  patients and  individuals  with other  degenerative  diseases,  since he
obtained his medical  degree from the  University  of Michigan in 1972. In 1983,
Dr. Brodie was  appointed by Governor  Richard Bryan to serve on the State Board
of Homeopathic Medical Examiners for the State of Nevada.

<PAGE>

                             PRINCIPAL STOCKHOLDERS

     The following table sets forth information  concerning the shares of Common
Stock of the  Company  owned of record and  beneficially  held as of the date of
this  Memorandum  by (i) each  person  known to the  Company to own of record or
beneficially 5% or more of the 9,533,200  outstanding  shares of Common Stock of
the  Company,  (ii) each  Director of the  Company,  and (iii) all  officers and
directors  of the  Company  as a group,  as of the date of this  Memorandum  and
adjusted  to reflect  share  holdings  after the sale of the  maximum  number of
Shares offered hereby.

<TABLE>
<CAPTION>
Ownership                          No Shares                  %                No Shares         %
Name & Position                    Pre Issue                                   Post Issue
<S>                                <C>                        <C>              <C>               <C>
Arnold Takemoto                    5,000,000                  52.45%           9,789,200         51.1%

</TABLE>

                     REMUNERATION OF DIRECTORS AND OFFICERS

     Directors of the Company who are also  employees of the Company  receive no
additional compensation for their services as Directors. The Company intends, in
the future, to pay Directors who are not employees of the Company,  compensation
of $500 per Director's  Meeting,  as well as reimbursements of any out of pocket
expenses incurred in the Company's behalf.

                                     REPORTS

     The books and records of the Company will be maintained by the Company. The
books of account and records shall be kept at the principal place of business of
CancerOption.com,   Inc.   and  each   shareholder,   or  his  duly   authorized
representatives,  shall  have upon  giving ten (10) days  prior  notice,  access
during  reasonable  business  hours to such books and records,  and the right to
inspect  and copy them.  Within 120 days  after the close of each  fiscal  year,
reports will be distributed  to the  shareholders  which will include  financial
statements  (including a balance sheet and  statements of income,  shareholder's
equity,   and  cash  flows)  prepared  in  accordance  with  generally  accepted
accounting   principals,   with  a   reconciliation   to  the  tax   information
supplementary supplied, accompanied by a copy of the accountant's report.

                                  LEGAL MATTERS

     Gary R.  Blume,  Esquire,  11801  North  Tatum  Blvd,  Suite 108,  Phoenix,
Arizona, 85028 will pass upon certain matters for the Company.

<PAGE>

                                   LITIGATION

     The Company is not presently  involved in any material  litigation or other
legal proceedings.

                             ADDITIONAL INFORMATION

     In the opinion of the Board of Directors of the  Company,  this  memorandum
contains  a fair  presentation  of the  subjects  discussed  herein and does not
contain  a  misstatement  of  material  fact or fail to  state a  material  fact
necessary to make any  statements  made herein not  misleading.  Persons to whom
offers are made will be furnished with such  additional  information  concerning
the Company  and other  matters  discussed  herein as they,  or their  purchaser
representative or other advisors,  may reasonably request. The Company shall, to
the extent such information is available or can be acquired without unreasonable
effort or expense,  endeavour to provide the  information  to such persons.  All
offerees  are  urged  to  make  such  personal  investigations,  inspections  or
inquiries as they deem appropriate.

     Questions or requests  for  additional  information  may be directed to Mr.
Arnold  Takemoto by calling (480)  991-8080.  Requests for additional  copies of
this  Memorandum  or  assistance  in  executing  subscription  documents  may be
directed to the Company.

                       STATE RESTRICTIONS AND DISCLOSURES
                      FOR UNREGISTERED SECURITIES OFFERINGS

NOTICE TO ARIZONA RESIDENTS:

     These securities are being sold in reliance upon Arizona's Limited Offering
exemption from registration pursuant to A.R.S. 44-1844.

     THE  SHARES  OFFERED  HEREBY  HAVE NOT BEEN  REGISTERED  UNDER THE  ARIZONA
SECURITIES  ACT, AS AMENDED,  AND  THEREFORE,  CANNOT BE  TRANSFERRED  OR RESOLD
UNLESS  THEY  ARE  REGISTERED  UNDER  SUCH  ACT  OR AN  EXEMPTION  THEREFROM  IS
AVAILABLE.

     As a purchaser of such securities  hereby represent that I understand these
securities cannot be resold without  registration  under the Arizona  Securities
Act or an exemption  therefrom.  I am not an  underwriter  within the meaning of
A.R.S 44-1801(17), and I am acquiring these securities for myself, not for other
persons.  If qualifying as a non-accredited  investor,  I further represent that
this  investment  does not  exceed  20% of my net  worth (  excluding  principal
residence, furnishings therein and personal automobiles).

<PAGE>

NOTICE TO CALIFORNIA RESIDENTS:

     These  securities  are being sold in  reliance  upon  California's  Limited
Offering Exemption. 25102(f) of the California Code, as amended.

     THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS MEMORANDUM HAS NOT
BEEN QUALIFIED WITH THE  COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA
AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE
CONSIDERATION  THEREFROM PRIOR TO SUCH  QUALIFICATIONS  IS UNLAWFUL,  UNLESS THE
SALE OF SECURITIES IS EXEMPT FROM THE  QUALIFICATIONS BY SECTION 25100, 25102 OR
26105 OF THE  CALIFORNIA  CORPORATIONS  CODE.  THE  RIGHTS  OF ALL  PARTIES  ARE
EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS
SO EXEMPT.

     THE  COMMISSIONER  OF  CORPORATIONS  OF THE  STATE OF  CALIFORNIA  DOES NOT
RECOMMEND OR ENDORSE THE PURCHASE OF THESE SECURITIES.

NOTICE TO COLORADO RESIDENTS:

     THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS  AMENDED,  OR THE  COLORADO  SECURITIES  ACT OF 1981 BY  REASON  OF  SPECIFIC
EXEMPTIONS  THEREUNDER  RELATING TO THE LIMITED  AVAILABILITY  OF THE  OFFERING.
THESE SECURITIES CANNOT BE SOLD,  TRANSFERRED,  OR OTHERWISE  DISPOSED OF TO ANY
PERSON OR ENTITY UNLESS  SUBSEQUENTLY  REGISTERED  UNDER THE  SECURITIES  ACT OF
1933, AS AMENDED,  OR THE COLORADO  SECURITIES ACT OF 1981, IF SUCH REGISTRATION
IS REQUIRED.

NOTICE TO NEW YORK RESIDENTS:

     THIS PRIVATE  PLACEMENT  MEMORANDUM  HAS NOT BEEN FILED WITH OR REVIEWED BY
THE ATTORNEY  GENERAL PRIOR TO ITS ISSUANCE AND USE. THE ATTORNEY GENERAL OF THE
STATE OF NEW YORK HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY
REPRESENTATION OF THE CONTRARY IS UNLAWFUL.

     THIS PRIVATE  PLACEMENT  MEMORANDUM DOES NOT CONTAIN AN UNTRUE STATEMENT OF
MATERIAL  FACT  AND  DOES  NOT OMIT  ANY  MATERIAL  FACT  NECESSARY  TO MAKE THE
STATEMENTS MADE, IN LIGHT OF THE  CIRCUMSTANCES  UNDER WHICH THEY WERE MADE, NOT
MISLEADING.  IT  CONTAINS A FAIR  SUMMARY OF THE  MATERIAL  TERMS AND  DOCUMENTS
PURPOSED TO BE SUMMARIZED HEREIN.

<PAGE>

Purchaser Statement:

     I  understand  that this  Offering  of Shares has not been  reviewed by the
Attorney   General  of  the  State  of  New  York   because  of  the   Offeror's
representations  that this intended to be a non-public  Offering pursuant to the
Regulation D Rule 504 or 505, and that if all of the conditions and  limitations
of Regulation D are not complied  with,  the Offering will be resubmitted to the
Attorney General for amended exemption. I understand that any literature used in
connection  with this Offering has not been  previously  filed with the Attorney
General and has not been reviewed by the Attorney General.  This Investment Unit
is being purchased for my own account for investment,  and not for  distribution
or resale to others.  I agree that I will not sell or otherwise  transfer  these
securities  unless they are registered under the Federal  Securities Act of 1933
or unless an exemption from such  registration is available.  I represent that I
have  adequate  means of providing  for my current  needs and possible  personal
contingencies  of financial  problems,  and that I have no need for liquidity of
this investment.

     It is understood that all documents,  records and books  pertaining to this
investment have been made available to my attorney, my accountant, or my offeree
representative  and myself,  and that,  upon  reasonable  notice,  the books and
records  of the  issuer  will be  available  for  inspection  by  investors,  at
reasonable hours at the principal place of business.

<PAGE>

                                    EXHIBITS

                             CancerOption.com, Inc.

                              SUBSCRIPTION DOCUMENT

1.   The  undersigned  hereby  subscribes  for  166,600  shares of common  stock
     (hereinafter  "Shares"),  as described in the Private  Offering  Memorandum
     dated  August  18th,  1999  ("Memorandum"),  of  CancerOption.com,  Inc., a
     Florida  corporation  (the  "Company"),  being offered by the Company for a
     purchase  price  of  $2.50  per  Unit  and  tenders  herewith  the  sum  of
     $_________________  in  payment  therefor,  together  with  tender  of this
     Subscription Document.

2.   The undersigned  represents and warrants that he is a bona fide resident of
     the State of ______________ .

3    The undersigned acknowledges:

     a.   Receipt of a copy of the Private Offering Memorandum;

     b.   That this subscription, if accepted by the Company, is legally binding
          and irrevocable;

     c.   That the Company has a very limited financial and operating history;

     d.   That the Shares have not been  registered  under the Securities Act of
          1933, as amended,  in reliance upon exemptions  contained in that Act,
          and that the Shares have not been registered under the securities acts
          of any state in reliance upon exemptions  contained in certain state's
          securities laws; and

     e.   That the  representations and warranties provided in this Subscription
          Document  are being  relied  upon by the  Company as the basis for the
          exemption from the registration  requirements of the Securities Act of
          1933 and of the applicable state's securities laws.

4.   The undersigned represents and warrants as follows:

     a.   That the  undersigned  subscriber  is  purchasing  said  Shares  as an
          investment and said Shares are purchased solely for the  undersigned's
          own account.

     b.   That  the   undersigned   subscriber  has  sufficient   knowledge  and
          experience  in financial  and business  matters to evaluate the merits
          and risks of an investment in the Shares;

<PAGE>

     c.   That the  undersigned  subscriber is able to bear the economic risk of
          an investment in the Shares;

     d.   That the  undersigned  subscriber has read and is thoroughly  familiar
          with the Private Offering  Memorandum and represents and warrants that
          he is aware of the high degree of risk  involved in making  investment
          in the Shares;

     e.   That the undersigned  subscriber's  decision to purchase the Shares is
          based  solely on the  information  contained  in the Private  Offering
          Memorandum  and on written  answers to such questions as he has raised
          concerning the transaction;

     f.   That the undersigned subscriber is purchasing the Shares directly from
          the Company and understands  that neither the Company nor the Offering
          is  associated  with;  endorsed  by nor  related  in any way  with any
          investment company, national or local brokerage firm or broker dealer.
          The  undersigned  subscriber's  decision to purchase the Shares is not
          based in whole or in part on any assumption or  understanding  that an
          investment  company,  national or local brokerage firm or other broker
          dealer is  involved  in any way in this  Offering  or has  endorsed or
          otherwise recommended an investment in these Shares.

     g.   That  the  undersigned  subscriber  has  an  investment  portfolio  of
          sufficient  value that he could  suitably  absorb a high risk illiquid
          addition such as an investment in the Shares.

     h.   The  undersigned   further   represents   that  (INITIAL   APPROPRIATE
          CATEGORY):

          [    ] I am a natural  person  whose  individual  net worth,  or joint
               worth with my spouse at the time of purchase, exceeds $200,000;

          [    ] I am a natural person who had an individual income in excess of
               $50,000  or joint  income  with my supose in excess of $50,000 in
               each of the two most recent years and who  reasonably  expects an
               income in excess of those amounts in the current year;

     i.   That  Regulation D requires the Company to conclude that each investor
          has  sufficient  knowledge  and  experience  in financial and business
          matters  as to be  capable  of  evaluating  the merits and risks of an
          investment in the shares,  or to verify that the investor has retained
          the services of one or more purchaser  representatives for the purpose
          of  evaluating  the risks of  investment  in the  shares,  and  hereby
          represents  and warrants that he has such  knowledge and experience in
          financial and business  matters that he is capable of  evaluating  the
          merits  and  risks of an  investment  in the  shares  and of making an
          informed   investment  decision  and  will  not  require  a  purchaser
          representative.

<PAGE>

5.   The  undersigned  understands  and agrees  that this  subscription  is made
     subject to each of the following terms and conditions:

     a.   The   Company   shall  have  the  right  to  accept  or  reject   this
          subscription,  in whole or part, for any reason.  Upon receipt of each
          Subscription  Document, the Company shall have until August 31st, 1999
          in which to accept or reject it. If no action is taken by the  Company
          within  said  period,  the  subscription  shall be deemed to have been
          accepted. In each case where the subscription is rejected, the Company
          shall return the entire  amount  tendered by the  subscriber,  without
          interest;

     b.   That the undersigned  subscriber will, from time to time,  execute and
          deliver such documents or other instruments as may be requested by the
          Company  in  order  to aid  the  Company  in the  consummation  of the
          transactions contemplated by the Memorandum.

6.   The  undersigned  hereby  constitutes  and appoints the Company,  with full
     power of substitution, as attorney-in-fact for the purpose of executing and
     delivering, swearing to and filing, any documents or instruments related to
     or required to make any necessary  clarifying or conforming  changes in the
     Subscription Document so that such document is correct in all respects.

7.   As used herein,  the singular  shall  include the plural and the  masculine
     shall include the feminine  where  necessary to clarify the meaning of this
     Subscription  Document.  All terms not defined  herein  shall have the same
     meanings as in the Memorandum.

     IN WITNESS WHEREOF, the undersigned has executed this Subscription Document
this _____ day of ____________, 1999.

<TABLE>
<CAPTION>
<S>                                 <C>
 Number of Shares                   ___________________
 Total amount tendered              $__________________

</TABLE>

INDIVIDUAL OWNERSHIP:                       ____________________________________
                                               Name  ( Please Type or Print )




                                            ____________________________________
                                               Signature
                                         Social Security Number_________________

<PAGE>

JOINT OWNERSHIP:                            ____________________________________
                                                Name  ( Please Type or Print )

                                            ____________________________________
                                                Signature

                                            ____________________________________
                                                Social Security Number


OTHER OWNERSHIP                             ____________________________________
                                                Name  ( Please Type or Print )

                                            By:_________________________________
                                                  ( Signature )

                                            ____________________________________
                                                     Title


                                            ____________________________________
                                                Employer Identification Number


ADDRESS:____________________________________________________________________
          Street                         City        State            Zip

Phone (Residence)_____________________ ; Phone (Business) ______________________

     I,________________________________,    do   hereby    certify    that   the
representations  made herein  concerning my financial  status are true, and that
all other  statements  contained  herein are true,  accurate and complete to the
best of my knowledge.


Date: ___________________ , 1999.


                                      __________________________________________
                                       Signature

<PAGE>

                             CERTIFICATE OF DELIVERY

     I hereby acknowledge that I delivered the foregoing  Subscription  Document
to _________________ on the _______ day of __________________ , 1999.



                                      __________________________________________
                                      Signature



                                   ACCEPTANCE
                           INVESTOR RELATIONS AGREEMENT
                          ----------------------------

THOR  EQUITY  GROUP,  INC.,  (hereafter  referred to as "Thor")  hereby  agrees,
pursuant to the terms of this agreement (the  "Agreement"),  to provide investor
relation services to Pantheon Technologies, Inc., a Florida Corporation (refered
to herein as the  "Company"),  in order to assist the Company in  obtaining  new
investors  in  the  Company's   stock  and  in  responding  to  inquiries   from
shareholders and the investment community.

SERVICES
- --------

THOR will  provide  various  services  to the  Company  during  the term of this
Agreement  in order to promote the Company and its  business  objectives  to the
investment  conununity.  The  services to be provided by THOR during the term of
this Agreement shall include but not be limited to the following:

Review and analyze  the  Company's  financial  data and  business  plan and make
recommendations  to strengthen the Company's  position in the financial  market:

Introduce market makers and broker-dealers to the Company;

Introduce  investors, potential shareholders,  and other sources of capital to
 the Company;

Advise the Company on matters relating to shareholders relations;

Assist the Company in communica:ting on a regular basis with its shareholders,

Assist the Company with the  distribution  of all press releases to the Business
wire, Dow Jones News service,  Bloomberg News Service, Reuters News Seevice. Fax
broadcast press releases to company shareholders.

FEES
- ----

Set forth below are the fees payable to undertake this eagagement;

Expenses

THOR shall be  responsible  for all of its costs and  expenses  incurred  in the
peformance of its  obligations and  responsibilities  outlined above. If Company
should terminte ths Agreement  without giving THOR 30 day advance notice,  or if
THOR should  terminate this  Agreernent due to Company's  failure to comply with
the terms of this Agreement,  Company shall be responsible for any cost incurred
after notice of said termination.

Additional Expenses

Any  additional  costs  such as  printed  matter,  brochures  for  the  Company;
advertising in financial newspapers, financial newsletters,  magazines, internet
advertising,  mass mailers,  postage,  travel and trade show expenses,  900 toll
free pbone call  services,  or any  additional  expenses  over and above  THOR's
consulting fees shall be at the sole expense of the Company. THOR shall consult

                                     1 of 3
<PAGE>

with the  Company  before  any  decisions  are made  with the  above  referenced
additional costs.

Consulting Fees
- ---------------
Consulting fees are as follows:
100,000 free trading shares of Pantheon Technologies, Inc., Symbol: PTTK

THOR will  provide  various  services  to the  Company  during  the term of this
Agreement  in order to promote the Company and its  business  objectives  to the
investment community.  The Company acknowledges that THOR may use all or part of
these free trading shares to conduct promotional services.

TERMINATION
- -----------

This Agreement shall be month-to-month from the date of execution. The indemnity
and  disclosure  provisions  contained  heron will remain  operative and in full
force and effect after  termination of this  Agreement.  THOR may terminate this
Agreement  upon 30 days  written  notice in the event that the Company  does not
fully cooperate with THOR or THOR determines that the Company's  actions are not
in substantial  compliance with all rules and regulations,  whether local, state
or federal,  provided,  that  Company will have 20 days from the receipt of said
notice to cure any default.

INDEMNIFICATION
- ---------------

Each party to this  Agreement  hereby  agrees to indemnify and hold harmless the
other party and its affiliates,  successors,  directors, officers, employees and
agents from all claims, demands, judgment,  expenses or fees arising out of said
party's good faith and non-negligent performance,  of the duties and obligations
set forth herein.

DISCLOSURE
- ----------

All non-public  written or oral information given to THOR by the Company will be
treated by THOR as  confidential  information and THOR agrees not to make use of
such information other than for the performance of this Agreement, and shall not
disclose  or relase  such  information  other than to: (I) third  parties  while
performing its services  pursuant to this  Agreement,  and (II) the  appropriate
executive  officers of the Company or as directed or permitted by such executive
officers, in writing.

                                     2 of 3
<PAGE>

ENTIRE AGREEMENT, ETC.
- ----------------------

This Agreement sets forth the entire  understanding  of the parties  relating to
the subject matter hereto and  supersedes and cancels any prior  communications,
understandings,  and  agreements  between the parties  relating to such  subject
matter.  This  Agreement  cannot  be  modified  or  changed,  nor can any of its
provision be waived, except by written agreement signed by all parties.

GOVERNING LAWS AND JURISDICTION
- -------------------------------

This  Agreement  shall be governed  by the laws of the State of Arizona  without
regard to the  principles  of conflict of laws.  And or any other state that the
company may incorporate in.

COUNTERPARTS
- ------------

This  Agreement  may be  executed  in  counterparts,  each of which,  when taken
together,  shall  constitute  one  original  document.  The  execution  of  this
Agreement  may be  evidenced  by the  transmission  of  telecopied  or facsimile
signatures, which will have full binding effect.

ARBITRATION
- -----------

Any  controversy,  claim  or  dispute  arising  out of or  resulting  from  this
Agreement,  or the breach thereof that cannot be resolved by negotiation,  shall
be resolved by  arbitration,  to be held in Arizona in accordance with the rules
and regulations of the Americam Arbitration  Association.  Failure of a party to
participate or cooperate  shall  constitute  grounds for default  judgment.  The
arbitrator  shall  award  legal  fees and  costs to the  prevailing  party.  The
decision of the arbitrator shall remain final.



/s/ George E. Mahfouz, Jr.                /s/ Timothy Bullinger
- ----------------------------------        ------------------------------
George E. Mahfouz, Jr.                    Timothy Bullinger
President, Thor Equity Group, Inc.        President, Pantheon Technologies, Inc.
Date: October 13th , 1998                 Date: October 13th, 1998

                                     3 of 3
<PAGE>

     This Subscription is accepted by  CancerOption.com,  Inc., as of the ______
day of ____________________ , 1999.



                                                     CancerOption.com, Inc.



                                             By :_______________________________
                                                     Director



                          INVESTOR RELATIONS AGREEMENT
                          ----------------------------

THOR  EQUITY  GROUP,  INC.,  (hereafter  referred to as "Thor")  hereby  agrees,
pursuant to the terms of this agreement (the  "Agreement"),  to provide investor
relation services to CancerOption.com,  Inc., a Florida Corporation (referred to
herein as the  "Company"),  in order to assist  the  Company  in  obtaining  new
investors  in  the  Company's   stock  and  in  responding  to  inquiries   from
shareholders and the investment community.

SERVICES*
- ---------

THOR will  provide  various  services  to the  Company  during  the term of this
Agreement  in order to promote the Company and its  business  objectives  to the
investment  community.  The  services  to be provided by THOR during the term of
this Agreement shall include but not be limited to the following:

Review and analyze  the  Company's  financial  data and  business  plan and make
recommendations to strengthen the Company's position in the financial market:

Introduce market makers and broker-dealers to the Company;

Introduce investors, potential shareholders, and other sources of capital to the
Company;

Advise the Company on matters relating to shareholders relations;

Assist the Company in communicating on a regular basis with its shareholders;

Assist the Company with the  distribution  of all press releases to the Business
wire, Dow Jones News service,  Bloomberg News Service, Reuters News Service. Fax
broadcast press releases to company shareholders.

FEES
- ----

Set forth below are the fees payable to undertake this engagement;

Expenses
- --------

THOR shall be  responsible  for all of its costs and  expenses  incurred  in the
performance of its obligations and  responsibilities  outlined above. If Company
should terminate this Agreement without  givingTHOR 30 day advance notice, or if
THOR should terminate this Agreement due to Company's failure to comply with the
terms of this  Agreement,  Company  shall be  responsible  for any cost incurred
after notice of said termination'.

Additional Expenses
- -------------------

Any  additional  costs  such as  printed  matter,  brochures  for  the  Company,
advertising in financial newspapers, financial newsletters,  magazines, internet
advertising,  mass mailers,  postage,  travel and trade show expenses,  800 toll


                                     1 of 1

<PAGE>

free phone call  services,  or any  additional  expenses  over and above  THOR's
consulting fees shall be at the sole expense of the Company.  THOR shall consult
with the  Company  before  any  decisions  are made  with the  above  referenced
additional costs.

Consulting Fees
- ---------------

Consulting fees are as follows:
$15,000.00 per month U.S.D.
Due the first day of each month for the tenn of the contract

Upon execution of this agreement  $15,000.00  U.S.D.  is due and payable to Thor
Equity Group, LLC. Once the consulting fees are received the services  contained
herein will commence.

TERMINATION
- -----------

This  Agreement  shall  be  month-to-month  from  the  date of  execution.  The
indemnity and disclosure  provisions  contained herein will remain operative and
in full force and effect after termination of this Agreement. THOR may terminate
this  Agreement  upon 30 days written  notice in the event that the Company does
not fully cooperate with THOR or THOR determines that the Company's  actions are
not in substantial  compliance  with all rules and  regulations,  whether local,
state or federal;  provided;  that Company will have 20 days from the receipt of
said notice to cure any default.

INDEMNIFICATION
- ---------------

Each party to this  Agreement  hereby  agrees to indemnify and hold harmless the
other party and its affiliates,  successors,  directors, officers, employees and
agents from all claims, demands, judgment,  expenses or fees arising out of said
party's good faith and  non-negligent  performance of the duties and obligations
set forth herein.

DISCLOSURE
- ----------

All non-public  written or oral information given to THOR by the Company will be
treated by THOR as confidential information,  and THOR agrees not to make use of
such information other than for the performance of this Agreement, and shall not
disclose or release  such  information  other than to: (1) third  parties  while
perforining its services  pursuant to this  Agreement,  and (II) the appropriate
executive  officers of the Company or as directed or permitted by such executive
officers, in writing.

                                     2 of 2

<PAGE>

ENTIRE AGREEMENT, ETC.
- ----------------------

This Agreement sets forth the entire  understanding  of the parties  relating to
the subject matter hereof, and supersedes and cancels any prior  communications,
understandings,  and  agreements  between the parties  relating to such  subject
matter.  This  Agreement  cannot  be  modified  or  changed,  nor can any of its
provision be waived, except by written agreement signed by all parties.

GOVERNING LAWS AND JURISDICTION
- -------------------------------

This  Agreement  shall be governed  by the laws of the State of Arizona  without
regard to the  principles  of conflict of laws.  And or any other state that the
company may incorporate in.

COUNTERPARTS
- ------------

This  Agreement  may be  executed  in  counterparts,  each of which,  when taken
together,  shall  constitute  one  original  document.  The  execution  of  this
Agreement  may be  evidenced  by the  transmission  of  telecopied  or facsimile
signatures, which will have full binding effect.

ARBITRATION
- -----------

Any  controversy,  claim  or  dispute  arising  out of or  resulting  from  this
Agreement, or the breach thereof, that cannot be resolved by negotiation,  shall
be resolved by  arbitration,  to be held in Arizona in accordance with the rules
and regulations of the American Arbitration  Association.  Failure of a party to
participate or cooperate  shall  constitute  grounds for default  judgment.  The
arbitrator  shall  award  legal  fees and  costs to the  prevailing  party.  The
decision of the arbitrator shall remain final.

/s/ George E. Mahfouz, Jr.                   /s/ Arnold Takemoto
- --------------------------                   ----------------------
George E. Mahfouz, Jr.                       Arnold Takemoto
President, Thor Equity Group, Inc.           President, CancerOption.com, Inc.
Date: 8-31-99                                Date: 8-31-99


                                     3 of 3

                              BLOCK TIME AGREEMENT
                                     between
                        CancerOption.com and ProNet, Inc.

This  Block  Time  Agreement  ("Agreement")  is  entered  into  by  and  between
CancerOption.com,  an Arizona  corporation  ("Company"),  and ProNet,  Inc.,  an
Arizona corporation. The effective date of this agreement is July 27, 1999.

RECITALS

Company  wishes to obtain the  services of ProNet,  Inc. to assist the  Company.
ProNet,  Inc. has negotiated the terms of such an agreement with Company and has
agreed to the terms as set forth hereafter.

AGREEMENT

The Parties hereby agree as follows:

1.   TERM OF AGREEMENT

Company hereby hires ProNet, Inc. and ProNet, Inc. accepts such employment for a
term of one month  commencing  July 27, 1999, and  terminating  August 27, 1999,
unless sooner terminated as hereafter provided.

1.1  GENERAL PROVISIONS

1.1.1  SURVIVAL  OF  AGREEMENT.  This  Agreement  shall not be  terminated  by a
restructuring  of the  CancerOption.com  or of  ProNet,  Inc.  If  either of the
parties restructures but remains in the business, the contract shall survive.

1.1.2 LEGAL REPRESENTATION.  Each party acknowledges that they were advised that
they were  entitled to  separate  counsel  and they have  either  employed  such
counsel or voluntarily waived their right to consult with counsel.

1.1.3 NOTICES.  All notices and other  communications  provided for or permitted
hereunder  shall be in writing and shall be made by hand  delivery,  first class
mail, or faxed, addressed as follows:

CancerOption.com                                    ProNet, Inc.
7332 East Butherus Drive                            2980 E. Northern Avenue
Suite 101                                           Suite B1
Scottsdale, AZ 85260                                Phoenix, AZ 85028
(480) 948-9199                                      (602) 850-0101
(480) 948-4480



<PAGE>



All such notices and communications shall be deemed to have been duly given when
delivered  by hand.  If  personally  delivered;  three (3)  business  days after
deposit in any United  States  Post  Office in the  Continental  United  States,
postage prepaid, if mailed, and when receipt is acknowledged, if faxed.

1.1.5  ATTORNEY'S  FEES. In the event that a dispute arises with respect to this
Agreement, the party prevailing in such dispute shall be entitled to recover all
expenses, including without limitation,  reasonable attorneys' fees and expenses
, incurred in ascertaining such party's rights or in preparing to enforce, or in
enforcing,  such  party's  rights  under this  Agreement,  whether or not it was
necessary for such party to institute suit.

1.1.6 COMPLETE  AGREEMENT OF THE PARTIES.  This is the complete agreement of the
parties  and it  supercedes  any  agreement  that  has been  made  prior to this
agreement.

1.1.7  ASSIGNMENT.  This  Agreement  is of a  personal  nature  and  may  not be
assigned.

1.1.8 BINDING. This Agreement shall be binding both of the parties hereto.

1.1.9 NUMBER AND GENDER.  Whenever the singular number is used in this Agreement
and when  required  by the  context,  the same shall  include  the  plural.  The
masculine  gender shall  include the feminine and neuter  genders,  and the word
"person"  shall  include a  corporation,  firm,  partnership,  or other  form of
association.

1.1.10  GOVERNING LAW. The parties hereby  expressly  acknowledge and agree that
this Agreement is entered into the state of Arizona and, to the extent permitted
by law, this Agreement  shall be construed,  and enforced in accordance with the
laws of the state of Arizona.

1.1.11  FAILURE TO OBJECT NOT A WAIVER.  The failure of a party to object to, or
to take affirmative  action with respect to any conduct of the other which is in
violation of the terms of this  Agreement  shall not be construed as a waiver of
the violation or breach or of any future  violation,  breach or wrongful conduct
until 90 days since the wrongful act or omission to act has passed.

1.1.12  UNENFORCEABLE  TERMS. Any provision  hereof  prohibited or unenforceable
under any applicable law of any jurisdiction shall, as to such jurisdiction,  be
ineffective without affecting any other provision of this Agreement. To the full
extent,  however, that the provisions of such applicable law may be waived, they
are  hereby  waived to the end that this  Agreement  be deemed to be a valid and
binding agreement enforceable in accordance with its terms.

1.1.13  EXECUTION IN  COUNTERPARTS.  This  Agreement  may be executed in several
counterparts and when so executed shall constitute one agreement  binding on all
the  parties,  notwithstanding  that all the  parties are not  signatory  to the
original and same counterpart.





<PAGE>



1.1.14  FURTHER  ASSISTANCE.  From time to time each  party  shall  execute  and
deliver  such fine  instruments  and shall take such  other  action as any other
party may reasonably request in order of discharge and perform their obligations
and agreements  hereunder and to give effect to the intentions expressed in this
Agreement.

1.1.15  INCORPORATION BY REFERENCE.  All exhibits  referred to in this Agreement
are incorporated herein in their entirety by such reference.

1.1.16  CROSS  REFERENCES.  All  cross-references  in  this  Agreement,   unless
specifically  directed to another agreement or document,  refer to provisions in
this  Agreement,  and  shall  not be  deemed  to be  references  to any  overall
transaction or to any other agreements or documents.

1.1.17 MISCELLANEOUS PROVISIONS. The various headings and numbers herein and the
growing of provisions  of this  Agreement  into  separate  divisions are for the
purpose of  convenience  only and shall not be  considered  a part  hereof.  The
language  in all  parts of this  Agreement  shall in all  case be  construed  in
accordance  to its fair  meaning as if prepared by all parties to the  Agreement
and not directly for or against any of the parties.

1.1.18  DELAY OF DUTIES.  ProNet,  Inc.  will not be liable for any delay due to
circumstances  beyond its control  including  work of the  companies  employees,
casualty, or unavailability of access to equipment.

1.1.19  FAILURE TO PAY. In the event that the company  fails to pay any periodic
or  installment  payment due  hereunder,  ProNet,  Inc.  may cease said  support
without breach pending payment or resolution of any dispute.

2.       SERVICES OF ProNet, Inc.

ProNet, Inc. agrees to provide to CancerOption.com the following srevices:

100 hours of strategic  consulting  time to be used  throughout the term of this
agreement. 80 hours of web design and development time to be used throughout the
term of this agreement.

Proxy items for strategic consulting hours will be as follows:

Technology  review of current  Cancer  Options Web Site, as listed in Apendix A:
Risk Analysis Proposal under section headed  "Technology  Risks",  consideration
especially  given to  possibility  of relocation  with a new ISP and site backup
strategies. A report will be provide ddemonstrating the findings of the review.

Any remaining strategic  consulting time will be given to the items listed under
the "Internet Business Model Risks" section of Appendix A: Risk Analysis.

Priority Items for web design and development will be as follows:



<PAGE>



Carefully review the homepage of the  CancerOptions.com  site and present design
alternatives to choose between Implement the final design choice.

Evaluate site as a whole and make changes as required.

2.1  SUBCONTRACTORS.  ProNet,  Inc. may at its discretion engage  subcontractors
"John Max" and "Julie Bonaduce" to perform work hereunder, provided that ProNet,
Inc. will pay said  subcontractors  and in all instances remain  responsible for
proper completion of this contract.

2.2 HOURS.  ProNet,  Inc. upon completion of the Block Time hours will charge at
the rates of two hundred  dollars an hour for  strategic  consulting,  and sixty
dollars per hour for design and development.

3.       NECESSARY SERVICES

3.1  PERFORMANCE  OF  DUTIES.  ProNet,  Inc.  agrees  that  he  shall,  and  any
subcontractor's  work shall be performed by  individuals  authorized  to perform
such work. This work will entail at all time faithfully,  industriously,  and to
the best of their ability,  experience  and talents,  all of the duties that may
reasonably  be assigned to them  hereunder  and,  shall  devote such time to the
performance of such duties as may be necessary therefor.

4.       COMPENSATION

In consideration for the services required of ProNet,  Inc.  hereunder,  Company
agrees to compensate ProNet, Inc. as follows.

4.1 PAYMENT.  Company  shall pay to ProNet,  Inc. the sum of  $24,800.00  in two
parts:  $12, 400.00  immediately upon signing this contract,  $12,400.00 15 days
after signing this contract.

4.2 EXPENSE  REIMBURSEMENT.  The Company shall  reimburse  ProNet,  Inc. for any
out-of-pocket  expenses,  to  include  but not  limited  to,  parts &  supplies,
hardware, software, cable, etc., incurred in connection with the negotiation and
execution of this Agreement and the performance of services  required of ProNet,
Inc. hereunder.

5.       INDEPENDENT CONTRACTOR

In performing services and duties hereunder,  ProNet, Inc. and any person acting
on ProNet's  behalf shall do so as independent  contractors and are not, and are
not to be deemed,  employees or agents of Company or any other person  acting on
behalf of Company  ProNet,  Inc.  shall be  responsible  for  meeting  any legal
requirements  imposed on ProNet,  Inc.  or any person  acting on his behalf as a
result of this Agreement,  including but not limited to the filing of income tax
returns and the payment of taxes and ProNet,  Inc.  agrees to indemnify  Company
for the  failure  to do so, if  Company  is  required  to make any such  payment
otherwise due by ProNet, Inc. or any such person acting on ProNet's behalf.


<PAGE>



6.       REMEDY FOR BREACH

Company  and  ProNet  agree  that they  shall  attempt  to  settle  any claim or
controversy  arising out of this agreement through  consultation and negotiation
in the spirit of mutual  friendship and cooperation.  If any such attempt should
fail, then the dispute shall first be submitted to a mutually acceptable neutral
advisor having expertise in the area of the dispute for initial fact finding and
mediation.  Neither  party shall  unreasonably  withhold  acceptance  of such an
advisor,  and  selection  of such an advisor  shall be made within 45 days after
written notice by one of the parties for such fact findings and  mediation.  The
cost of such fact finding and mediation, and of all other subsequent alternative
dispute  resolution  agreed  upon by the  parties,  shall be shared  equally  by
Company and  ProNet.  Any dispute  which the parties  cannot so resolve  between
themselves in good faith within six months of the date of the initial  demand in
writing by either party for such fact finding  shall be finally  determined by a
court within Maricopa County, Arizona.

7.       TERMINATION

7.1 CAUSES FOR TERMINATION.  This Agreement shall terminate immediately upon the
occurrence of any one of the following events.

7.1.1    The expiration of the term hereof;

7.1.2    The written agreement of the parties;

7.1.3. The occurrence of circumstances  that make it impossible for the business
of the Company to be continued;

7.1.4 The occurrence of  circumstances  that make it impossible for the business
of ProNet, Inc. to be continued;

7.1.5 ProNet's breach of his duties hereunder, unless waived by Company or cured
by ProNet,  Inc.  within 10 days after  Company's  having given  written  notice
thereof to ProNet, Inc.

7.1.6 Company's breach of its duties hereunder, unless waived by ProNet, Inc. or
cured by Company within 30 days after ProNet, Inc.'s having given written notice
thereof to Company.

7.2 COMPENSATION UPON TERMINATION.  Unless otherwise  mutually agreed in writing
by the parties,  the  termination  of this Agreement due to any cause other than
that specified in subsection  7.1.4 shall not relieve  Company of its obligation
to make any proper  payment of money  which would have been  required,  or could
have been required by ProNet,  Inc.,  pursuant to Sections 4.1, 4.2, and 4.3, if
this Agreement had not been so terminated.

IN WITNESS  WHEREOF,  the parties have executed this Agreement on the date first
written above.



<PAGE>


CancerOption.com:


/s/
- ------------------------------------




ProNet,Inc.

/s/ Jonathan S. Teets
- ------------------------------------
Jonathan S. Teets




ADNet International
4514 Chamblee Dunwoody Road, Suite #239                     INVOICE
Atlanta, GA. 30338
770-936-8308 Fax 770-220-7302
                                                                INVOICE NO: 2935
                                                             DATE: April 7, 1999

<TABLE>
<CAPTION>
<S>          <C>          <C>           <C>          <C>           <C>


To:     Pantheon Technologles, Inc              Ship To:
        7332 East Butherus, Suite #101                      N/A
        Scottsdale, AZ 85250

Salesperson  P.O. Number  Date Shipped  Shipped Via  F.O.B. Point  Terms
- -----------  -----------  ------------  -----------  ------------  -----
M. Henserson N/A          N/A           N/A          N/A           Upon Receipt

</TABLE>
<TABLE>
<CAPTION>
<S>             <C>                                 <C>             <C>

QUANTITY        DESCRIPTION                         UNIT PRICE      AMOUNT
- --------        -----------                         ----------      ------
One             Custome website, incorporating all                  $19,775.00
                articulated components, pursuant
                to Addendum-A dated April 7, 1999,
                attached hereto and made a part of
                this agreement by regerence hereof.


                Due this invoice: One half (1/2)of
                engagement fee                                      ($9,887.50)
</TABLE>

                                   PAID
                                   ----
                                 1007-4-8-99

Make all checks payable to: ADNet International
If you have any questions concerning this invoice, call: Michael Henderson,
770-936-8308

               THANK YOU FOR YOUR BUSINESS!
<PAGE>

                                   Addendum-A
                                   ----------

This Addendum-A in consideration  of the mutual promises made herein,  is made a
part of, by reference hereto.  Invoice #2935, dated April 7, 1999 by and between
ADNet International, hereinafter known as ADNet International, hereinafter known
as "ADNet",  and Pantheon  Technologies,  hereinafter  known as  "Pantheon"  for
construction,  delivery and  publication  of an Internet  website to include the
following specifications, described as follows:

1. Overview - The website will feature custom  graphics and  incorporation  of a
custom logo,  with custom  navigation  elements all produced and optimized for a
28.8 kbps delivery to the consumer. We may find it necessary to incorporate some
stock photography in certain areas to augment a professional look and feel.

We expect to use limited  animation,  if desired , to facilitate fast load times
and a straightforward delivery of copy and navigational element grouping to make
the website intuitively understandable. We assume all copy, graphics, and photos
are to be delivered in a digital format.

All  Pages  will  have  all  contact   information   for   www.cancerchoice.net,
prominently displayed, including phone, fax, e-mail, and physical address.

(Page Layout: This is not a final layout sequence but identifies the information
that  we  believe  is  minimally  required  to make an  effective  and  complete
presentation.)

     Home Page

This page will  contain an "opt-in"  e-mail  newsletter  or product  information
subscription  form that captures minimal prospect  information.  The sign-up may
activate a series of prepared  automated  e-mail messages and "calls to action",
delivered to the prospect over a  pre-determined  successive time schedule.  The
system is designed to capture more  demographic  and  psychographic  information
about the prospect.

Alternatively,  this can be used as a "front end" e-mail  capture and newsletter
delivery  system,  with all  contact  information  captured  in a  database  for
proactive e-mail follow-up.

The Home Page will have, as a minimum, the following navigation elements:

About Us
Research
Supplements,
Moderated Forum
Investor Relations
Testimonials
Affiliate Programs Signup (Optional)
Links page
Special offers
FAQ's
For the Press (Press release archive)
Online Privacy Statement, Guarantee, Shipping and Disclaimers
Newsletter archive
Contact us

>    About Us - Company  profile  featuring  longevity  or history  of  company,
     founder bio and photograph,  mission  statement,  benefits to the consumer,
     and core philosophy.

>    Research - A page that can be updated  daily with current  information  and
     links to the latest  technological  breakthroughs  in cancer and healthcare
     developments.   This  page  may  be  segmented   into   defined   areas  of

<PAGE>

     concentration,  depending on the  frequency of  available  information  and
     should  link  to  the  exact   information   pages  presenting  the  latest
     information.

Note: We suggest that all pages  requiring an updating  function shall be of the
Active  Edit style page or be  accessed  through  an  administrative  module for
continious   updating.   The  Active   Edit  page  demo  can  be   accessed   at
www.activecredit.com  with User Name:  cars,  and Password:  demo.  The software
allows for  unlimited  editing and updating in plain text or HTML,  and supports
graphic uploads  without  disturbing the "look and feel" of the page, and can be
accessed remotely from any location in the world, provided the user has Internet
access.

The pages are generally  constructed  with  "password  protection"  so that only
designated employees have access.

> Supplements - A nutritional product supplement line of products presented in a
"shopping cart" for consumer purchase

The shopping cart will be initially  populated with approximately  10-15 of your
most  popular  products.  They  will be  displayed  with a  thumbnail  photo and
description  that will  "blow-up"  to  accentuate  the  product  detail and some
detailed product description that describes the benefit for the malady.

Consumers are generally  motivated to make Internet  purchases  because  product
discounts   are   offered   over   the   full   retail   purchase   price   (see
www.mothernature.com  or  www.greentree.com).  In  addition,  since the Internet
purchase is often an "impulse buy",  some "express"  shipping  options should be
offered.  If  offered,  we suggest a hypertext  link to the vendor s  "tracking"
page,   i.e.,  UPS  or  Federal   Express.   Shipping  costs  will  have  to  be
pre-determined  presumably based on weight, as well as selection of the shipping
vendor.

In addition, sales tax options need to be identified, depending on the State of
residency of the consumer.

The shopping  cart will allow  management  to add,  replace,  or update text and
graphics  through an  administrative  module for on-site changes.  Further,  all
purchases will be handled  through a secure order form, and it is suggested that
the credit card clearing be  represented  through an  established  vedor such as
Fleet Bank, or  equivalent.  This will add to the  credibility  and integrity of
your offering and convey an additional touch of security for the consumer.

> Moderated Forum - Designed as an open forum to allow the focused discussion of
cancer related products, topics,  treatments,  etc. from the general public. You
will be provided an  administrative  area for  moderating  the  postings,  etc.,
behind a password protected area.

> Investor  Relations  - This area will  highlight  detailed  information  about
Pantheon   Technologies   public  stock   offering,   possibly  with  historical
performance,  current pricing, and links to new announcements or press releases.
You may offer  additional  general  stock market  information,  on the page,  or
provide it through a service  provider,  to encourage repeat  visitation.

You may also wan to provide an "opt-in" box for the  prospect to requet  written
information about the company.

>  Testimonials  - Selected  testimonial  copy form  consumers who have received
specific benefits from the products,  and/or, a tribute to the customer service,
professionalism, or expertise of the Pantheon Technologies staff.

<PAGE>

> Links - An updateable page (again Active Edit0, featuring links to affinity
websites, recognized vendors, information sources, etc. The links should be
catogorized and contain a descriptive comment or endorsement of the linked page
that you are reccommending.

> Special Offers - An "Active Edit" style page(s) allowing your key staff to
update the information with new product or special pricing, on a timely basis.

> FAQ's - A series of  questions  and  answers  designed  to shorten the product
sales cycle by providing concise information in an easy to read format.

> For the Press - A repository for all of Pantheon Technologies press releases,
presented in decending chronological order.

> Online Privacy Statement, Guarantee, Shipping and Disclaimers - An area that
insures that the information captured from the consumer will be held in strict
confidence and privacy.  Also, you can present your product guarantees in a
narrative fashion.

Additionaly, any disclaimers and/or company proprietary consent statements and
copyrights can be addressed here.

> Newsletter Archive - An area of archived newsletters,  available by individual
date and subject.  The archive may be password protected,  allowing only viewers
entry who have provided you with additional concise demographic or psychographic
information.

> Contact Us - A static form page requiring the user to complete certain minimal
information for direct contact by the company. We prepare this form so that upon
successful  input,  and  depressing  the "send"  button the prospect  receives a
custom  "Thank  You" form and an  immediate  confirmation  of the receipt of the
inquiry in their e-mail box.

2. Deliver Time: We estimate  approximately  six (6) weeks for complete delivery
of the website, commencing from date of full delivery of all materials.

3. Cost  Estimate:  We estimate a total cost for this portion of the proposal at
$19,775, including training.

Payment  Terms:  Payment  terms are 50% down upon initial  engagement,  25% upon
first  publication  (where  the  preliminary  website  is  posted on the web for
initial edit and review) and 25% upon final publication.

4.  "Pantheon"  will  deliver  all copy,  text and photos in digital  format for
inclusion in the website.

5.  The  foregoing  attempts  to  outline  the  scope of the  agreement  without
precluding  either  party from  verbal or written  modifications  to same,  with
sufficient  notice,  either in written or verbal  form,as is  necessary  for the
satisfaction of the customer, within the scope of ADNet's ability to perform.

     Dated this 8th day of April, 1999

   ADNet International                       Pantheon Technologies


   By: ________________                      By: /s/ Arnold Takemoto
                                                 ---------------------------
                                                  Arnold Takemoto, President


                               SUBLEASE AGREEMENT
                           Between TEG/Thor Equity LLC
                                       And
                             CancerOption.com, Inc.

Lease of Premises:

7332 E. Butherus Drive
Suite 101
Scottsdale, AZ 85260
Square Feet: 1513 office space

Base Rent: $2,,681.36
Year 2 and Year 3 minor increase in base rent

Commencement Date: April 1, 1999
Expiration Date: March 31, 2002
Tenant has the option to extend the aforementioned lease an additional 3
years at prevailing market rates

/s/ George E. Mahfouz, Jr.                   /s/ Arnold Takemoto
- --------------------------                   ------------------------
George E. Mahfouz, Jr.                       Arnold Takemoto, President
TEG/Thor Equity Group LLC                    CancerOption.com


4-14-99                                      4-14-99
- -------                                      -------
Date                                         Date



<TABLE>
<CAPTION>
<S>                                <C>                 <C>            <C>         <C>
PANTHEON TECHNOLOGIES, INC.               SHAREHOLDER LIST                        PAGE: I
                                          AS OF 04/27/99                          FORM: 10A
                                                                                  DATE; 04/27/99
                                                                                  TIME: 14:03:15

REGISTRATION                       ACCOUNT NO.         TAXPAYER ID    SERIES         SHARES
- ------------                       -----------         -----------    ------         ------
SAN L. ARNOLD                      PA0020                              C             2,000
9441 BEVERLY ST                                                                      ------
BELL HOWER CA 90706                                                    TOTAL         2,000

HELEN AUSTIN                       PA0125                              C           210,000
739 W FLINT ST                                                         W           210,000
CHANDLER AZ 85224                                                                  .......
                                                                       TOTAL       420,000

CHARLES AUSTIN                     PA0126                              C           190,000
739 W FLINT ST                                                         W           190,000
CHANDLER AZ 85224                                                                  -------
                                                                       TOTAL       380,000

CEDE & CO                          PA0115                              C           744,000
                                                                                   ........
                                                                       TOTAL       744,000

CHUAN-NA CHANG                     PA0085                              C             2,000
208 WEST 41ST AVE                                                                    -----
VANCOUVER, B.C. V5Y 2E4                                                TOTAL         2,000

LANCE DUSANJ                       PA0130                              W             7,500
61 WEST 61ST AVE                                                                     -----
VANCOUVER SC                                                           TOTAL         7,500
V6H IY7

GEORGIA PACIFIC SEC                PA0133                              C             2,000
STE 1600 TWO BENTALL CENTRE                                                          ......
555 BURRAND ST                                                         TOTAL         2,000
VANCOUVER SC V7X 1S6

DUSTIN GOWITT                      PA0096                              C             1,000
11416 78 AVE                                                                        ......
DELTA, B.C. V4C IN9                                                    TOTAL         1,000

HERDEV S RAYAT                     PA0122                              C           190,000
7890 E DESERT COVE RD                                                              .......
SCOTTSDALE AZ 85260                                                    TOTAL       190,000

RODNEY L. KIEFFER                  PA0135                              C               500
RD. 3, BOX 3388A                                                                      .....
HOUSTON PA 19540                                                       TOTAL           500

KIRKLAND CAPITAL SA                PA0117                              W           175,000
PO BOX 170 FRONT ST                                                                -------
CHURCHILL BLGD                                                         TOTAL       175,000
GRAND TURK TCI

</TABLE>
<PAGE>
<TABLE>
<CAPTION>
<S>                                <C>                 <C>            <C>         <C>

PANTHEON TECHNOLOGIES, INC.               SHAREHOLDER LIST                        PAGE: 2
                                          AS OF 04/27/99                          FORM: 10A
                                                                                  DATE: 04/27/99
                                                                                  TIME: 14:03:15

REGISTRATION                       ACCOUNT NO.         TAXPAYER ID    SERIES         SHARES
- ------------                       -----------         -----------    ------         ------
ROB KOZAK                          PA0033                              C             2,000
1103-9595 ERICKSON OR                                                                ------
BURNABY, B.C. V3J 2N9                                                  TOTAL         2,000

LION EXPLORATIONS LTD              PA0036                              C            20,000
P.O. BOX 120, FRONT ST                                                              .......
GRAND TURK                                                             TOTAL        20,000
TURKS & CAICOS

GEORGE MAHFOUZ JR                  PA0123                              C           205,000
1003 E REDFIELD DR                                                     W           205,000
SCOTTSDALE AZ 85260                                                                -------
                                                                       TOTAL       410,000

PAULA MAHFOUZ                      PA0124                              C            30,000
1003 E REDFIELD DR                                                     W           200,000
SCOTTSDALE AZ 85260                                                                .......
                                                                       TOTAL       230,000

MOGRARI TRADING & MARKETING, INC.  PAOOQl                              C             1,500
464 BEATRICE ST LANE                                                                 .....
PORT MOODY, B.C. V3N 2Y8                                               TOTAL         1,500

PAUL MURPHY                        PA0006                              C             1,000
6435 CAMBIE ST                                                                      ......
VANCOUVER, B.C.                                                        TOTAL         1,000

PACIFIC INT SEC                    PA0110                              C             1,000
1900-666 9URRARD ST                                                                  .....
VANCOUVER BC                                                           TOTAL         1,000
V6C 3Nl

JASSVIR S RAYAT                    PA0120                              C           150,000
7890 E DESERT COVE AVE                                                 W           190,000
SCOTTSDALE AZ 85260                                                                .......
                                                                       TOTAL       340,000

KUNDAN S RAYAT                     PA0121                              C           150,000
$131 HIGHGATE ST                                                       W           150,000
VANCOUVER BC                                                                       .......
CANADA VSR 3G2                                                         TOTAL       300,000

HARMEL RAYAT                       PA0132                              C            20,000
5131 HIGHGATE ST                                                       W            20,000
VANCOUVER BC                                                                        ......
V5R 3GZ                                                                TOTAL        40,000

HERDEV S RAYAT                     PA0136                              W           190,000
7590 E DESERT COVE AVE                                                             .......
SCOTTSDALE AZ 85260                                                    TOTAL       190,000

</TABLE>
<PAGE>
<TABLE>
<CAPTION>
<S>                                <C>                 <C>            <C>         <C>

PANTHEON TECHNOLOGIES, INC.               SHAREHOLDER LIST                        PAGE: 3
                                          AS OF 04/27/99                          FORM: 10A
                                                                                  DATE: 04/27/99
                                                                                  TIME: 14:03:05

REGISTRATION                       ACCOUNT NO.         TAXPAYER ID    SERIES         SHARES
- ------------                       -----------         -----------    ------         ------

RAYMOND B SCHOOLEY                 PAG040                              C              2,000
P.O. BOX 463010                                                                       -----
ESCONDIDO CA 92046                                                     TOTAL          2,000

SHEFFIELD MANAGEMENT LTD           PA0119                              C            100,000
PO BOX 135 FRONT ST                                                    W            100,000
CHURCHILL BLDG                                                                      -------
GRAND TURK TCI                                                         TOTAL        200,000

ARIAN SONEILI                      PA0129                              W              2,500
16436 GLENNSIDE CT                                                                    -----
SURREY BC                                                              TOTAL          2,500
V4N IV7

SOLA MANAGEMENT SA                 PA0116                              W            175,000
101 EAST HILL Ft MRKT STN N                                                         ........
NASSAU BAHAMAS                                                         TOTAL        175,000
PO BOX M-10850

ARNOLD TAKEMOTO                    PA0137                              R          3,000,000
                                                                                  .........
                                                                       TOTAL      3,000,000

WARINDER THOULI                    PA0131                              W             10,000
9-1525 BEAR CREEK RD                                                                 .......
KELOWNA OC                                                             TOTAL         10,000
V7Y 1A5

VILLA HOLDINGS                     PA0118                              C            341,600
PO BOX 61 FRONT ST                                                     W            341,600
CHURCHILL BLDG                                                                      ........
GRAND TURK TCI                                                         TOTAL        653,200

ROBERT F. VIZCARRA                 PAGO18                              C              1,000
514 E. SAXTON AVE                                                                    ......
SAN GABRIEL CA 91776                                                   TOTAL          1,000

RODGER WIST                        PA0127                              R          2,000,000
739 W FLINT ST                                                                    ---------
CHANDLER AZ 85224                                                      TOTAL      2,000,000

</TABLE>
<PAGE>

<TABLE>
<CAPTION>
<S>                                       <C>                                     <C>

PANTHEON TECHNOLOGIES, INC.               SHAREHOLDER LIST                        PAGE: 4
                                          AS OF 04/27/99                          FORM: 10A
                                                                                  DATE: 04/27/99
                                                                                  TIME: 14:03:05
REPORT SELECTION CRITERIA
 ...........................
CLASS          : Common
SERIES         : ALL
MIN. SHARES    : 1

STATE          : ALL
ENTITY         : ALL
</TABLE>
<TABLE>
<CAPTION>
<S>                     <C>                     <C>


COMMON SERIES R            SHARES               SHAREHOLDERS
                           ------               ------------
This Criteria           5,000,000                          2
All Other                       0                          0
                        ---------               ------------
TOTALS                  5,000,000                          2


COMMON SERIES C            SHARES               SHAREHOLDERS
                           ------               ------------
This Criteria           2,366,600                         23
ALL Other                       0                          0
                        ----------              ------------
TOTALS                  2,366,600                         23

COMMON SERIES W            SHARES               SHAREHOLDERS
                        ---------               ------------
This Criteria           2,166,600                         15
ALL Other                       0                          0
                        ---------               ------------
TOTALS                  2,166,600                         15

</TABLE>

                     BERENFELD, SPRITZER, SHECHTER & SHEER

                          CERTIFIED PUBLIC ACCOUNTANTS

              A Reliable Partner in Today's Demanding Marketplace

In  today's  economic  climate,   businesses  and   professionals   face  fierce
competition in an ever-changing  financial environment.  Effective management of
their  financial  matters is  essential if their  businesses  are to survive and
grow.

Berenfeld,  Spritzer, Shechter & Sheer is a progressive accounting firm with the
highest  standards of  professional  excellence,  managed by an experienced  and
diversified executive team.

Why has Berenfeld, Spritzer, Shechter & Sheer grown and retained clients through
generations of ownership? Because of our focus on personal attention. We believe
strongly in the value of responding individually to our clients' needs. That has
made us a reliable partner in today's demanding marketplace.

Berenfeld, Spritzer, Shechter & Sheer combines the best attributes of both large
and small firms. We provide financial,  tax and accounting services for domestic
and foreign clients.  We help them harness the power of computers.  In addition,
we provide additional  services in the area of litigation  support,  mergers and
acquisitions,  divestitures,  estate planning and personal financial matters. We
don't force a choice  between  quality  and  affordability.  We offer  clients a
cost-efficient  perspective  on all projects.  We also offer  clients  something
unique.

                                A Global Network

Berenfeld,  Spritzer,  Shechter & Sheer is one of a limited number of accounting
firms in the United  States,  and the only firm in Florida,  that is  affiliated
with  the  London-based  International  Association  of  Practicing  Accountants
(IAPA).  This professional  network gives us access to strategic support in such
areas as marketing analysis,  regulatory  compliance and taxation throughout the
world.

                            Solutions For The Future

Berenfeld,  Spritzer, Shechter & Sheer believes in long range planning, creative
hard  work,  and  prudent  but  progressive   solutions  for  its  clients.  Our
broad-based,  cost-efficient  and flexible  capabilities have earned the kind of
trust that permits clients to concentrate on their own opportunities for growth.

Accounting is a service industry. Our profession demands attention to detail.The
detail  that  sets  us  apart  is  our  personal  and  relentless  dedication to
our clients.

<PAGE>

                            ACCOUNTING AND AUDITING

Berenfeld, Spritzer, Shechter & Sheer provides a full range of core services for
businesses  and  professionals,  large and small.  We help our  clients  develop
strategies  that  focus  on  growth,  not  survival.   Consistent  with  prudent
accounting  practices,  we provide  financial details that are both accurate and
understandable.  We respond  with the highest  degree of integrity as quickly as
possible. And always, Berenfeld,  Spritzer,  Shechter & Sheer excels at personal
attention to client needs.

 Accounting and Write-up Services

 Audit and Review of Financial Statements

 Compilation Services for Small Businesses

 Design and Installation of Accounting and Inventory Control Systems

                                    TAXATION

Berenfeld,  Spritzer,  Shechter & Sheer is uniquely prepared to help control the
tax costs of businesses  and  individuals.  We focus on new  solutions,  not old
problems.  We determine the best legal alternatives for today's  complicated tax
laws. We help out clients manage the impact of change.

 Personal, Corporate, Partnership and Fiduciary Tax Returns

 Payroll and Sales Tax Returns

 Intangible and Tangible Property Tax Returns

 Estates, Trusts and Charitable Matters

 Tax Planning and Projections

                       COMPUTER-BASED ACCOUNTING SERVICES

Berenfeld,  Spritzer,  Shechter  & Sheer can help  improve  the  efficiency  and
productivity  of your firm with our,  Computer  Services  Department.  We design
computer-based  accounting and information  systems that more effectively manage
payroll, inventory, production, sales, marketing and customer service. We advise
clients on the proper selection of accounting programs, utilities,  productivity
software  and  other  computer-related  solutions.  Where  appropriate,  we will
install these programs for the client,  provide instruction and deliver on going
support.

 Computer-based Accounting and Information Solutions

 Individual Assessment and Design of Client Systems

 On-site Installation and Instruction

 On-going Support as Business Grows
<PAGE>

                             INTERNATIONAL TAXATION

Our clients  represent  the  diversity  of the  Florida  economy:  products  and
services,  leisure and travel,  health care,  creative arts and real estate.  An
ever-increasing  base of  clients is  represented  by  foreign  individuals  and
corporations  who wish to begin or develop a presence in the United  States.  We
can offer special experience and resources for the foreign investor.

Our membership in the International Association of Practicing Accountants (IAPA)
gives clients the advantage of our affiliation with colleagues  throughout North
America, South America, Europe, the Far East and Australia.

 U.S. Tax Return Preparation for International Operations

 Financial Services for Offshore Corporations

 Tax Planning for Foreign Investments in the U.S.

 Tax Returns for U.S. Expatriates and Resident and Non-Resident Aliens

 Inter-Company Pricing Issues

                              ADDITIONAL SERVICES

Non-accounting  and tax matters  increasingly  are important to individuals  and
corporations.  Growing,  managing and disposing of financial  resources requires
skilled and  knowledgeable  attention  to small  details.  Berenfeld,  Spritzer,
Shechter & Sheer can help clients in many matters associated with their business
and  personal  lives.  As with  our  other  services,  we  provide  professional
assistance, flexible response and close personal attention.

 Litigation Support

 Business Plans

 Custom-Tailored Management Reporting Programs

 Retirement and Financial Planning

 Family Tax Matters

 Real Estate Sales and Acquisitions

 Feasibility Studies
<PAGE>

                                    PARTNERS

LAWRENCE J. BERENFELD, C.P.A.

        The founding partner, Larry started the firm in the late 1960s. Prior to
that,  he served  four years in the  United  States Air Force and went on to the
University of Florida,  where he graduated  with a Bachelor of Science degree in
Business  Administration.  Larry brings more than 35 years of  experience in all
aspects of tax and  accounting  with  concentrations  in  construction  and real
estate  development.  Within the firm, he is the  administrative  partner and is
responsible  for  the  implementation  and  management  of the  quality  control
procedures. His interests include sports, travel, cooking and photography.

MICHAEL SPRITZER, C.P.A.

        Mike joined the firm in 1972. He received his Bachelor of Science degree
in  Accounting   from  Brooklyn   College  and  a  Masters  degree  in  Business
Administration  from the University of Michigan.  Before joining the firm,  Mike
worked  with a Big  Six  accounting  firm  and  later  was  employed  by a large
international financial institution in Geneva, Switzerland. Mike represents many
foreign  based  investors  and  businesses,  as well as U.S.  clients  who  have
established businesses overseas. His community activities include volunteer work
for the Union of American Hebrew  Congregations  and the South Dade Board of the
Greater Miami Jewish Federation.

PHILIP J. SHECHTER, C.P.A.

        A Miami native,  Phil Shechter,  has been  practicing  accounting  since
1982,  when he received his Bachelor of Science  degree in  Accounting  from the
University of Florida.  Phil manages the firm's small  business  department  and
heads the litigation  division.  He has extensive experience in the travel and I
leisure  industry.  He is also the partner in charge of estate tax  planning and
systems analysis.  In his free time, Phil volunteers for  organizations  such as
the Coconut Grove Chamber of Commerce and the Miami Children's  Hospital. A past
president of the Miami Sundown Rotary Club, he spends each Thanksgiving  cooking
and sharing dinner at the Catholic Home for Abused Children.

EMERY B. SHEER, C.P.A.

        Born and raised in Pennsylvania, Emery holds a degree in Music Education
with  graduate  studies  in  Opera  Performance  at  Boston  University.  He has
completed graduate studies in Accounting and Taxation at the University of Miami
and  Florida  International   University.   With  particular  expertise  in  the
entertainment   industry,  his  client  list  includes  performing  artists  and
non-profit  organizations.  Emery  is an  active  member  of both  the  American
Institute  of Certified  Public  Accountants  and Florida Institute of Certified
Public Accountants,  where he served as president of the South Dade Chapter. His
wife is an accomplished violinist,  having toured with such celebrities as Frank
Sinatra and Rod Stewart. Emery enjoys basketball, singing and skiing.

MARC A. BERENFELD, C.P.A.

        Marc graduated from the University of Florida with a Bachelor of Science
degree in Accounting in 1985 and joined the firm shortly thereafter.  He manages
the firm's  common  interest  realty  associations  and  management  information
systems divisions. Marc has extensive background in litigation support services,
real  estate   accounting,   computer  systems  and  condominium  and  homeowner
associations. He serves on the Common Interest Realty Associations  committee of
the Florida  Institute of Certified Public  Accountants.  In his free time, Marc
volunteers  as the  head  basketball  coach  of the  Dave & Mary  Alpers  Jewish
Community  Center's varsity basketball team and for the Coconut Grove Chamber of
Commerce. Marc also enjoys playing basketball and other team sports, cooking and
reading.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission